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ABSTRACT 
 The single largest cause of compound attrition during drug development is due to 
inadequate tools capable of predicting and identifying protein interactions. Several tools have 
been developed to explore how a compound interferes with specific pathways. However, these 
tools lack the potential to chronically monitor the time dependent temporal changes in 
complex biochemical networks, thus limiting our ability to identify possible secondary signaling 
pathways that could lead to potential toxicity. To overcome this, we have developed an in silico 
neuronal-metabolic model by coupling the membrane electrical activity to intracellular 
biochemical pathways that would enable us to perform non-invasive temporal proteomics. This 
model is capable of predicting and correlating the changes in cellular signaling, metabolic 
networks and action potential responses to metabolic perturbation. 
The neuronal-metabolic model was experimentally validated by performing biochemical 
and electrophysiological measurements on NG108-15 cells followed by testing its prediction 
capabilities for pathway analysis. The model accurately predicted the changes in neuronal 
action potentials and the changes in intracellular biochemical pathways when exposed to 
metabolic perturbations. NG108-15 cells showed a large effect upon exposure to 2DG 
compared to cyanide and malonate as these cells have elevated glycolysis. A combinational 
treatment of 2DG, cyanide and malonate had a much higher and faster effect on the cells. A 
time-dependent change in neuronal action potentials occurred based on the inhibited pathway. 
We conclude that the experimentally validated in silico model accurately predicts the changes 
in neuronal action potential shapes and proteins activities to perturbations, and would be a 
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powerful tool for performing proteomics facilitating drug discovery by using action potential 
peak shape analysis to determine pathway perturbation from an administered compound.  
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CHAPTER-1: INTRODUCTION 
1.1. Proteomics 
A good understanding of the factors affecting disease progression is essential for 
commencing treatments and making therapeutic monitoring decisions. The study of disease 
progression in humans has been accomplished through several approaches as listed in Figure 1 
and includes genomics, transcriptomics and proteomics.  
 
Figure 1: Biochemical contexts of different studies for disease progression  
Deoxyribonucleic acid (DNA) contains all the necessary information required to build and 
maintain the cell. Great progress has been made to understand the structure of a DNA in 
identifying the genetic abnormalities caused in a specific disease condition [1]. Genes are 
expressed in varying combinations and nearly 21,000 genes have been identified and 
sequenced [2]. The complete set of DNA in a single cell of an organism is referred to as genome. 
Genomics is the study of structure and function of genomes. DNA transcribes into ribonucleic 
acid (RNA), followed by translation into a protein.  
All genome sequences are now available and researchers are trying to determine the 
molecular and functional properties of each gene to understand the role of gene products in 
complex biological processes. The transcriptome is the set of all RNA molecules that include 
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messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding 
RNA produced in the cells. The analysis of mRNA has become popular in recent years [3]. 
Several methods such as serial analysis of gene expression and DNA microarray technology are 
applied. However, the quantification of mRNA does not reflect the cellular proteins. Several 
factors including pH, hypoxia and drug administration define the expression and activity of 
proteins. The proteins interact and work in conjunction to maintain a functional biological 
system. Cells respond to stimuli by regulating the level and activity of cellular proteins the cell 
responds to any stimuli. Cellular processes are mediated through a large network of protein-
protein interactions that are spatially and temporally regulated in the cell. A poor correlation 
has been shown between mRNA and protein expression levels [4]. 
Proteomics is the study of the expression, function and interactions of proteins in the 
proteome on a large scale [5]. The term proteomics was coined by Marc Wilkins during the 
1990’s, redefining the thought process of a biological working system. Proteomics offers a 
comprehensive analysis of a specific proteome, including abundances, variations and 
modifications in order to understand cellular processes. The phenotype of the cell is 
determined by the proteins that carryout cellular activities [6]. Each protein such as the 
membrane receptor, ion channel, transcription factor, kinases or chaperones has a specific 
function. Malfunction of the definitive proteins is the major cause of disease and serves as an 
indicator for the disease. Proteins are also the primary targets for several drugs [6]. Therefore, 
a logical step is to study the structure and functional properties of the working parts of the 
biological systems at different levels. Such a study would provide a comprehensive global 
comparison between different cell types, tissues, organs and the entire organism. More 
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importantly the study of proteomics enables us to grain a deeper insight into the mechanism of 
disease progression which could eventually help in developing a therapy. 
Proteome is the expressed protein complement of a genome and represents the subset of 
all the gene products. A proteome is more complex than a genome, since any protein that is a 
product of a single gene can exist in multiple forms in the same cell or different types of cells 
due to post translational modifications. A proteome may vary with time and cellular 
requirements. For example, exposure of a cell to elevated temperatures causes an increase in 
expression of heat shock proteins. These changes affect the structure and function of the 
proteins. The survival of the cells is dictated by the gene expression and activity of their 
corresponding proteins. The proteome of the cell can comprise all the different forms of 
proteins and is complicated to study. Protein metabolism, the production and degradation of 
proteins is responsible for regulating the rate of cellular processes. Proteins after synthesis 
undergo major biochemical changes due to post translational modifications. Proteins are also 
involved in the energy metabolism networks in a cell. The life time and expression of proteins 
also varies, as some proteins may rapidly degrade, are only expressed in certain situations or a 
few may even last for a life time [7]. Proteins are synthesized and released into the cytosol or 
other compartments from the ribosomal machinery.  There are two major mechanisms by 
which cells degrade proteins, namely, the lysosome and the proteasome.  The degradation of 
cytosolic and nuclear proteins occurs within the proteasomes. In lysosome degradation, the 
entire protein enters the lysosome, followed by protein disassembly and degradation. The 
proteasome mechanism, unlike the lysosome system, is equipped to achieve metabolic balance. 
The rate of protein synthesis is determined by factors such as the amount of messenger RNA 
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(mRNA) and the rate of degradation by ubiquitination. Both lysosome and proteasome 
mechanisms are irreversible and do not respond to the rate of mass action kinetics of their 
products [7]. Posttranslational modification (PTM) is a step in protein biosynthesis where 
polypeptide chains undergo folding, cutting and other processes before becoming an active 
mature protein. Protein phosphorylation is a PTM of proteins in which a serine, a threonine or a 
tyrosine residue is phosphorylated by a protein kinase by the addition of a covalently bound 
phosphate group. Protein phosphorylation regulates protein functions by turning the control 
on/off during cell cycle, cellular signaling cascades and other cellular processes [1]. Proteins 
undergo wear and tear upon exposure to free-radicals and other biological agents leading to 
protein damage. External factors including environmental agents such as radiation, chemicals 
and drugs can lead to protein modification followed by inactivation. It is critical to maintain a 
balance between protein synthesis and degradation. The steady state of the cell reflects the 
ratio of the equilibrium constant between these two processes. Wheatley et al. has shown that 
30 - 90% of all proteins are defective and improperly folded even after transferring to the 
endoplasmic reticulum [8]. When a change in the protein concentration occurs, either due to 
altered physiological process or an onset of a disease condition, a new steady state 
concentration is achieved by the cell [7]. 
The human genome project led to the classification of proteins encoded by the human 
genome and enabled the classification of genes based on their functions [2].  Table 1 lists the 
classification of proteins into functional categories based on human genome. The expression of 
different genes is required for the synthesis of different proteins in different functional 
categories. Proteins associated with intermediary and nucleic acid metabolism account for 
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about 15% of proteins in the proteome. 
Table 1: Classification of proteins into functional categories based on human genome 
Functional category % Genes Functional category % Genes 
Cell adhesion 1.9 Ion channel 1.3 
Hydrolase 4.0 Motor 1.2 
Carrier protein 0.7 Structural 1.0 
Transcription factor 6.0 Protooncogene 2.9 
Nucleic acid enzyme 7.5 Calcium binding 0.1 
Signaling molecule 1.2 transporters 1.7 
Receptor 5.0 Immunoglobulin 0.9 
Kinase 2.8 Extracellular matrix 1.4 
Regulatory molecule 3.2 Cytoskeletal 2.8 
Transferase 2.0 Chaperone 0.5 
Synthase 1.0 Lyase 0.4 
Oxidoreductase 2.1 Ligase 0.2 
Isomerase 0.5 Intracellular transporter 1.1 
Miscellaneous 4.3 Unknown 41.7 
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The proteins involved in protein synthesis and turnover are about 15-20%. The signaling and 
DNA binding proteins constitute 20-25% of the proteins. Around 41.7% of the function of the 
genome is still unknown and determining their functionality is a challenge. It is important to 
identify and quantify huge variations in the protein profiles that are observed in different cell 
types. 
Proteomics focuses on the interactions between multiple proteins as a part of a large-
scale analysis and should be performed at a much higher level [1].The information from the 
functional characterization of a proteome will help us gain new insights into biology and 
medicine. Recent advances in the development of proteomic tools have allowed the evaluation 
of systemic changes in protein expression in responses to perturbations to a biological system 
[5]. In addition, proteomic biomarkers deliver a more reliable result when compared to 
traditional biomarkers since multiple interacting protein species are evaluated simultaneously 
in response to metabolic perturbation [5]. Proteomics is applied to characterize the behavior of 
the entire system rather than a single protein. Proteomics is a potential tool for drug discovery 
with an inception to identify novel biomarkers. 
1.2. Applications of proteomics 
Proteomics technology is advancing rapidly and could revolutionize our fundamental 
understanding of how a cell ‘works’ by identifying the responses to both internal and external 
stimuli. The major applications of proteomics are performing mining, profiling including steady 
state determination, mapping interaction and identifying protein modifications/functions [1]. 
These applications enable scientists to perform pathway analysis which involves examining 
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thousands of proteins simultaneously involved in several pathways. 
Protein mining is the identification of all the proteins present in the sample followed by 
cataloging to determine how levels have changed in an experiment. Protein mining is 
performed to resolve numerous proteins and uses tools such as mass spectrometry (MS) in 
combination with software to determine the identity of the protein. Several approaches, each 
offering a set of advantages, have been adapted for protein mining and build a database. By 
combining the database and software tools, the protein of interest could be studied which 
otherwise could only be achieved by performing gene-expression analysis [1]. 
The largest application of proteomics is in profiling protein expression. Protein profiling 
facilitates the identification of the state of proteins in a biological sample or a cell exposed to 
physical/chemical stimuli and is mainly performed to compare the states of proteins in healthy 
vs. diseased cells. Protein profiling is an advanced form of protein mining and the obtained 
information could lead to identification of drug targets. Protein profiling is mostly conducted by 
employing two dimensional gel electrophoresis (2D-GE). Cancer proteomics relies on protein 
profiling to compare the transformed and non-transformed cells directly. Many novel tumor 
biomarkers and clues for cancer development have been identified. Protein profiling has been 
performed on several tissues such as breast, bladder, esophageal and prostate [3]. Protein 
microarrays are now widely used and are the fastest method to profile a protein. 
Mapping the protein-protein interactions enable us to understand how protein 
interactions occur in living systems. The study of protein-protein interactions allows us to 
simultaneously assess the status of all the proteins in a pathway. Most of the cellular processes 
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occur in close association with other proteins. The process of cell growth, cell death and cell 
cycle are all regulated by signaling pathways through protein complexes. The interactions 
between protein networks dictate cellular functions such as cellular signaling and metabolic 
pathways. A majority of information has been obtained by performing in-vitro studies using 
single and purified proteins with a yeast two-hybrid system. Most proteomic techniques offer 
the ability to characterize multiple proteins interactions by pairing them. Multiple protein 
complexes have been identified and their role in cellular pathways has been determined. 
Protein-protein interaction is one of the most resourceful and demanding application of the 
pharmaceutical industry. 
Identification of protein modifications allows us to map the structural and functional 
changes in proteins. Proteins undergo PTM in response to extracellular and intracellular signals. 
In addition, exposure to environmental hazards generates reactive species that may modify 
proteins. MS is a powerful tool for analyzing protein modifications. Antibodies are widely used 
for detecting protein modifications but with this method the precise sites where the 
modifications occur cannot be determined. Simultaneous characterization of the modified 
regulatory proteins during a signaling cascade is important. Analysis of protein function is 
performed to understand the molecular mechanisms underlying the biochemical process 
occurring in the cell. It includes the study of how proteins interact with other compounds or 
metabolites. The interactions of proteins occur at multiple stages such as with a single pathway, 
whole cells, tissues or an entire organism [9]. It is important to understand all these functions 
as several disease conditions arise as a consequence of alterations in protein functions. 
Furthermore, all the physiological functions such as signaling networks, energy production and 
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consumption of the cells are dependent upon the activity of the proteins. 
1.3. Tools for proteomics 
 Several tools have been developed to systematically characterize and obtain a 
comprehensive profile of the functions in biological systems. Biochemical assays have 
reproduced some of the cellular pathways outside the cell but do not address the interactions 
with the myriad of other pathways within the cell [10]. Early stages of proteomics have heavily 
relied on biochemical assays but it is a very low throughput technology. Biochemical assays 
were also involved in studying gene regulation, especially the interactions between nucleic 
acids and proteins [11].  
Imaging using high-throughput microscopic screening instruments have generated a 
large set of images by incubating cells with one or more fluorescent probes [12]. However, it is 
a difficult task to derive the patterns that link the generated images back to the biochemical 
reactions. Although fluorescent probes have supplied a wealth of information, they suffer from 
several draw backs such as toxicity due to photobleaching and triggering a cascade of signaling 
pathways due to the interaction of the probe with cellular proteins or metabolites. Live cells 
when exposed to an excitation light may be subjected to photodynamic effect, causing cellular 
damage by direct contact with molecular oxygen [13]. The optical resolution affected by the 
noise and photobleaching could alter the image quality leading to altered intracellular protein 
levels. Imaging is a powerful tool with high resolution and even small objects are identified. 
However, the images needs to be interpreted carefully as few images could be exaggerated and 
may not appear according to scale [13]. 
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 MS is the workhorse for performing proteomics and offers high sensitivity to detect 
digested or intact proteins [14]. Current modifications allow targeting the protein modification 
of interest such as phosphorylation, oxidation and ubiquination [15]. MS requires the proteins 
or peptides to be in gas phase for analyzing them. MS is used to detect and quantify proteins in 
biological matrix but is not yet capable of separating the complex protein mixtures from the 
unprocessed biological matrix [16]. Matrix assisted laser desorption/ionization (MALDI) is 
employed where the sample is dissolved into a matrix followed by exposure to laser [3]. The 
major advantage of MALDI is that no purification of the sample in 2D-gel is required to separate 
the proteins. A disadvantage of MALDI is that the matrix aids ionization and desorption when 
hit with a short laser pulse and can also cause a drift in the protein mass. 
2D-GE is widely used and allows the separation of numerous proteins in a single 
experiment. 2D-GE can also determine the extent of a proteins expressions and changes in their 
expression levels from sample to sample. Several drug targets have been identified employing 
2D-GE technique. Separated proteins may be identified using MS or by using antibodies.  A 
multidimensional 2D-GE offers an advantage over the traditional gel electrophoresis by 
allowing the separation of several samples in a single experiment by comparing the controls 
with the diseased samples [15].  As an alternative to 2D-gel for protein quantification, isotope-
coded affinity tags (ICAT) have been developed. ICAT relies on labeling proteins obtained from 
different sources with chemicals of different isotope composition. The application of different 
labels allows quantifying the difference using a mass spectrometer. The ICAT method also 
enables the detection of low concentration of proteins. The major drawback of profiling using 
the ICAT method is that the proteins must contain cysteine residues and these must be spaced 
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far enough apart for the proteases to cleave them. Liquid chromatography (LC) has advanced in 
the recent years and offers an advantage of separating proteins in the liquid phase. LC can be 
coupled to MS (LC-MS) for identifying and further characterizing the sample. The volume of 
sample required for LC is in the nanoscale, making it more useful to do proteomics in a 
microfluidic device. The major disadvantage of LC is that during the separation of small 
volumes, the flow rates are restricted [15].  
Protein microarrays (PMAs) are powerful tools for capturing and measuring multiple 
proteins in a high throughput fashion for the study of potential biomarkers but are expensive 
[16]. In this method, cells are typically lysed and exposed to protein arrays along with specific 
antibodies. PMAs are designed specifically to ‘catch’ the protein of interest and characterize it. 
PMAs can be used in combination with other approaches to identify a specific protein. The 
changes in protein concentrations, modifications and interactions can all be studied using 
PMAs. Another major advantage of PMAs is that a specific set of proteins such as all the 
mitochondrial proteins can be targeted for analysis [15]. 
Nanoproteomics (NP) addresses the current limitations in selectively reaching a target 
protein in vivo by applying physical and biological barriers to detect low concentration targets 
[17]. NP offers rapid and miniaturized assay, real time analysis, low sample consumption and 
high sensitivity. However, the toxicity and biocompatibility of these techniques needs to be 
studied further [18]. 
Several reagents such as antibodies have been developed and characterized to improve 
proteomics but are limited to capturing and detecting a specific protein. Many other methods 
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such as immunoblotting, analytical ultracentrifugation, surface plasma resonance (SPR) and 
circular dichrosim are also employed to perform proteomics [15]. All these tools are excellent 
and powerful to perform proteomics but are incompetent to chronically monitor the 
interactions non-invasively.  
1.4. Challenges in proteomics 
 The biggest challenge for proteomics lies in the proteome’s complexity. A single gene 
encodes multiple proteins. The human genome contains 21,000 protein encoded genes that 
generate an estimated 250,000 to one million different proteins in a human cell [19]. The 
genome is a static blueprint of a cell whereas the proteome is dynamic and dependent on 
varying extracellular stimuli [20]. PTM leads to protein variability, causing different expression 
profiles and polymorphism that makes it difficult to detect [16]. The isolated proteins during 
cellular interactions must be in their native forms for an accurate analysis. In spite of the 
availability of several new advanced technologies, detection of low levels of proteins in a 
complex biological mixture still remains a challenge. Few eukaryotic cells have a low to high 
protein ratio of 1:106, making it difficult to analyze and track the changes in the sample. Also, it 
is difficult to identify transcription factors, protein kinases and regulatory proteins as they are 
expressed in low number. Further purification or extractions methods may be employed to 
isolate the protein of interest from the proteome [3]. Also, certain protein extraction and 
separation techniques are skill-based and remain difficult to automate [21]. 
Most of the methods including 2D-GE or performing biochemical assays are not high-
throughput. Performing an MS may require a substantial amount of time for data acquisition, 
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processing and analysis [3]. Quantification of hundreds of proteins can be achieved by 
performing MALDI time-of-flight MS (MALDI-TOF MS) but not all proteins in the sample can be 
detected, yielding a low-resolution analysis. A higher resolution of the sample can be obtained 
by using a MS/MS but it would require significant time and resources to interpret data. 
Performing a wide dynamic range of analysis has been another limitation of MS/MS [19]. Most 
of these systems are invasive, thereby activating other signaling pathways which lead to cellular 
apoptosis. Moreover, these systems detect only the end-point, cost ineffective, lack the 
capability for chronic monitoring of cellular functions interactions and are limited to the 
pathways being analyzed. Instead, a study of the entire biological system as a single entity is 
necessary and would provide profound insights. 
1.5. Systems biology driven proteomics 
Systems biology employs a centralizing approach to characterize biological systems, where 
the interactions described mathematically to establish a computable model. Systems biology 
aims to increase our understanding and predicting the behavior of a biological system. The key 
utilities of model building are (1) to organize information from different sources into a cohesive 
model, (2) to determine what species and interactions play a vital role a specific pathway of 
interest or the entire cell, (3) identification of new inter-dependencies on cellular process and 
(4) to learn all the quantitative features on a large scale. System biology based tools are now 
widely used to perform drug discovery due to the physiological relevance of results and the 
ability to perform high content screening. These tools aid in analyzing cellular pathways 
providing a deeper understanding of several biochemical processes including metabolic 
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pathways [22]. 
Most biological systems behavior cannot be limited to a single molecule or pathway instead 
they result due to the interactions occurring at different levels among different cellular 
compartments. Modeling of the reconstructed system, if possible at different levels, would 
allow performing simulations and predicting hypothesis. The earlier stages of the developed 
systems could be small containing few proteins representing a signaling pathway and 
eventually lead to a whole-cell model [23]. Since systems biology is hypothesis driven, the 
model is validated by perturbations and validating with the experimental datasets. A dynamic 
analysis of the changes in the model enables the identification of changes in protein activity. In 
modeling biological systems, cellular networks are divided into signaling, regulatory and 
metabolic that responds to perturbations and alters cellular activities.  Currently, a biological 
system is best characterized using metabolic models [24]. The basis of reconstruction and 
development of cellular networks is well documented and have also received much interest. 
Analysis of these networks can be aimed at performing a quantitative or qualitative analysis 
[25]. For example, a boolean network can be implemented to perform quantitative and kinetic 
models for quantitative analysis of cellular signaling pathways.  
Proteomics was identified as an essential discipline for building precise network models 
[23]. Proteomic analysis and Systems Biology have come closer during the past decade and 
present a promising approach to unveil functions of proteins in complex cellular networks. 
Proteomic analysis by employing systems biology would be a powerful tool. It has become 
obvious that protein analysis needs to be performed on a large- scale as the rate of drug 
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attrition has increased. The complex dynamics of proteins makes it difficult to study. Proteins 
are the actual effectors for maintaining cellular hemostasis by driving the cellular pathway and 
cannot be simply be studied by looking at a gene, mRNA or in fact a single protein. A large 
amount of experimental data is being generated using several tools such as PMAs, imaging and 
LC-MS/MS [24]. The data obtained from all the proteomic tools can be integrated into a single 
system for further analysis. Proteomic tools can be applied to study the protein-protein 
interactions and protein functions as a result of perturbations in biological process on a large 
scale. Most of the limitations and challenges of the proteomic tools could be addressed by 
coupling existing tools and data to systems biology driven models. However, none of the 
current standalone tools or tools coupled to systems biology can monitor the cellular pathways 
or the dynamic changes that a protein undergoes in response to perturbations [23]. 
1.6. Motivation 
A system capable of determining temporal profiles of living cells to perturbations of a 
compound as it interacts with a cell over a period of time providing a rich set of information 
that could be captured non-invasively would be beneficial [26,27]. Such system would provide 
insight into the mechanistic details of cellular pathways, predict the response of proteins 
interactions in cellular systems to multiple perturbations beyond those from which models are 
derived and guide the design of perturbations for a desired response. Tools based on 
monitoring the state and activities of the excitable cells are frequently used to quantify the 
physiological responses to external stimuli [28,29].  
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Neurons exhibit an action potential (AP) that gives complex information about the 
internal/external environment of excitable cells. The AP shape contains a significant amount of 
information, as it is dependent on concerted action of ion channels located on cell membrane 
that are tightly regulated by receptors and intracellular messenger systems [30,31]. Ion 
channels are regulated by all common intracellular mechanisms including phosphorylation and 
second-messenger dependent systems [32] as intracellular ions play the significant role of 
second messengers in cells [33]. The membrane electrical activity is highly dependent on the 
state, physiology and pathophysiology of the cells [34].  The AP generation and shape are 
determined by Na+, K+, Ca2+, ATP, other second messenger dependent channels and pumps [35-
37]. Calcium [38], sodium [39], and potassium [40] channel modulators have been shown to 
affect the shape of cellular action potentials [27].  
Cellular metabolism and membrane electrical properties are tightly integrated. The 
changes in AP are characteristic to the biochemical pathway affected by chemical or biological 
entities [26,27,41]. Deconvolution is the quantitative determination of underlying ionic currents 
of AP which would not only enable the detection of altered pathways but also potentially 
differentiate compounds with different mechanisms of actions [27,41]. Cellular 
electrophysiology is the gold-standard technique for measuring ionic currents of an excitable 
cell and the electrical components in the cell membrane, including primary ion channels. The 
information obtained from the system is highly complex in nature and needs to be 
deconvoluted using an in silico tool to gain a deeper understanding on the dynamics of the 
physiological processes [26].  
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1.7. Previously developed models 
Previously developed models of cellular pathways in cells have been effective in 
modeling pathways and enhancing drug discovery. Techniques for network modeling of cellular 
pathways span a wide spectrum of complexity. Models of signaling pathways have been 
reconstructed by combing and analyzing information available in the public domain, including 
DNA sequence data, protein sequence data, literature, pathways recorded in public databases, 
gene expression data, mass spectrum data and metabolic profiles. However, these networks 
often have delivered several false positives or false negatives due to noise and incomplete data. 
The great majority of cell models were also tailored towards one or two specific cell 
activities, mostly carbon flux, respiration, signaling, gene activation and electrophysiology. 
Computational models incorporating ion channels to represent whole-cell AP models relate the 
changes in membrane potential to the sum of inward and outward ionic currents. They typically 
consisted of 10-70 differential equations with multiple parameters. Gleeson et al. introduced 
NeuroML, which offers a multilayer approach of electrophysiological features from individual 
cells with selected ion channels to morphologically reconstructed multi-compartment neurons 
forming networks with others [42].  However, the modeled neurons were limited to their 
electrophysiological function since metabolic events were not included. Lewis et al. modeled 
complex signaling interactions between astrocytes and motor neurons by including metabolic 
pathways for each cell type [43].  Zhou et al. published their comprehensive work on the 
electrophysiological activity of cardiac myocytes and influences of the mitochondrial TCA cycle 
[44]. Masson et al. explored the link between electrical activity and insufficient metabolic 
energy by merging the classical Hodgkin-Huxley conductance model [45]. Their model provided 
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theoretical basis to study the dependence of cellular bioenergetics on membrane electrical 
activity. The metabolic model was not detailed enough to perform analysis of cellular pathways. 
Cortassa et al. developed a computational model by integrating cardiac electrophysiology, 
contraction and mitochondrial bioenergetics to obtain a greater insight into their interactions 
and dependencies [46]. The model lacked the detailed glycolytic and pentose phosphate 
pathway along with the deconvolution module to predict the responses of action potentials.  
Experimentally validated models have already been developed which are coupled to the 
electrophysiological properties of the cell membrane to complex intracellular pathways [47,48]. 
These models have been used to predict the physiological changes in the intracellular 
mechanisms such as gene expression, activation of secondary messenger systems and 
phosphorylation [49]. Several publications from leading groups in systems biology are all 
extraordinary milestones towards large-scale and whole-cell modeling. A first ‘real’ whole-cell 
model of Mycoplasma genitalium was built by combining all the molecular components to 
study the unexplored cellular behavior [50]. However, experimentally validated computational 
models including all major functions and organelles of mammalian cells, especially neurons, are 
currently not available.  
A popular way to develop more complex and comprising models is to extend existing 
pathway models with further reactions and species or in some cases the combination of two or 
more existing models. The latter approach comes with challenges as the employed models 
were usually proposed by different groups, which used different time frames, units, and often 
worked with pathways of different cell types if not species. In our previous work, we have 
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demonstrated the use of neuronal cells as sensor elements for toxin detection [27,41]. The 
interrupted AP showed differences we believe could vary depending upon the pathway being 
inhibited by a compound, protein or gene.  
1.8. Objectives of dissertation 
The objective of this dissertation is to develop and experimentally validate an insilico tool 
that would predict action potential time-series by enabling chronic monitoring of intracellular 
networks and intracellular proteins activities.  
To achieve the aforesaid objectives the following tasks have been performed 
1. The basal metabolism of NG108-15 cells has been determined by performing 
biochemical measurements. 
2. The NG108-15 cellular metabolic model was reconstructed and experimentally validated 
by employing the biochemical measurements.  
3. A neuronal module for deconvolution of neuronal action potentials was constructed and 
the electrophysiological parameters were extracted.  
4. The effects of inhibition of cellular proteins involved in energy producing metabolic 
pathways were evaluated by measuring the biochemical and electrophysiological 
changes in NG108-15 cells. 
5. A coupled neuronal-metabolic model including the sub-cellular compartment was built 
to generate a series of action potentials followed by predicting the changes in 
intracellular ion concentrations and protein activities. 
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6. An experimental validation of neuronal-metabolic model was performed by simulating 
multiple scenarios of inhibiting cellular proteins involved in cellular bioenergetic 
pathways for predicting protein activities and action potential time-series. 
7. An in-depth analysis of predicted temporal activities of cellular proteins during 
metabolic perturbations was carried out to evaluate the model predictive capabilities. 
1.9. Dissertation outline 
This dissertation describes development and experimental validation of neuronal 
metabolic model. 
Chapter 2 provides the theory behind the cellular metabolic pathways and general 
approach for model development is discussed. The ionic basis of membrane electrical 
properties, cellular electrophysiological techniques and the theory behind Hodgkin-Huxley 
model are explained.  
Chapter 3 describes the experimental methods employed in measuring the effects 
metabolic inhibitors. This chapter includes details of the modifications of surfaces, cell culture, 
biochemical assays and patch clamp electrophysiology protocols that were utilized. 
Chapter 4 illustrates the development of neuronal-metabolic model. The coupling of 
different intracellular pathways including the metabolic reactions was explained. The chapter 
also includes the reconstruction and a detailed description of biophysical components involved 
in neuronal module. The integration of both the modules followed by methodologies employed 
for parameter estimation is described. The chapter also included a detailed description on how 
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experimental conditions were simulated 
Chapter 5 provides a discussion on the results obtained from the model. The basal 
metabolic properties of NG108-15 cell are presented. The calibration of model to steady state 
using the experimental data is explained. The deconvolution of action potentials to extract the 
ion channel parameters has been described in detail. Also, a discussion on how the neuronal-
metabolic model was simulated to steady state and perturbations induced were estimated is 
provided. The experimental validation of simulated results for all the drugs and drug 
combinations including the characteristic analysis of action potential time series data is 
presented. The predicative capabilities of the model are demonstrated in this chapter. 
Chapter 6 concludes the dissertation by outlining the outcomes from the model and the 
future work involved in developing the model is discussed in detail. 
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CHAPTER-2: THEORY 
 
In this chapter the cellular metabolism and membrane electrical properties were reviewed. 
An understanding of the fundamental theory behind the biochemical and biophysical 
interactions occurring during cellular function is a prerequisite. The core cellular pathways 
involved in energy metabolism followed by describing the basics of modeling and kinetic 
analysis are presented. The second half of the chapter describes the characterization of 
membrane electrical properties following the description of the measurement techniques and 
their mathematical basis. 
2.1. Cellular Metabolism 
Cellular metabolism plays a vital role in cellular functions. The metabolic reactions can be 
categorized into two broad categories, namely degradation and synthetic pathways. The 
biochemical reactions occurring in a pathway are organized, localized and regulated in a cell 
[51]. The rates of intracellular enzymes i.e., regulatory proteins dictate cellular activities. The 
protein activities are modified in a cell to maintain a favorable environment for obtaining highly 
efficient cellular processes. At steady state, a cell requires carbon for biosynthesis and ATP for 
cellular functions [51]. These requirements are met by central metabolic pathways that include 
glycolysis, pentose phosphate pathway (PPP), mitochondria and endoplasmic reticulum. 
2.1.1. Glycolysis and PPP 
The glycolytic pathway is one of the core metabolic process during which one molecule 
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of glucose is converted into two molecules of pyruvate by producing ATP. Glycolysis is also 
known as the Embden-Meyerhof pathway that has two phases [51]. In phase one, conversion of 
glucose into fructose-1,6-bisphosphate is catalyzed by hexokinase (HK), phosphogluccose 
isomerase (PGI) and phosphofructokinase (PFK). HK and PFK consume two molecules of ATP to 
mediate conversions. During the second phase of glycolysis, fructose-1,6-biphosphate is further 
metabolized into pyruvate by consuming two ADP molecules and produces four molecules of 
ATP. The fate of pyruvate is dependent on cellular oxygen utilization. In hypoxia conditions, 
pyruvate generated gets converted into lactate and is transported by monocarboxylate 
transporters (MCT) [52]. In contrast, during normoxia pyruvate enters the mitochondria and 
gets further metabolized to generate ATP. Additionally, the glycolytic enzymes such as HK, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and enolase have been shown to be 
multifunctional as they play a role in cellular transcription [52]. 
The pentose phosphate pathway (PPP) is an alternative pathway for metabolizing 
carbon entering glycolysis. The end product of PPP, ribose-5-phosphate, is utilized in the 
synthesis of nucleic acids. PPP generates NADPH that is utilized for ATP production. The activity 
of PPP differs from cell-to-cell. For example, muscle cells lack PPP as they utilize carbohydrates 
for energy generation whereas red blood cells lack mitochondria forcing the cell to completely 
rely in PPP for NADH generation [53]. On the other hand, neurons, which are of interest here, 
have been shown to possess active PPP [54]. The PPP and glycolysis are interconnected. The 
enzyme transketolase in PPP mediate the conversion of xylulose-5phosphate to glyceraldehyde-
3-phosphate. The produced glyceraldehyde-3-phosphate enters the second phase of glycolysis 
directly to generating pyruvate and ATP [52].  
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2.1.2. Mitochondria 
Mitochondria are considered as the power house of the cell. Two major mitochondrial 
pathways namely, the TCA cycle and electron transport chain generate ATP.  Pyruvate 
generated during glycolysis is transported into mitochondria by monocarboxylate transporters 
present on the mitochondrial membrane. Pyruvate is converted into mitochondrial acetyl-CoA 
which acts as the starting point for the TCA cycle. The acetyl group from Acetyl-CoA is 
transferred to oxaloacetate to generate citrate. A series of cyclic reactions convert citrate to 
oxaloacetate by performing two decarboxylations and four steps of oxidation to form malate 
followed by regenerating oxaloacetate. The ATP production from the TCA cycle occurs during 
the conversion mediated by succinyl-CoA lyase [53]. The TCA cycle generated NADH and FADH2 
are transported by succinate dehydrogenase (SDH) to the electron transport chain for ATP 
production. The TCA cycle generates precursors for biosynthesis of several amino acids. The 
major sites of regulations of TCA cycle were citrate synthase, isocitrate dehydrogenase and α-
ketoglutarate dehydrogenase. The TCA cycle is also sensitive to the buildup of metabolites by 
lowering its activity [53].  
The electrons generated in glycolysis are transported into mitochondria by the malate-
aspartate shuttle (MAS) or glyceraldegyde-3-phosphate shuttle (G3P). The expression and 
efficiency of these shuttles varies in different cell types [51]. MAS and G3P transport 6 and 3 
electron equivalents respectively. The electrons from NADH and FADH2 are passed into the 
inner mitochondrial membrane by complexes I, III and IV. The electrons then move towards 
oxygen and protons from the cytosol are consumed to increase the pH in the mitochondrial 
membrane creating a potential difference. The protons move through F1F0-ATPase to 
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synthesize ATP. The mitochondrial ATP is transferred into the cytosol by the adenine nucleotide 
transporter [53]. 
2.1.3. Endoplasmic reticulum 
The endoplasmic reticulum (ER) has several functions including folding and transport of 
proteins. The ER also acts as stress modulator by altering intracellular calcium levels. The 
intracellular calcium levels in a cell are maintained at low concentrations when compared with 
sodium and potassium concentrations. The low calcium concentrations are necessary as several 
proteins get activated or deactivated from calcium binding. Thus, cellular calcium 
concentrations must always be maintained in homeostasis and in check to avoid activation of 
unwanted signaling cascades [55]. The intracellular calcium concentrations are maintained by 
two mechanisms, buffering and sequestering. Buffers are calcium-binding proteins that absorb 
95-99% of free cytosolic calcium [55]. Calcium sequestering usually occurs in the ER.   
The ER consists of three major channels that mediate calcium fluxes. The 
sarco/endoplasmic calcium ATPase (SERCA) pump moves cytosolic calcium into the ER against 
the concentration gradient by consuming cellular ATP. To generate feedback and maintain 
homeostasis, cells have inositol triphosphate (IP3) and ryanodine (RyR) receptors. A negative 
and positive feedback is obtained from channels when calcium is bound to them. These 
receptors have been shown to control several cellular processes such as cell cycle and 
membrane electrical activity [55]. 
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2.1.4. Metabolic alterations in cancer cell 
Cancer cells have exhibited aerobic glycolysis i.e., higher glycolytic activity compared to 
normal cells even in the presence of sufficient oxygen. This phenomenon was first described by 
Otto Warburg in the year 1930. The prime cause for metabolic alterations was due to lowered 
mitochondrial activity and was resolved by Warburg in 1956. This effect of cells possessing 
aerobic glycolysis was termed as the ‘Warburg effect’. The Warburg effect was considered as 
one of the prominent symptoms in cells with altered metabolic activities. Researchers have 
rationalized this effect to describe (a) defective mitochondria, (b) adaption to hypoxia, (c) 
oncogenic signaling and (d) overexpression of cellular proteins [52].  
Impaired mitochondrial function forces the cell to depend on glycolysis for ATP 
generation. Mitochondrial damage was assumed as low levels of ATP were being produced. 
Analysis of mitochondrial DNA (mtDNA) levels revealed high mutations in cancer cells [52]. 
Several factors such as reactive oxygen species (ROS) and low levels of chaperones could cause 
mutations [52]. Hypoxia has been shown to directly modulate energy metabolism. Tumors have 
been shown to have a restricted supply of oxygen creating a hypoxic environment that would 
increase glucose utilization and lactate production leading to acidification. It’s well established 
that inhibiting glycolytic activity with 2-deoxy-glucose (2DG), Oxamate or 3-bromopyruvate has 
a significant effect on cancer cells [52,56,57].  
The enzymes that play a vital role in TCA cycle dependent ATP production are fumarate 
hydratase (FH) and succinate dehydrogenase (SDH). Studies have showed that inhibiting SDH 
caused accumulation of succinate and suppresses the TCA cycle activity [52]. SDH is an 
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important enzyme as it is involved in both the TCA cycle and electron transport chain. A loss in 
SDH activity would arrest mitochondrial energy metabolism completely. Cancer cells have been 
shown to possess increased ROS levels. It is possible that increased ROS levels may lower or 
inhibit ROS-sensitive enzymes [52]. 
2.1.5. Metabolic Modeling 
Metabolic modeling employs systemic integration of experimental knowledge into a 
mathematical framework that enables the prediction of dynamic behavior in cellular 
machinery. Currently metabolic models are largely validated based on constrained-based 
approaches. Most metabolic models are usually aimed at the identification of molecular targets 
for controlling cellular activities. Models based on ordinary differential equations (ODEs) have 
been successful at determining cellular fluxes, metabolite concentrations and protein activities. 
An ODE for a certain component (C) is usually represented by determining the rate of 
production (𝑣𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛) and consumption (𝑣𝑐𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛) as shown in equation 1. 
𝑑
𝑑𝑡
[𝐶] = 𝑣𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛 − 𝑣𝑐𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛 
(1) 
The rate of production and consumption depends on kinetics of proteins involved in 
pathways. The basic kinetic method that describes the activity of most proteins is Michaelis-
Menten kinetics. Proteins are complex and so it their activity. A biochemical determination of 
protein activities and estimation of their kinetics has enabled the derivation of kinetics of 
specific proteins or a common kinetic equation for describing a set of proteins [58,59]. 
Several tools, such as Pathways Tools [60], have been developed to implement and 
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model the kinetics of a set of proteins. The initial conditions were usually estimated using 
experimental data. The numerical equations can then be solved using an ODE solver. Due to a 
large interest in model development, a Systems Biology Markup Language (SBML) has been 
developed to exchange models of different biochemical networks [61]. Parameter estimation 
currently is one of the biggest challenges in systems biology. An increase in the number of 
interactions exponentially increases the parameter estimation space. To overcome this several 
strategies have been proposed. A toolbox (COBRA) in MATLAB has been developed by 
constraint-based modeling for quantitative prediction of cellular networks [62]. The model 
predictions obtained from COBRA have delivered the best set of parameters and when 
evaluated the model predications were accurate [62]. 
2.2. Cellular electrophysiology 
The flow of ions across the membrane creates a voltage difference called biopotential. 
The changes in the biopotential may occur due to several factors such as temperature, pH, ionic 
concentrations or extrinsic current [63]. Cellular electrophysiology is the study of membrane 
electrical properties of a cell. The goal of performing electrophysiology is to detect electrical 
signals generated by excitable cells such as neurons, muscle, cardiac, pancreatic and sensory 
neurons. Cellular electrophysiology involves measuring changes in voltage or current across the 
membrane. A voltage clamp recording is performed to measure changes in sodium and 
potassium currents by holding voltage constant and a current clamp is obtained by holding 
current constant thereby measuring changes in membrane potential. 
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2.2.1. Ionic basis of action potentials 
Cells at rest have a certain potential called a resting membrane potential, due to 
difference in ionic concentrations across the membrane. The intracellular potassium 
concentration is about 10-14 times higher compared to the extracellular potassium 
concentration leading to a negative reversal potential. The concentrations of sodium and 
calcium are very low intracellular and high extracellularly generating a positive reversal 
potential. The plasma membrane contains ‘open’ potassium channels that allow the passage of 
potassium ions. The resting membrane potential is mainly determined by the movement of 
potassium ions since it is occurring down the concentration gradient through the open 
potassium channels. The resting membrane potential of a typical cell is about -60 mV to -70 mV 
and the reversal potential of potassium is close to the resting potential. A change in resting 
membrane potential always changes the intracellular potassium concentration and reversal 
potential [64]. 
An action potential (AP) represents changes in cellular membrane potentials generated 
when a required strength of electric current is passed through the membrane of an electrically 
excitable cell. Different cells exhibit action potentials of different shapes including a variation in 
AP amplitude and time course. The time course of AP’s varies from 1 ms in neurons to 5s in 
cardiomyocytes [63]. AP is a cyclic process where membrane depolarization, hyperpolarization 
and resting membrane potential cycle are a result of alterations in ion permeability. 
During an AP, an initial depolarization changes the conformation of voltage-gated 
sodium channels and allows an influx of sodium ions. The propagation of this AP depolarizes the 
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adjacent region thereby opening voltage-gated sodium channels and increasing the sodium 
influx. A combination of factors established due to differences in ionic concentrations and 
resting membrane potential drives sodium ions into the cell. As more sodium ions enter the 
cell, the membrane is depolarized, further causing a larger influx of sodium and the 
permeability of sodium in that specific region increases. But when the reversal potential of 
sodium matches the cellular membrane potential, the sodium influx ceases [64]. During the 
closure of voltage gated sodium channels, voltage gated potassium channels open leading to an 
increased potassium permeability. The potassium efflux causes the membrane to repolarize 
back to the resting membrane potential. The voltage-gated calcium channels are also opened 
simultaneously with potassium channels and closed upon reaching resting membrane potential. 
Upon reaching the resting membrane potential the sodium, potassium and calcium ion 
channels close [64]. 
Action potentials cause characteristic changes in membrane potentials by rearranging 
ionic balances across the membrane. The movement of ions across the membrane generates a 
change in voltage. Although the changes in voltage are significant, the actual number of ions 
that move across the membrane are very small compared to number of ions in the total volume 
of the cytosol. The ionic fluxes during AP were measured initially by performing an experiment 
on giant squid axons. The movement of ions across the membrane was characterized by using 
radioactive sodium and potassium. It was found that depending on the size of a neuron, during 
single AP generation about one potassium ion per 300,000 in the cytosol is exchanged for 
extracellular sodium. So the changes in the total cytosolic ionic concentrations during an AP are 
negligible [64].  
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2.2.2. Measurement techniques 
Several techniques such as patch-clamp, extracellular recordings and planar patch clamp 
are employed for performing cellular electrophysiology. Each technique offers a set of 
advantages and disadvantages. Both intracellular and extracellular recordings have been 
performed to study membrane activity. During patch clamp electrophysiology, the recordings 
are usually performed by patching cell using a sharp electrode to measure changes in 
membrane potential. Several variations in patch clamp techniques have been exercised 
depending on the study. An on-cell patch is performed where patch membrane is kept intact 
and currents are measured without disturbing intracellular pathways. Another variation is an 
inside-out patch. During an inside out-patch, the cell is patched and pipette is withdrawn 
quickly to exposing intracellular contents of the cell to external environment. A whole-cell 
patch is the most common patch employed during patch clamp electrophysiology. Patch clamp 
techniques enables measurements of single ion channel properties. The principle behind patch 
clamp relies on the high-resistance seal formed between sharp electrode and cell membrane. 
The resistance of the seal varies from patch-to-patch but usually a giga-ohm seal is necessary to 
maintain a stable patch. During a whole-cell patch, a small surface of the cell membrane is 
drawn into the pipette, and by applying suction the membrane is broken enabling access into 
the whole-cell. A ground electrode lies in the extracellular chamber acting as a reference 
electrode. The electrodes are connected to an amplifier for detecting and measuring changes 
across cellular membrane. An outside-out patch is formed by patching a cell and slowly 
withdrawing the pipette along with a bleb of cellular membrane containing the ion channel of 
interest. The activity of ion channels in the bleb can then be measured. Perforated patch clamp 
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employs rupturing the cell membrane by incorporating a small amount of antibiotic. A giga-ohm 
seal is formed during perforated patch by just touching pipette to the membrane. Since the 
membrane is not ruptured, a long term measurements can be performed. 
Patch clamp electrophysiology is the gold standard for measuring membrane electrical 
activity. It is a short term and technique driven. To overcome this microelectrode arrays have 
been developed and are capable of measuring electrical activity over long periods. Optical 
measurement systems based on changes in emitted fluorescence signal upon incorporation of a 
dye are also used. The fluorescent probes are voltage sensitive and emit fluorescence when a 
change in voltage occurs. The changes in fluorescent intensities need to be tracked and 
processed for quantifying. To perform high throughput electrophysiology, the planar patch 
clamp technique has been developed. During planar patch clamp, cells are suspended in a 
solution and added to a chip containing micro pipettes. Suction is applied in the micropipettes 
to create a seal followed by record membrane electrical activities. 
2.2.3. Hodgkin-Huxley model 
Hodgkin & Huxley’s mathematical description of AP formalism is the most widely used to 
describe an AP and relies on the opening and closing of channels, selectively allowing ions to 
move across the membrane [65].  A series of voltage clamp experiments were performed and 
the experimental data was fitted to obtain sodium conductance of voltage gated sodium 
channels consisting of activation ‘m’ and inactivation ‘h’ gates. The potassium conductance was 
also determined which consisted of a single activation gate ‘n’. The ionic conductances were 
obtained from, 
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𝑔𝑁𝑎 = 𝑔𝑚𝑎𝑥𝑚
3ℎ (2) 
𝑔𝐾 = 𝑔𝑚𝑎𝑥𝑛
3 (3) 
Where 𝑔𝑚𝑎𝑥 is the maximum conductance of ion channel. The exponents on m, n and h were 
determined by obtaining a fitting of the model to experimental data. The gating variables were 
postulated and determined for voltage-gated time constants i.e., τm , τh and τn. The leak 
conductances were incorporated to account for small conductances in the membranes. The 
ODE’s for the HH model are given by, 
𝐶 𝑑𝑉
𝑑𝑡
= −𝑔𝑁𝑎𝑚
3ℎ(𝑉𝑚 − 𝑉𝑁𝑎) − 𝑔𝐾𝑛
4 (𝑉𝑚 − 𝑉𝐾) − 𝑔𝑙𝑒𝑎𝑘(𝑉𝑚 − 𝑉𝑙𝑒𝑎𝑘) + 𝐼𝑎𝑝𝑝 
(4) 
𝑑𝑛
𝑑𝑡
=  𝛼𝑛(1 − 𝑛) − 𝛽𝑛𝑛 
(5) 
𝑑𝑚
𝑑𝑡
=  𝛼𝑚(1 − 𝑚) − 𝛽𝑚𝑚 
(6) 
𝑑ℎ
𝑑𝑡
=  𝛼ℎ(1 − ℎ) − 𝛽ℎℎ 
(7) 
The model could mimic the neuronal dynamics accurately but were computationally 
inefficient for parameter estimation and model simulation [66]. To create a more accurate 
estimation of parameters, a functional form for the voltage dependence of the rate constants 
that takes into account more realistic effect of the electrical field on the ion channel protein 
was developed by Destexhe et al. [67]. Mohan et.al have developed a linear thermodynamic 
formalism that was then used to describe the voltage and time dependence of the ionic 
conductance, which eliminated the need for ‘guessing’ the function for the voltage-dependence 
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of rate constants and the same form could be used for characterization of all ion channels [27].  
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CHAPTER-3: EXPERIMENTAL METHODS 
 
In this chapter, the methodology implemented to perform experiments is described in 
detail. NG108-15 cells, a neuroblastoma-glioma hybrid neuronal cell line were used for 
developing and charactering the model. The NG108-15 cell line was developed by fusing a 
mouse N18TG2 neuroblastoma cell with a rat C6-BU-1 glioma cell in the presence of an 
inactivated Sendai virus. The NG108-15 cells line was developed in 1971 by Bernd Hamprecht 
[68]. These cells do not form synapses and possess functional properties of neurons making 
them ideal for performing high-throughput drug screening and pathway analysis. A 
combination of biochemical and electrophysiological measurements were performed to 
characterize and develop the model. 
3.1. Surface modification 
Glass coverslips (22 mm × 22 mm, Thomas Scientific) were coated with N-1[3-
(trimethoxysilyl) propyl] diethylenetriamine (DETA) according to previously published protocols 
[10]. The protocol involved cleaning coverslips using a mixture (1:1) of hydrochloric acid and 
methanol followed by soaking it in concentrated H2SO4 for 30 min. The cover slips were rinsed 
with deionized (DI) water for 30 min, immersed in boiling in deionized water for 30 min, rinsed 
with acetone and placed in an oven at 70 oC for 20 min to allow drying. The cleaned surfaces 
were treated with a 0.1% (v/v) mixture of organosilane in toluene to form a thin film of DETA 
(United Chemical Technologies., Bristol, PA). The DETA coated coverslips were heated to a 
temperature just below the boiling point of toluene, rinsed with toluene, reheated to a 
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temperature just below the boiling point again and then oven dried [27]. The DETA surface was 
analyzed using contact angle measurements and X-ray photon spectroscopy (XPS) [69]. 
3.2. Preparation of culture medium and patching Solutions 
3.2.1. Culturing and differentiation medium 
NG108-15 culturing medium was prepared by adding 50ml of 10% fetal bovine serum 
(FBS) (Gibco, NY, USA ) and 10ml of hypoxanthine-aminopetrin thymidine (HAT) medium 
supplement (Sigma-Aldrich Corp, St.Louis, USA) to 500ml of Dulbecco’s modified eagle’s 
medium (DMEM, Gibco). The differentiation medium was prepared by adding 10 ml of B27 
(Gibco) to 500ml of DMEM (Gibco) media. The prepared medium was sterilized by filtration and 
stored at 4 oC. 
3.2.2. Intracellular patch solution 
Intracellular solution was prepared by dissolving 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) and ethylene glycol tetraacetic acid (EGTA) in water. The 
mixture was sonicated to ensure that EGTA is completely dissolved. Following sonication, NaCl, 
KCl, MgCl2 and CaCl2 were added to the solution. DI water was added to make up the volume to 
50 mL. The osmolarity of the solution was verified using an osmometer (Fiske) and adjusted to 
280-290 mOsm by adding HEPES. The pH of the solution was adjusted to 7.2 at room 
temperature. The prepared solution was aliquoted into 1mL vials and stored at 4 oC. The 
osmolarity was checked prior to performing the experiment. The composition of the solution is 
listed in Table 2.  
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Table 2: Composition of intracellular patch solution 
Compound Concentration (mM) 
Sodium chloride 10 
Potassium chloride 140 
Magnesium chloride 2 
Calcium chloride 0.5 
Ethylene glycol tertaacetic acid 1 
HEPES buffer 10 
 
3.3. NG108-15 cell culture 
The NG108-15 cell line (passage number: 16) was obtained from Dr. M. W. Nirenberg, 
National Institute of Health (NIH) and was sub-cultured according to previously published 
protocols [27,41]. A vial of NG108-15 cells stored under liquid nitrogen was thawed and 
immediately resuspened in 9ml of culturing medium. The medium with the cells was 
centrifuged at 1000 RPM for 5 min. The supernatant was removed and the cells were 
resuspened in 1ml of fresh culturing medium. A cell count was performed using tryphan blue in 
a hemocytometer. During resuspension, cells were mixed slowly to avoid cell damage and care 
was also taken to avoid bubbles. The suspension containing cells was then added to a T-75 flask 
(Corning, NY, USA) containing 20ml of fresh differentiation medium. The flask was placed in a 
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standard cell culture incubator at 37 oC for 72 hours to achieve 90% confluency (Figure 2).  
 
Figure 2: A representative image of NG108-15 cells after reaching 90% confluency on Day 3. 
DETA coated cover slips were sterilized by rinsing with ethanol in a biosafety hood. The 
coverslips were allowed to dry in the hood and transferred to 6-well plates (Corning, NY) 
followed by the addition of 3ml of fresh differentiation media. The plates were placed in the 
incubator for 20 min. Cells were collected from the T75 flask by removing the culturing media 
and adding 10ml of fresh differentiation media. The flask was tapped to detach the cells. The 
medium with cells was centrifuged for 5 min at 1000 RPM.  The supernatant were removed and 
resuspened in 1ml of fresh differentiation medium. Cell count was performed using tryphan 
blue in a hemocytometer. The cell mixture was diluted and plated at different densities. Cells 
were plated at 4×105 cells per well for patch clamp electrophysiology and 8×105 to 1×106 cells 
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per well for biochemical assays. A half media change was performed every 2 days. The 
morphology of cells was examined every day and experiments were performed after 4 days 
(Figure 3). 
 
Figure 3: Differentiation of NG108-15 cells. The morphology of cells on DETA coated coverslips on DIV-1 (A), 3 (B), 4 
(C) and 5 (D) is shown at 10x 
3.4. Biochemical assays 
The basal metabolism of the NG 108-15 cells was determined by performing biochemical 
assays on day four. The rate of glucose uptake, lactate production, ATP and ADP concentrations 
were determined. 
A B 
C D 
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3.4.1. Glucose assay 
The differentiation medium was taken out from the 6 well plate and 1ml of fresh 
differentiation medium or differentiation medium containing drug was added. Samples were 
collected every 20 min and the glucose concentration was analyzed using a colorimetric assay 
kit.  (Biovision, Inc; Catalog #K606-100).  A sample of 4 µL was diluted by adding 16µL of assay 
buffer solution and 2µL of the diluted sample was further diluted to total volume of 50µL/well. 
The glucose standard curve was prepared by diluting the glucose standard to 1nmol/µL 
by adding 10µL of the glucose standard to 990µL of glucose assay buffer. Various volumes, 
namely 0, 2, 4, 6, 8 and 10 µL of the above solution were added into each well individually. The 
volume was adjusted to 50µL/well with glucose assay buffer to generate 0, 2, 4, 6, 8 and 10 
nmol/well of the glucose standard.  
Enough reagents for the number of assays to be performed were pre-mixed. For each 
well, a total 50µL reaction mix was prepared by adding 46µL glucose assay buffer, 2µL glucose 
probe and 2µL glucose enzyme mix. Then 50µL of glucose reaction mix was added to each well 
to obtain 100µL per well. The plate/reaction was then placed in an incubator at 370C for 30 min. 
The absorbance was measured at 570nm using a Synergy HT mulitwell plate reader (BioTek 
Instruments, Inc.). A calibration curve was performed simultaneously and the background was 
corrected using the blank (Figure 4).  
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Figure 4: Glucose assay standard curve 
The concentrations of the samples were determined by the following equations: 
𝐶 =
𝑆𝑎 × 𝐷
𝑆𝑣
 
(8) 
Where, C = Actual concentration from the graph; Sa = Sample amount (in nmol) from standard 
curve; Sv = Sample volume added to the sample wells; D = Dilution factor 
Calculation of Flux per minute per cell (Fmc), 
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(9) 
Where, C2 = Concentration of glucose present at time (T2), C1 = Concentration of glucose 
present at time (T1) and Cc = Cell count. 
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3.4.2. Lactate assay 
Samples were collected every 20 min and the lactate concentration was analyzed using 
a colorimetric assay kit (Biovision, Inc; Catalog #K606-100). Samples were collected 
simultaneously while performing the glucose assay. A sample of 4 µL was diluted by adding 
16µL of assay buffer solution and 2µL of the diluted sample was further diluted to total volume 
of 50µL/well. 
The lactate standard curve was prepared by diluting the lactate standard to 1nmol/µL by 
adding 10µL of the lactate standard to 990µL of lactate assay buffer and it was mixed well. 
Various volumes, namely 0, 2, 4, 6, 8 and 10 µL of the above solution were added into each well 
individually. The volume was adjusted to 50µL/well with glucose assay buffer to generate 0, 2, 
4, 6, 8 and 10 nmol/well of the lactate standard.  
Sufficient reagents for the number of assays to be performed were pre-mixed. For each 
well, a total 50µL reaction mix was prepared by adding 46µL lactate assay buffer, 2µL lactate 
probe and 2µL lactate enzyme mix. Then 50µL of lactate reaction mix was added to each well so 
that each well totaled 100µL in volume. The plate/reaction was then placed in the incubator at 
370C for 30 min. The absorbance was measured at 570nm using as Synergy HT mulitwell plate 
reader (BioTek Instruments, Inc.). A calibration curve was performed simultaneously and the 
background was corrected using the blank (Figure 5). 
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Figure 5: Lactate assay standard curve 
Calculation of the Unknown concentration using linear trend:  
𝐶 =
𝑆𝑎 × 𝐷
𝑆𝑣
 
(10) 
Where, C = Actual concentration from the graph; Sa = Sample amount (in nmol) from standard 
curve; Sv = Sample volume added to the sample wells; D = Dilution factor 
Calculation of Flux per minute per cell (Fmc), 
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(11) 
Where, C2 = Concentration of glucose present at time (T2), C1 = Concentration of glucose 
present at time (T1) and Cc = Cell count. 
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3.4.3. ATP assay 
On day 4, differentiation medium was replaced with the either fresh or drug containing 
medium. Cells were incubated and samples were collected for every 20 min and 60 min. Cells 
were rinsed twice and collected by trypsinization. The detached cells were resuspended in 
extracellular solution and cell count was performed. Cells were centrifuged and 100uL of ATP 
assay buffer was added to the cells followed by adding 20 µL of PCA and 5 µL of neutralization 
solution (Deproteinizing Sample Preparation Kit, Biovision, Inc, Catalog#: K808-200). The sample 
was then frozen until all the remaining samples were collected. 50 µL of the sample was 
analyzed using the ATP assay kit (Biovision, Inc; Catalog #K354-100). 
The ATP standard curve was prepared by diluting the ATP standard to 1nmol/µL by 
adding 10µL of the ATP standard to 990µL of ATP assay buffer. Various volumes, namely 0, 2, 4, 
6, 8 and 10 µL of the above solution was added into each well individually. The volume was 
adjusted to 50µL/well with ATP assay buffer to generate 0, 2, 4, 6, 8 and 10 nmol/well of the 
ATP standard. 
 Reagents for the number of assays to be performed were pre-mixed. For each well, a 
total 50µL reaction mix was prepared by adding 44µL ATP assay buffer, 2µL ATP probe, 2µL ATP 
developer min and 2µL ATP converter. Then 50µL of ATP reaction mix was added to each well 
so that each well totaled 100µL in volume. The plate/reaction was then placed in the incubator 
at 370C for 30 min. The absorbance was measured at 570nm using as Synergy HT mulitwell 
plate reader (BioTek Instruments, Inc.). The calibration curve was performed and the 
background was corrected by subtracting the value from the 0 lactate control from all readings 
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(Figure 6). 
 
Figure 6: ATP assay standard curve 
Calculation of the ATP concentration(C) using linear trend:  
𝐶 =
𝑆𝑎 × 𝐷
𝑆𝑣
 
(12) 
Where, C = Actual concentration from the graph, Sa = Sample amount (in nmol) from standard 
curve, Sv = Sample volume added to the sample wells, D = Dilution factor, Total cell volume = 
number of cells × cell volume. 
Dilution factor (D) was calculated as, 
𝐷 =
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑣𝑜𝑙𝑢𝑚𝑒
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 + 𝑃𝐶𝐴 + 𝑁𝑒𝑢𝑡𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
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3.4.4. ADP assay 
An ADP assay was performed in parallel with the ATP assay. On day 4, differentiation 
medium was replaced with either fresh or drug containing medium. Cells were incubated and 
samples were collected for every 20 min and 60 min. Cells were rinsed twice and collected by 
trypsinization. The detached cells were resuspended in extracellular solution and cell count was 
performed. Cells were centrifuged and 100µL of ADP assay buffer was added to the cells 
followed by adding 20µL of PCA and 5µL of neutralization solution (Deproteinizing Sample 
Preparation Kit, Biovision, Inc, Catalog#: K808-200). The sample was then frozen until all the 
remaining samples were collected. 50uL of the sample was analyzed using the ADP assay kit 
(Biovision, Inc; Catalog #K355-100). 
The ADP standard curve was prepared by diluting the ADP standard to 1nmol/µL by 
adding 10µL of the ADP standard to 990µL of ADP assay buffer and it was mixed well. Various 
volumes, 0, 2, 4, 6, 8 and 10 µL, of the above solution was added into each well individually. The 
volume was adjusted to 50µL/well with ADP assay buffer to generate 0, 2, 4, 6, 8 and 10 
nmol/well of the ADP standard. 
 Required quantity of reagents for the number of assays to be performed was pre-mixed. 
For each well, a total 50µL reaction mix was prepared by adding 44µL ADP assay buffer, 2µL 
ADP probe, 2µL ADP developer min and 2µL ADP converter. Then 50µL of ATP reaction mix was 
added to each well so that each well totaled 100µL in volume. The plate/reaction was then 
placed in the incubator at 370C for 30 min. The absorbance was measured at 570nm using as 
Synergy HT mulitwell plate reader (BioTek Instruments, Inc.). The calibration curve was 
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performed and the background was corrected by subtracting the value from the blank from all 
readings (Figure 7). 
 
Figure 7: ADP assay standard curve 
Calculation of the ADP concentration(C) using linear trend:  
𝐶 =
𝑆𝑎 × 𝐷
𝑆𝑣
 
(14) 
Where, C = Actual concentration from the graph; Sa = Sample amount (in nmol) from standard 
curve; Sv = Sample volume added to the sample wells; D = Dilution factor; Total cell volume = 
number of cells × cell volume. 
Dilution factor (D) was calculated as, 
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𝐷 =
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑣𝑜𝑙𝑢𝑚𝑒
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 + 𝑃𝐶𝐴 + 𝑁𝑒𝑢𝑡𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
 
(15) 
3.5. Patch clamp electrophysiology 
Patch clamp electrophysiology was performed on the NG108-15 cells to collect 
parameters for the model. Whole cell recordings were performed to assess changes in cellular 
membrane electrical activity. The instrumentation and the methodology to record cellular 
electrical activity are described in the following sections. 
3.5.1. Instrumentation 
The experimental setup for performing patch clamp electrophysiology is shown in figure 
2A. It consists of a a Zeiss Axioscope 2 FS plus upright microscope (Figure 8B) which was 
mounted on a Gibraltar platform with motors for movement in X and Y directions (Figure 8B). 
The whole system was mounted on a vibration-isolation table to avoid unwanted vibrations 
during recording. A Faraday cage was also installed round the system and grounded to protect 
the interior against external electric fields and electrostatic discharges. Micromanipulators 
were used to precisely manipulate the patch pipette at a micrometer resolution. The pipette 
holder was attached to the headstage (Figure 2B) and was also equipped with a flexible tube to 
control pressure.  
The electrodes were prepared using a Shutter 97 pipette puller (BF150-86-10; Sutter, 
Novato, CA) as shown in Figure 8B. The voltage clamp and current clamp measurements were 
performed on a Multiclamp 700B amplifier (Axon Instrument, Foster City, CA, USA) as shown in 
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Figure 2C. An Axon Digidata 1322A (Figure 8C) interface was used to filter the signals at 2 kHz 
and digitized at 20 kHz. The probe from Axon Digidata 1322A was connected to the 
micromanipulators and pipette holder. All data acquisition was performed using pClamp 10 
software (Axon Instruments, Foster City, CA, USA).  
 
Figure 8: Set up of the electrophysiology rig having the microscope mounted on a gibraltor stage (A). Pipette puller 
(B), Amplifier (C), micromanipulator (D) is also shown 
 
A B 
C 
D 
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3.5.2. Whole cell recordings 
Whole-cell patch recordings were performed on the stage of a Zeiss Axioscope 2 FS Plus 
upright microscope (Axiovert 200, Carl Zeiss, Göttingen, Germany). The recordings were 
obtained at room temperature (21-25 oC) in the recording chamber containing differentiation 
medium. The recording chamber was continuously perfused with the differentiation medium. 
To investigate the effect of the drugs on action potential, metabolic inhibitors were added to 
the medium. Patch pipettes (4–6 MΩ resistance) were prepared from borosilicate glass with a 
Sutter P97 pipette puller and filled with intracellular solution.  
The cell to be patched was observed under a 40X objective. The electrode was 
positioned till the tip was bright on the monitor and immerse in the patch chamber (Figure 9). 
The pipette offset was compensated. The objective was lowered followed by the electrode until 
one could see the electrode was above the cell (Figure 10). The Seal Resistance was recorded 
and the electrode was pushed towards the cell membrane. The pipette then touched the cell 
and an increase of 0.5mohms was observed. The initially applied pressure was removed and 
gentle suction was applied by mouth. If required, constant pressure was applied to form a seal. 
The image of the cell was saved. A holding potential of -70mV (in Multiclamp) was applied to 
form the gigaohm seal. The leakage current on the amplifier was less than 30pA. The gigaohm-
seal formed was recorded and the pipette capacitance (fast & slow) was compensated. A short 
slight suction ‘Kiss’ was applied to open the cell membrane and the capacitive transient was 
observed. The membrane resistance was recorded and the seal test window was switched off.  
The membrane potential was checked by switching to I=0 mode. The whole cell 
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parameters (click Auto) followed by leak subtraction (auto) were compensated. The stability of 
the patch was checked by clicking on membrane test and results were saved. The gain and 
Bessel were set to 5 and 3 respectively. The ionic currents were measured in voltage clamp 
mode using 10mV voltage steps from a holding potential of -85mV. By holding the voltage 
constant the changes in current was measured in voltage clamp mode. A p/6 protocol was 
implemented upon compensating for the whole cell capacitance and series resistance. The 
access resistance of the patched cells was less than 20 MΩ. Experimental parameters such as 
membrane resistance, membrane capacitance, resting membrane potential and injected 
stimulus current were noted. The protocol in clampex was then initiated. The membrane test 
was again performed and the results were saved. 
 
Figure 9: An image showing the glass electrode, ground electrode, patching chamber, objective lens on an 
electrophysiology rig 
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The action potentials were recorded by switching to IC mode and by compensating for 
bridge balance. The holding current was adjusted to get a membrane potential of -70mV. A 2 
ms depolarizing current injections was injected to initiate action potentials. The perfusion 
system was switched to add the drug. The APs were continuously recorded until either the 
patch was lost or the cell could no longer generate an AP. The membrane test was checked and 
results were saved.  
 
Figure 10: Picture of NG108-15 cell during electrophysiological recording 
A voltage clamp recording was again performed at the end to see the effects of drugs on 
VC recording. All the recordings were corrected for a junction potential that developed during 
the interface between the patch electrode and the bath solution. The Multiclamp 700B files 
were also saved for extraction of any other parameters, if necessary. Data was saved and 
imported into MATLAB using a custom code for parameter estimation. 
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CHAPTER-4: MODEL DEVELOPMENT 
 
The neuronal-metabolic model was built in a top-down approach by integrating the 
ensemble metabolic model to a modified Hodgkin Huxley based neuronal module. The models 
were implemented with physiological compartments, including physiological volumes. The 
metabolic compartments were nested in the cytosolic volume and the total cellular volume was 
nested in the extracellular volume. The compartments were implemented as volumetric ratios 
as shown in Table 3.  
Table 3: Volumetric ratios of nested cellular compartments 
Compartment Volumetric ratio Reference 
Total Intracellular volume 1 Estimated 
Bulk cytosolic space 0.65 [70] 
Sub-cellular space 0.02 [70] 
Mitochondria 0.05 [71] 
Endoplasmic reticulum 0.1 Estimated 
Others (Nucleus, Lysosomes) 0.28 Estimated 
 
A modular approach was utilized during model reconstruction. The model development was 
completed in 3 major developmental stages, (1) reconstruction of a neuronal metabolism, (2) 
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development of neuronal module and (3) the integration of models for predicting effects of 
metabolic perturbations. Each of these modules is described in the following sections. 
4.1. Reconstruction of metabolic model 
The metabolic module for NG108-15 cells includes the core metabolic pathways for 
carbon metabolism and cellular bioenergetics and was reconstructed by combining glycolysis 
[72], mitochondria [59] and endoplasmic reticulum [73,74] modules. The model was 
reconstructed in MATLAB Simbiology. Simbiology allows for rapid expansion of the model by 
facilitating the addition of other cellular processes through Systems Biology Markup Language 
(SBML). It also provides access to several solvers for simulation of dynamic models of cellular 
process. The equations can be programmed directly in MATLAB but Simbiology enables us to 
implement it in a graphic user-interface (GUI) by creating a diagram for visualization. The data 
can be imported and exported easily from Simbiology. Moreover, it is backed up by the entire 
MATLAB suite which can help perform various analyses using any custom code. A detailed list of 
reactions, fluxes, parameters and metabolite concentrations are depicted in the Appendix. 
4.1.1. Glycolysis model 
The glycolysis module was adapted from a comprehensive model of energy and redox 
metabolism for human erythrocytes [58]. This mathematical model converts glucose to lactate 
through a series of 13 reactions, from hexokinase to lactate dehydrogenase via 2,3-
biphosphoglyceate shunt involving 19 reactants (Figure 11). Glycolysis requires oxidized 
Nicotinamide adenine dinucleotide (NAD+) and reduced Nicotinamide adenine dinucleotide 
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(NADH). The NADH is utilized by the cells and is recycled back to NAD+.  Several reactions are 
capable of performing this conversion and one of them is the lactate dehydrogenase (LDH) that 
converts pyruvate into lactate. The lactate is then transported out of the cell via the 
monocarboxylate transporters (MCT). The MCT’s are also equipped to transport pyruvate. 
 
Figure 11: Glycolytic module consisting of glycolysis, pentose phosphate pathway and glutathione 
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In addition, the glycolytic module also contains ten other reactions that include 
glutathione oxidation, glutathione reduction and pentose phosphate pathway (PPP). The 
glutathione reduction and oxidation dictates the conversion of Nicotinamide adenine 
dinucleotide phosphate (NADPH) to NADP thereby influencing the lactate dehydrogenase 
enzyme activity. The glutathione process has been lumped together into a generalized reaction. 
A sink for phosphoribosylpyrophosphate (PRPP) has been included for the consumption of 
carbon entering the PPP to avoid the accumulation of intracellular metabolites. The ATP 
dependent exchangers were incorporated and calibrated to match the activities obtained from 
the neuronal module. A generalized ATP consumption reaction has been implemented to 
represent all the other ATP utilizing pathways. The total adenine concentration has been 
maintained constant by including the conservation condition and an adenine kinase reaction 
that mediates the conversion of ADP to AMP and ATP [72]. The total adenine nucleotides 
including the NAD+ and NADH, NADP and NADPH and FAD+ and FADH2 were held constant. The 
temporal behavior of the metabolite concentration is based on ordinary differential equations. 
All the rate equations have a general form as described in equation 16,  
𝑣 = 𝑉𝑚𝑎𝑥 ×  𝑟(𝑋) × (∏ 𝑥𝑖
𝑐+𝑖𝑗
𝑖
− 
1
𝑞
∏𝑥𝑖
𝑐−𝑖𝑗
𝑖
) 
(16) 
Where c+ and c- are the positive and negative elements of the stoichiometric matrix, q is the 
equilibrium constant and r(X) is the regulatory function for saturation, allostery, etc [58]. Earlier 
models have described the HK, PFK, PK, DPGM, DPG, G6PD, 6PGD and GSSR to be completely 
irreversible. An increase of backward fluxes by several orders of magnitude due to high 
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accumulation of metabolites was avoided by using rate equations based on equation 16. The 
equilibrium constants and kinetic equations were taken from several other sources [58]. The 
equations for AK, PGK and enolase were based on data from previously published results [58]. 
AK and PGK were considered to have a random BiBi mechanism. PGM and enolase are based on 
an UniUni mechanism [58]. 
4.1.2. Mitochondrial model 
The mitochondrial model was adapted from a cardiac mitochondrial metabolism model 
and consists of 22 reactions involving 27 reactants [59]. The total mitochondrial volume was set 
to be 5% of the total cell volume [71]. The model incorporates the main mitochondrial 
electrophysiological and metabolic process including the oxidative phosphorylation and matrix-
based process in mitochondria (Figure 12). The reaction rates of the enzymes in the TCA cycle 
namely, citrate synthase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase and malate 
dehydrogenase have been implemented as described and implemented as described by 
Cortassa et al [59]. Sensitivity to calcium is also incorporated for IDH and KDGH. The TCA cycle 
in the model can be divided into two pathways, the tricarboxylate (oxaloacetate to α-
ketoglutarate) and the dicarboxylate (α-ketoglutarate to oxaloacetate) pathway. Acetyl-CoA 
and oxaloacetate react and produce α-ketoglutarate (αKG), NADH, and CO2. αKG serves as a 
substrate of the dicarboxylate pathway producing OAA that resupplies and initiates the 
tricarboxylate pathway. 
The mitochondrial model involves the complete oxidation of acetyl CoA to generate 
NADH and ATP. Acetyl CoA is the point of convergence for carbohydrate, amino acid and fatty 
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acid metabolism. The oxidation of acetyl CoA produces NADH and FADH2, which are oxidized to 
propel oxidative phosphorylation. The model includes both the explicit electrical gradient (ΔΨm) 
and the proton gradient across the mitochondrial inner membrane established by oxidative 
phosphorylation. The protons from NADH and FADH2 are oxidized pumping protons across the 
mitochondrial inner membrane establishing a proton motive force and proton gradient. The 
large ΔΨm of the inner mitochondrial membrane determines the electrochemical transport of 
ions across, including calcium influx and efflux. The proton motive forces drive the 
phosphorylation of matrix ADP to ATP by F1F0-ATPase. The F1F0-ATPase activity accounts for the 
reversibility of the enzyme when the ΔµH collapses. 
 
Figure 12: Diagram showing mitochondrial module in Simbiology 
The Adenine Nucleotide Transporter (ANT) transports the ATP from the inner 
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membrane of the mitochondria to the cytosol and reaction was implemented. The model also 
incorporates a proton leak that influences the mitochondrial membrane potential and proton 
motive force that follows a thermokinetic formulation. The mitochondrial membrane potential 
is determined by, 
dΔΨm
dt
=
𝑉𝐻𝑒 + 𝑉𝐻𝑒(𝐹) − 𝑉𝐻𝑢 − 𝑉𝐴𝑁𝑇 − 𝑉𝐻𝑙𝑒𝑎𝑘 − 𝑉𝑁𝑎𝐶𝑎 − 2𝑉𝑢𝑛𝑖
𝐶𝑚𝑖𝑡𝑜
 
(17) 
Where, 𝑉𝐻𝑒 , 𝑉𝐻𝑒(𝐹), 𝑉𝐻𝑢, 𝑉𝐴𝑁𝑇, 𝑉𝐻𝑙𝑒𝑎𝑘 , 𝑉𝑁𝑎𝐶𝑎 𝑎𝑛𝑑  𝑉𝑢𝑛𝑖 are the rates of NADH oxidation, FADH2 
oxidation, F1F0-ATPase , adenine nucleotide transporter, sodium-calcium exchanger and calcium 
uniporter. The redox (Ares), phosphorylation (AF1) potentials and the proton motive force (ΔµH) 
are the driving forces. The coefficients in the equations and the rate constants of are obtained 
from Cotrassa et.al [59]. In addition, the model considers the explicit dependence of the TCA 
cycle dehydrogenases on mitochondrial calcium concentration. The influx of calcium through 
the Ca+2 uniporter and the Na-dependent Ca+2 efflux driven by Na+/Ca+2 antiporter determines 
the mitochondrial calcium concentration. The phosphate transport into the mitochondria also 
has the general form described in equation 16. 
4.1.3. Endoplasmic reticulum Model 
The endoplasmic reticulum (ER) model was included to study the effect of calcium on 
cellular dynamics. The ER model consists for the IP3 receptor, sarcoplasmic reticulum calcium 
ATPase (SERCA) and a calcium leak (Figure 13). These pumps were implemented as described in 
Chen et.al [74]. The activation/inhibition of the general plasma membrane receptor has been 
coupled with the activation of phospholipase C (PLC), which converts phosphatidylinositol 4,5-
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biphosphate (PIP2) to inositol 1,4,5-triphosphate and diacylglycerol (DAG). The rate equation 
for the hydrolysis of PIP2 and IP3 and DAG by PLC was implemented using Michaelis-Menten 
kinetics and multiplied by its Boolean value. Therefore, when the Boolean value is zero, the 
reaction rate is zero, and when the Boolean value is one, the reaction rate is given by equation 
18, 
𝑣 = 𝑉𝑚 ∗  (
[𝑃𝐼𝑃2]
𝐾𝑚+[𝑃𝐼𝑃2]
)    
(18) 
 
Figure 13: Implemented endoplasmic reticulum module in Simbiology 
A simple rate equation was implemented for IP3 and DAG consumption, which used 
mass action kinetics IP3 then, activates IP3R calcium channels on the endoplasmic reticulum 
membrane, through which endoplasmic reticulum calcium is released into the cytosol. While 
the flux of calcium to and from the mitochondria has been addressed by the implementation of 
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the mitochondrial metabolism model [59], the ER calcium flux has been addressed by 
implementing reactions as described in Marhl et al. [73]. The IP3 calcium channel kinetics was 
modified as described by Chen et al and includes a dependence of IP3 that was absent in the 
channel reaction rate as described by Marhl et al.  
4.1.4. Ensemble metabolic model 
The glycolysis and the mitochondrial model were coupled by including the reactions for 
pyruvate transport into mitochondria followed by conversion of acetyl Co-A by pyruvate 
dehydrogenase (Figure 14). The rate equation for pyruvate transport into mitochondrial space 
had the general form previously described in equation 16, 
𝑣 = 𝑉𝑚𝑎𝑥 ([𝑃𝑦𝑟]𝑐𝑒𝑙𝑙 − 
[𝑃𝑦𝑟]𝑚𝑖𝑡𝑜
𝐾𝑒𝑞𝑃𝑇
) 
(19) 
Where, 𝐾𝑒𝑞𝑃𝑇 is the equilibrium constant for pyruvate transport, [𝑃𝑦𝑟]𝑀𝑖𝑡𝑜 and [𝑃𝑦𝑟]𝑐𝑒𝑙𝑙 are 
the concentrations of pyruvate in the mitochondria and cytosol. The rate equation for pyruvate 
dehydrogenase was implemented using the irreversible mass action kinetics as described by 
Nazaret et al. [75] and is shown below. 
𝑣 = 𝐾𝑃𝐷𝐻 ([𝑃𝑦𝑟]𝑀𝑖𝑡𝑜 − 
[𝐴𝑐𝐶𝑜𝐴]𝑚𝑖𝑡𝑜
𝐾𝑒𝑞𝑃𝐷𝐻
) [𝐶𝑜𝐴]𝑚𝑖𝑡𝑜 [𝑁𝐴𝐷]𝑚𝑖𝑡𝑜 
(20) 
Where, 𝐾𝑃𝐷𝐻  is the Michaelis constant for PDH, 𝐾𝑒𝑞𝑃𝐷𝐻 is the equilibrium constant for PDH, 
[𝑃𝑦𝑟]𝑀𝑖𝑡𝑜, [𝐴𝑐𝐶𝑜𝐴]𝑚𝑖𝑡𝑜, [𝐶𝑜𝐴]𝑚𝑖𝑡𝑜and [𝑁𝐴𝐷]𝑚𝑖𝑡𝑜are the concentrations of pyruvate, Acetyl-
CoA, CoA and NAD in mitochondria. 
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Figure 14: Reconstructed NG108-15 metabolic model in MATLAB Simbiology 
The Glycerol-3 Phosphate (G3P) shuttle for transferring the NADH equivalents into the 
mitochondria was incorporated using irreversible mass action kinetics. The shuttle is 
irreversible and not as efficient as the malate-aspartate shuttle (MAS). It can generate only 1.5 
ATP compared to 2.5 ATP transferred by MAS [51]. The reducing equivalents of NADH are 
transferred to glycerol-3 phosphate which is converted to dihydroxyacetone phosphate on the 
mitochondrial membrane by mitochondrial glycerol-3phosphate dehydrogenase. Thus the 
reducing equivalents are transferred to FAD to form FADH2 in the mitochondria which are 
further oxidized to generate the required proton motive force for ATP production. 
The cytosolic ATP and ADP levels are linked to the mitochondrial Adenine Nucleotide 
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Transporter activity. The ATP consumption by the ATP-dependent pumps was incorporated and 
matched to the activity of that obtained in the neuronal module. The generalized ATPase 
reaction was also included to represent all the other ATP consuming processes in the cell. The 
general ATPase reaction will further be categorized upon incorporation of other modules and 
ATP dependent reactions. The mitochondrial calcium uptake and release was tied to the 
cytosolic calcium concentration. The cytosolic calcium concentration is again dependent on the 
calcium fluxes from the endoplasmic reticulum and the neuronal module. The phosphate 
transport into the cell and mitochondria was implemented based on equation 16. 
The cellular volume of NG108-5 cells was calculated using the equation of volume for a 
sphere. A radius of 22.5µm was used and is within the experimentally observed range published 
by American Type Culture Collection (ATCC) and also in agreement with the cell volume 
reported by Dubois el al. [76].  
4.1.5. Parameter estimation for metabolism model 
The rate equations in the metabolic model contain several parameters such as Vmax, Km, 
Ki etc. The values of the parameters are dependent on mutations, binding of effectors, lack of 
cofactors, etc.. In the glycolytic module only specific parameters such as the maximum activity 
Vmax is considered to alter as it reflects the concentration of the enzymes and the structural 
modifications of the enzyme [58]. The Vmax’s for the set of glycolytic, PPP, pyruvate transport 
and lactate transport reactions were scaled directly. The mitochondrial module has no Vmax’s 
but instead the mitochondrial enzyme concentration (E) is altered directly.  
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The flux of all the reactions in the metabolic reaction was obtained by forcing the model 
to a steady state. The steady state fluxes were set to obey the flux balance condition as shown 
below to represent the conservation of mass for reaction system. In steady state, the 
dependent change of metabolic concentrations in equation 21 is zero. The sundials solver was 
used with an absolute tolerance of 1.0e-8 and a relative tolerance of 1.0e-5. Sundials solver was 
recommended by MATLAB for running simulations that use rules and events. 
∑𝑁𝑖𝑗
𝑟
𝑗=1
𝑉𝑗 =  ∑𝑁𝑖𝑗
𝑟
𝑗=1
(𝑉𝑗
(+)
− 𝑉𝑗
(−)
) = 0 
(21) 
Optimization was performed using built-in MATLAB optimization routines. The function 
‘fmincon’ computes a constrained minimum of a function by varying the variables within 
specific bounds. Metabolites fluxes have been included as constraints in FBA. The fluxes of 
glucose uptake and lactate release were constrained during parameter estimation. The 
intracellular levels of ATP and ADP were also constrained during flux balance analysis by 
applying sum of squared residuals. 
Model optimization was carried out by applying the weighted least squares fitting 
method. The least square method minimizes the summed square of residuals. The residuals are 
the difference between simulated values and experimental values, 
𝑟𝑛 = 𝑆𝑛 − 𝐸𝑛  (22) 
The fit was improved by incorporating an additional scaling factor (weight) in the fitting 
process. The error estimate with weighted least-squares regression was determined by 
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𝑠𝑠𝑟 =  ∑𝑤(𝑟
𝑛
)2 (23) 
Where, the simulated flux is given by 𝑆 and the experimental flux by 𝐸. The influence of 
parameter estimate is response is determined by weight 𝑤. An arbitrary weight has been 
implemented to prioritize parameters during estimation. The algorithm implemented during 
parameter extraction is shown in Figure 15. 
 
Figure 15: Flowchart for estimation of metabolic model parameters 
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4.2. Development of neuronal module 
The neuronal module was implemented on the cell membrane (Figure 16). The ions 
move from the extracellular space to the sub-cellular space and from the subcellular space to 
the bulk cytosol. A modified Hodgkin-Huxley formulation based on incorporating a 
thermodynamic approach was employed to implement the neuronal module. The rate of 
change in membrane potential (Vm) was determined using, 
𝑑𝑉
𝑑𝑡
=  
− 𝐼𝑖𝑜𝑛 + 𝐼𝑠𝑡𝑖𝑚
𝐶𝑚
  
(24) 
Where, Cm is the membrane capacitance, Istim is the stimulus current and Iion is the sum of all the 
ionic currents.  
 
Figure 16: Schematic representation of neuronal module 
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The total ionic current 𝐼𝑖𝑜𝑛 and the leakage current 𝐼𝐿 were defined as, 
𝐼𝑖𝑜𝑛 = 𝐼𝑁𝑎 + 𝐼𝐾 + 𝐼𝐶𝑎  + 𝐼𝐾𝐴𝑇𝑃 + 𝐼𝑁𝑎𝐾𝐴𝑇𝑃𝑎𝑠𝑒 + 𝐼𝑁𝐶𝑋 + 𝐼𝐶𝑎𝐴𝑇𝑃𝑎𝑠𝑒 + 𝐼𝐿𝑁𝑎 + 𝐼𝐿𝐾
+ 𝐼𝐿𝐶𝑎 + 𝐼𝐿𝐺𝑒𝑛  
(25) 
Where, 𝐼𝑁𝑎, 𝐼𝐾  𝑎𝑛𝑑 𝐼𝐶𝑎 is the current generated from the voltage gated sodium, potassium and 
calcium channels, 𝐼𝐾𝐴𝑇𝑃  is from ATP-dependent potassium channel, 𝐼𝑁𝑎𝐾𝐴𝑇𝑃𝑎𝑠𝑒 is from the 
sodium-potassium exchanger, 𝐼𝐶𝑎𝐴𝑇𝑃𝑎𝑠𝑒 is from the calcium pump, 𝐼𝑁𝐶𝑋 is from the sodium 
calcium exchanger. 𝐼𝐿𝑁𝑎 + 𝐼𝐿𝐾  𝑎𝑛𝑑 𝐼𝐿𝐶𝑎are the specific ionic leakages for sodium, potassium and 
calcium ions. 𝐼𝐿𝐺𝑒𝑛represents the general leak. The method for determination of all the ionic 
currents is described in the following sections. 
4.2.1. Voltage gated channels 
The voltage gated sodium, potassium and calcium ion channels were implemented using 
the thermodynamic formulation [27]. These gates are controlled and activated by changes in 
membrane potential. A simple two state (open/close) formalism is adapted to describe the 
channel activation and inactivation. The voltage gated ionic currents are given by 
𝐼𝑁𝑎 = 𝑔𝑁𝑎𝑚
3ℎ(𝑉𝑚 − 𝑉𝑁𝑎) (26) 
𝐼𝐾 = 𝑔𝐾𝑛
4(𝑉𝑚 − 𝑉𝐾) (27) 
𝐼𝐶𝑎 = 𝑔𝐶𝑎𝑒
3(𝑉𝑚 − 𝑉𝐶𝑎) (28) 
Where 𝑔𝑁𝑎, 𝑔𝐾, 𝑔𝐶𝑎, 𝑉𝑁𝑎, 𝑉𝐾 and 𝑉𝐶𝑎 are maximum ion channel conductance and reversal 
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potentials of sodium, potassium and calcium respectively. The dynamics of gating variables 𝑚, 
ℎ, 𝑛, and 𝑒 with their steady state values 𝑚∞, ℎ∞, 𝑛∞, and 𝑒∞ as and the respective voltage 
dependent time constants 𝜏’s are given by,  
𝑑𝑚
𝑑𝑡
=
𝑚∞ −𝑚
𝜏𝑚
 (29) 
𝑑ℎ
𝑑𝑡
=
ℎ∞ − ℎ
𝜏ℎ
 (30) 
𝑑𝑛
𝑑𝑡
=
𝑛∞ − 𝑛
𝜏𝑛
 (31) 
𝑑𝑒
𝑑𝑡
=
𝑒∞ − 𝑒
𝜏𝑒
 (32) 
The voltage dependent steady state parameters and their respective time constants were 
determined using the general formula, 
𝑚∞ =
1
1 + 𝑒−𝑧𝐹(𝑉𝑚−𝑉1/2)/𝑅𝑇
 (33) 
𝜏𝑚 =
𝐴
𝑒(𝑧𝐹𝜉/𝑅𝑇)(𝑉𝑚−𝑉1/2)cosh (𝑧𝐹(𝑉𝑚 − 𝑉1/2)/2𝑅𝑇)
 (34) 
Where, 𝑧 is relates to the number of moving charges during the opening and closing of the ion 
channels, 𝑉1/2 is the half activation/inactivation potential of an ion channel; 𝐴 is related linearly 
to the activation or inactivation time constant, 𝜉 is the asymmetric position of the moving 
charge in the cell membrane, 𝑅 is real gas constant, 𝐹 is Faraday’s constant, 𝑇 is temperature, 
𝑅𝑚 is membrane resistance and 𝑉𝑚 is the resting membrane potential. 
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The reversal potentials were calculated as follows, 
𝑉𝑁𝑎 = 59.16 log10 (
[𝑁𝑎]𝑜𝑢𝑡
[𝑁𝑎]𝑖𝑛
) =  65 𝑚𝑉 (35) 
𝑉𝐾 = 59.16 log10 (
[𝐾]𝑖𝑛
[𝐾]𝑜𝑢𝑡
) = − 85 𝑚𝑉 (36) 
𝑉𝐶𝑎 =
59.16
2
log10 (
[𝐶𝑎]𝑜𝑢𝑡
[𝐶𝑎]𝑖𝑛
) =  124 𝑚𝑉 (37) 
Where the Na+, K+ and Ca+2 are the intracellular and extracellular ionic concentrations. The 
resting membrane potential was back calculated from the experimental holding potentials 
using the reversal potentials and the maximum ionic conductance using equation 38. 
𝑉𝑚 = 
𝑔𝑁𝑎𝑉𝑁𝑎 + 𝑔𝑘𝑉𝐾 + 𝑔𝐶𝑎𝑉𝐶𝑎 + 𝑔𝑙𝑒𝑎𝑘𝑉𝑙𝑒𝑎𝑘
𝑔𝑁𝑎 + 𝑔𝐾 + 𝑔𝐶𝑎 + 𝑔𝑙𝑒𝑎𝑘
  
(38) 
4.2.2. ATP dependent potassium channel 
An ATP-dependent potassium channel was incorporated and is activated when the 
cellular ATP decreases. The equation has been adapted from Cunningham et al. [77] and is 
defined as, 
𝐼𝐾𝐴𝑇𝑃 = 𝑔𝐾𝐴𝑇𝑃  𝑧(𝑉𝑚 − 𝑉𝐾) (39) 
𝑧 =  
1
1 + (
[𝐴𝑇𝑃]
𝑘12
)
𝛾 
(40) 
Where, 𝑔𝐾𝐴𝑇𝑃  is the maximum conductance of z is the gating variable, [ATP] is the ATP 
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concentration, k12 is 0.06, 𝑉𝐾 is the reversal potential of potassium and the hill coefficient (𝛾) is 
1. 
4.2.3. ATP dependent sodium-potassium pump 
The sodium potassium exchanger has been implemented as described by Kager et al.  
[78] to restore the balance for sodium and potassium ions. The pump contributes an 
electrogenic factor as it transports 3 Na+ in exchange for 2 K+ by consuming ATP. The ATP 
dependence was incorporated for ATP consumption and to determine its activity based on 
changes in intracellular ATP levels [79]. 
𝐴𝑝𝑢𝑚𝑝 = ((1 +
𝐾𝑚𝐾
[𝐾𝑜]
)
−2
) × ((1 +
𝐾𝑚𝑁𝑎
[𝑁𝑎𝑖]
)
−3
) × ((1 +
𝐾𝐴𝑇𝑃
[𝐴𝑇𝑃]
)
−1
) (41) 
𝐼𝐾𝐴𝑇𝑃𝑎𝑠𝑒 = −2 ∗ 𝐼𝑚𝑎𝑥
𝑁𝐾𝐴 ∗ 𝐴𝑝𝑢𝑚𝑝 (42) 
𝐼𝑁𝑎𝐴𝑇𝑃𝑎𝑠𝑒 = 3 ∗ 𝐼𝑚𝑎𝑥
𝑁𝐾𝐴 ∗ 𝐴𝑝𝑢𝑚𝑝 (43) 
The pump is modeled using the above modified rate equation where 𝐾𝑚𝐾 is 3.5 mM/L, 𝐾𝑚𝑁𝑎 of 
10 mM/L and 𝐾𝐴𝑇𝑃 = 5 mM [78,79]. 𝐼𝑚𝑎𝑥
𝑁𝐾𝐴 is the maximal flux generated by the pump to 
compensate the leaks and other pumps to obtain a steady state at rest. The literature reported 
value for 𝐼𝑚𝑎𝑥
𝑁𝐾𝐴 is 0.013 mA/cm2[78]. 
4.2.4. Sodium-calcium exchanger  
The sodium calcium exchanger (NCX) transports 3 Na+ in exchange for Ca+2 and is 
electrogenic. The exchanger was implemented using the formulation as described by 
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Courtemanche et al. [80,81].  
𝐾𝑏 = 𝑒
(
𝛾 𝑉𝑚 𝐹
𝑅𝑇 ) (44) 
𝐾𝑞𝑎 = 𝑒
(
(𝛾−1) 𝑉𝑚 𝐹
𝑅𝑇
)
 (45) 
𝐴𝑁𝐶𝑋 =
([𝑁𝑎]𝑖
3  ×  [𝐶𝑎]𝑜 × 𝐾𝑏) − ([𝑁𝑎]𝑜
3  ×  [𝐶𝑎]𝑖 × 𝐾𝑞𝑎)
(𝐾𝑚𝑁𝑎
3 + [𝑁𝑎]𝑜
3  ) (𝐾𝑚𝐶𝑎 + [𝐶𝑎]𝑜) (1 + 0.1𝐾𝑞𝑎)
  (46) 
𝐼𝑁𝑎𝑁𝐶𝑋 = −3 ∗ 𝐼𝑚𝑎𝑥
𝑁𝐶𝑋 ∗ 𝐴𝑁𝐶𝑋 (47) 
𝐼𝐶𝑎𝑁𝐶𝑋 = 2 ∗ 𝐼𝑚𝑎𝑥
𝑁𝐶𝑋 ∗ 𝐴𝑁𝐶𝑋 (48) 
Where, 𝐾𝑚𝑁𝑎   is 87.5 mM, 𝐾𝑚𝐶𝑎  is 1.38 mM, 𝐼𝑚𝑎𝑥
𝑁𝐶𝑋 is the maximal flux, and the voltage 
dependence parameter 𝛾 is 0.35. 
4.2.5. ATP dependent calcium pump 
The ATP dependent calcium pump has been incorporated as described by Kager et al. 
[81]. The ATP dependence was incorporated to calculate ATP consumption. 
𝐴𝐶𝑎𝑎𝑡𝑝 = ((1 +
𝐾𝑚𝐶𝑎
[𝐶𝑎𝑖]
)
−1
) × ((1 +
𝐾𝑚𝐴𝑇𝑃
[𝐴𝑇𝑃]
)
−1
) (49) 
𝐼𝐶𝑎𝐴𝑇𝑃𝑎𝑠𝑒 = 𝐼𝑚𝑎𝑥
𝐶𝑎𝑎𝑡𝑝 ∗ 𝐴𝐶𝑎𝑎𝑡𝑝 (50) 
Where, 𝐾𝑚𝐶𝑎 is 6.9 µM [81] and 𝐾𝑚𝐴𝑇𝑃 is 2.5 mM (estimated). 𝐼𝑚𝑎𝑥
𝐶𝑎𝑎𝑡𝑝 is the maximal flux for the 
Ca-ATPase pump and is estimated to simulate steady state. 
  
72 
 
4.2.6. Leakages 
Specific ionic leakages were implemented as described by Kager et al. [78].  
𝐼𝐿𝑁𝑎 = 𝑔𝑙𝑒𝑎𝑘𝑁𝑎(𝑉𝑚 − 𝑉𝑁𝑎) (51) 
𝐼𝐿𝐾 = 𝑔𝑙𝑒𝑎𝑘𝐾(𝑉𝑚 − 𝑉𝐾) (52) 
𝐼𝐿𝐶𝑎 = 𝑔𝑙𝑒𝑎𝑘𝐶𝑎(𝑉𝑚 − 𝑉𝐶𝑎) (53) 
𝐼𝐿𝑔𝑒𝑛 = 𝑔𝑙𝑒𝑎𝑘𝑔𝑒𝑛(𝑉𝑚 − 𝑉𝑙𝑒𝑎𝑘) (54) 
The 𝑔𝑙𝑒𝑎𝑘𝑁𝑎, 𝑔𝑙𝑒𝑎𝑘𝐾  and 𝑔𝑙𝑒𝑎𝑘𝐶𝑎  are the maximum leak conductance of sodium, potassium and 
calcium ions. The maximum leak conductance and reversal potential for general leak are 
determined by choosing the holding potentials of -85 and -80 mV. At these potentials the cell is 
hyperpolarized and has no significant contribution from the voltage gated ion channels. The 
maximum leak conductance of leakage is, 
𝑔𝐿𝑒𝑎𝑘𝑔𝑒𝑛 =
(5 − 𝑅𝑚) (𝐼85 − 𝐼80)
(5 𝑅𝑚)
  (55) 
The 𝐼85 𝑎𝑛𝑑 𝐼80 are the total ionic currents at the holding potential of -85 and -80 mV. 𝑅𝑚 is the 
membrane resistance. The leakage reversal potential was determined using, 
𝑉𝑙𝑒𝑎𝑘 =
𝐼𝑖𝑜𝑛𝑖𝑐
𝑉𝑚
𝑔𝑙𝑒𝑎𝑘𝑔𝑒𝑛
+ 𝑉𝑚  (56) 
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𝐼𝑖𝑜𝑛𝑖𝑐
𝑉𝑚 = 𝐼𝑁𝑎 + 𝐼𝐾 + 𝐼𝐶𝑎  + 𝐼𝐾𝐴𝑇𝑃 + 𝐼𝑁𝑎𝐾𝐴𝑇𝑃𝑎𝑠𝑒 + 𝐼𝑁𝐶𝑋 + 𝐼𝐶𝑎𝐴𝑇𝑃𝑎𝑠𝑒 + 𝐼𝐿𝑁𝑎
+ 𝐼𝐿𝐾 + 𝐼𝐿𝐶𝑎  
(57) 
The reversal potential for leakage was calculated based on the fact that the membrane current 
at resting membrane potential was zero. The membrane resistance and resting membrane 
potential were experimentally determined. 
4.2.7. Ionic concentrations 
The ionic currents were converted into chemical units to determine the changes in the 
ionic concentrations. Ionic concentration was obtained by multiplying ionic current in 𝑝𝐴 with a 
surface factor (𝐹𝑆). The surface factor was determined by, 
𝐹𝑆 =
𝐶𝑢𝑟𝑟𝑒𝑛𝑡 
𝐹𝑎𝑟𝑎𝑑𝑎𝑦 ∗ 𝐶𝑒𝑙𝑙 𝑉𝑜𝑙𝑢𝑚𝑒
 
(58) 
𝐹𝑆  =  
10−12  
𝑚𝑜𝑙 𝐶
𝑠
96485 
𝐶
𝑠  ∗
(50 × 10−15) 𝑚3
 
 
𝐹𝑆  =  2.073 × 10
−7
𝑚𝑜𝑙
𝑚3 𝑚𝑠
 
 
The model was compartmentalized and the diffusion of ions was considered to take place from 
the center of the sub-cellular space to the center of the bulk cytosolic space. The diffusion of 
ion (I) is given by [70], 
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𝐽𝐼(𝐶1−𝐶2) = 𝐷𝐼(𝐶1−𝐶2)𝐴 
[𝐼]𝐶1 − [𝐼]𝐶2
𝛥𝑥𝐶1−𝐶2
 
(59) 
Where, the ion diffuses a distance (x) through area (A) from the center of one compartment 
(C1) to another compartment (C2). The parameters (Table 4) were obtained from the Rabbit 
ventricular myocyte [70]. The diffusion distance of 0.45 from the subcellular space to middle of 
the bulk cytosolic space was calculated assuming a length of 1.8 m. The distance determines 
the transfer functions for the ionic fluxes between compartments. The lumped nature of the 
compartments was thereby adjusted to the physical geometry [70]. 
Table 4: Parameters for flux determination 
Parameter Value Reference 
Cell length 100 µm [70] 
Cell radius 10  µm [70] 
Sub-cellular space depth 45 nm [70] 
Area (Subcell - bulk) 3.01 × 10-6 cm2 [70] 
DNa (Subcell - bulk) 1.09 × 10
-5  cm2/s [82] 
DK (Subcell - bulk) 1. 96 × 10
-5  cm2/s [83] 
DCa (Subcell - bulk) 1.22 × 10
-6  cm2/s [82] 
Distance (𝛥𝑥) 0.5  µm [70] 
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The changes in the subcellular space and bulk cytosol sodium concentration was determined 
using the equation, 
𝑑
𝑑𝑥
[𝑁𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 = 
−𝐼𝑁𝑎
𝑡𝑜𝑡𝑎𝑙 𝐹𝑆 + 𝐽𝑁𝑎([𝑁𝑎]𝐵𝑢𝑙𝑘 − [𝑁𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙)
𝑉𝑆𝑢𝑏𝑐𝑒𝑙𝑙
 
(60) 
𝑑
𝑑𝑥
[𝑁𝑎]𝐵𝑢𝑙𝑘 = 
𝐽𝑁𝑎([𝑁𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 − [𝑁𝑎]𝐵𝑢𝑙𝑘)
𝑉𝐵𝑢𝑙𝑘
 
(61) 
The changes in the subcellular space and bulk cytosol potassium concentration was determined 
using the equation, 
𝑑
𝑑𝑥
[𝐾]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 = 
−𝐼𝐾
𝑡𝑜𝑡𝑎𝑙  𝐹𝑆 + 𝐽𝐾([𝐾]𝐵𝑢𝑙𝑘 − [𝐾]𝑆𝑢𝑏𝑐𝑒𝑙𝑙)
𝑉𝑆𝑢𝑏𝑐𝑒𝑙𝑙
 
(62) 
𝑑
𝑑𝑥
[𝐾]𝐵𝑢𝑙𝑘 = 
𝐽𝐾([𝐾]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 − [𝐾]𝐵𝑢𝑙𝑘)
𝑉𝐵𝑢𝑙𝑘
 
(63) 
The changes in the subcellular space and bulk cytosol calcium concentration was determined 
using the equation, 
𝑑
𝑑𝑥
[𝐶𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 = 
−𝐼𝐶𝑎
𝑡𝑜𝑡𝑎𝑙 𝐹𝑆 + 𝐽𝐶𝑎([𝐶𝑎]𝐵𝑢𝑙𝑘 − [𝐶𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙)
𝑉𝑆𝑢𝑏𝑐𝑒𝑙𝑙
 
(64) 
𝑑
𝑑𝑥
[𝐶𝑎]𝐵𝑢𝑙𝑘 = 
𝐽𝐾([𝐶𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 − [𝐶𝑎]𝐵𝑢𝑙𝑘)
𝑉𝐵𝑢𝑙𝑘
 
(65) 
Where, 𝐼𝑁𝑎
𝑡𝑜𝑡𝑎𝑙, 𝐼𝐾
𝑡𝑜𝑡𝑎𝑙  and 𝐼𝐶𝑎
𝑡𝑜𝑡𝑎𝑙  are the total specific currents generated by the movement of 
sodium, potassium and calcium respectively. 𝑉𝑆𝑢𝑏𝑐𝑒𝑙𝑙 and 𝑉𝐵𝑢𝑙𝑘 are the volumes of the sub-
compartments. 
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4.2.8. Parameter estimation for electrophysiological recordings 
The coupled ordinary differential equations were numerically integrated in MATLAB 
using a built-in differential equation solver ‘ode15s’ to solve a set of differential equations. A 
relative tolerance of 10-5 and an absolute tolerance of 10-6 were used. A custom graphical user 
interface (GUI) was created in MATLAB for parameter estimation and all the ion channels of the 
neuronal module including the leakage correction were incorporated.  
The experimentally measured voltage clamp and current clamp were imported into 
MATLAB for deconvolution. The initial fitting parameters were obtained from the previously 
published average values [27,78].  The potassium currents in the voltage clamp recordings were 
fitted followed by calcium and sodium currents. A simultaneous fit was then performed on the 
voltage gated ion channels to obtain a first estimate for ion channel parameters. Using the 
obtained ion channel parameters and to avoid numerous solutions considering the large set of 
parameters being fitted, a second optimization was performed to extract a quasi-unique set of 
parameters by fitting the simulated action potentials to experimental measurements. The 
fittings were not sufficiently optimized to balance the ionic concentrations and could not 
produce a steady state. So, a third optimization routine was performed by optimizing the 
activities of pumps, exchangers and specific leakages. The 𝐼𝑚𝑎𝑥 for ion exchanges and 𝑔𝑚𝑎𝑥 for 
specific ionic leakages were determined. The action potential time series data was then fitted 
to further validate the experimental action potentials. The second and third steps of the 
optimization routines were repeated to fit the experimental recordings. 
The optimization was performed using built-in MATLAB optimization routines. The 
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function ‘fmincon’ computes a constrained minimum of a function by varying the variables 
within specific bounds. This was carried out in combination with the sum of squared residuals 
(ssr) as described in the following equation, 
𝑠𝑠𝑟 =  ∑(𝑆(𝑡𝑛) − 𝐸(𝑡𝑛)
𝑛
)2 (66) 
Where, the simulated value is given by 𝑆 and the experimental value by 𝐸 at time 𝑡𝑛. 
4.3. Integration of neuronal and metabolic models 
The model was numerically integrated using MATLAB (2014a) in a modular approach. It 
was modeled and simulated using a desktop computer running Windows 7 on a 2.95GHz Intel 
Core2-Quad CPU and 8GB RAM. The obtained results were analyzed and plotted in MATLAB. 
The neuronal module and the metabolic model were coupled to form the neuronal-
metabolic model. The models were interfaced to exchange the intracellular ATP, ionic 
concentrations and the membrane potentials. Additional ATP consumption reactions such as 
NaK-ATPase and Ca-ATPase were incorporated into the metabolic model. The activity of these 
reactions was matched to that of the neuronal model. The metabolic model can sense only the 
bulk cytosolic concentrations. The neuronal module coupled to the deconvolution algorithm 
extracted the ion channel parameters which were then imported into the neuronal-metabolic 
model. The neuronal module calculates currents and the changes in the ionic concentrations. 
The obtained concentrations were fed into the metabolic model. The metabolic model was 
simulated following the determination of the metabolic activity. The new metabolite and ionic 
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concentrations were again feed into the neuronal module. 
The action potential was simulated for every one second. The ionic exchangers usually 
restored the ionic balances within a few milliseconds. Stimulating an action potential every one 
second gives the ionic exchanges ample time to restore ion balances. The model was simulated 
to simultaneously generate a series of action potentials and run the metabolic model to 
determine the intracellular fluxes and changes in ionic concentrations. The model also 
predicted the changes in intracellular protein activities and metabolic concentrations. To 
simulate drug effects, the event created in Simbiology was turned ‘on’ and the model was 
simulated. The simulation results were compared to the experimentally determined values. 
4.4. Simulating experimental conditions 
To simulate the drug effects an event was created in the metabolic model (Simbiology-
MATLAB) to introduce a drug effect that inhibits the enzyme activity. The inhibitors tested 
(Table 5) only bind and inhibit the enzymes in the metabolic pathway. The inhibitors do not 
bind to ion channels, so the ion channel parameters were held constant while fitting the drug 
induced time-series data. The only parameters allowed to change are the reversal potentials for 
the ion channels and cellular ATP concentrations in the neuronal module. So when fitting the 
effects of ion channel inhibitors, the ion channel parameters can be changed as they bind to the 
ion channel directly, thereby modifying its properties. 
The Vmax of the targeted enzyme was reduced, using a scaling factor. The scaling factor 
allows a function for the dose-response curve, describing the effect of a compound on the 
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enzyme [84]. The scaling factor ‘b’ typically relates the drug concentration [D] according to, 
𝑏 =
1
1 + (
[𝐷]
𝐼𝐶50
)
𝑛 
(67) 
Where IC50 is the drug concentration at which a 50% reduction in the enzyme activity is 
observed, which n is the Hill coefficient of the dose-response curve and is often assumed to be 
one as one drug molecule is necessary to inhibit the enzyme [84]. The IC50 values were obtained 
by fitting the model to metabolic experimental data.  
The neuronal-metabolic model was simulated to predict the changes in cellular 
metabolism and action potentials. The specific Vmax’s or the enzyme concentration that were 
reduced to simulate the drug effects are listed below. 
Table 5: List metabolic inhibitors and their targets 
Drug Enzyme 
2DG Hexokinase 
Cyanide Mitochondrial Oxidative Phosphorylation 
Malonate Succinate Dehydrogenase 
2DG + Cyanide Hexokinase and Oxidative Phosphorylation 
2DG + Malonate Hexokinase and Succinate Dehydrogenase 
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CHAPTER-5: RESULTS 
 
The results obtained from the experiments and computational model are analyzed in this 
chapter. The basal metabolism was evaluated for calibrating the metabolic model to steady 
state. The core energy producing metabolic pathways namely glycolysis, mitochondrial TCA 
cycle and the electron transport chain were inhibited using 2DG, cyanide and malonate. A 
combinational inhibition of these pathways was also performed to experimentally validate the 
metabolic and electrophysiological responses. The neuronal-metabolic model was simulated to 
predict the metabolic fluxes and action potential time-series. The simulation data was 
compared to the experimental measurements. The results presented in this chapter 
demonstrate the predictive capabilities of the model. 
5.1. Bioenergetics of NG108-15 cells 
The NG108-15 cells were obtained by fusing mouse N18TG2 neuroblastoma and rat C6-
BU-1 glioma cells in presence of sendai virus. During the fusion process reprogramming of core 
cellular metabolic pathways may occur. The reprogramming of cellular metabolic pathways 
impacts cellular functions and bioenergetics. To characterize and quantify NG108-15 cellular 
bioenergetics, the basal metabolism was determined by measuring the glucose utilization, 
lactate secretion, cellular ATP and ADP levels. 
5.1.1. Glucose and lactate flux 
The carbon flux was determined by measuring glucose uptake and lactate release. The 
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glucose uptake was found to be 495.19 + 63.72 pM/hr/cell and is in close range to that found in 
glioblastoma cells previously [85]. The lactate flux was determined to be 851.05 + 74.72 
pM/hr/cell. The rates of lactate production are consistent with the expected flux for glioma 
cells [86]. The measurement of carbon flux revealed that 85% of the carbon entering the cell 
was ending up as lactate and only 15% of carbon is being utilized by other pathways in the cell. 
The glycolytic and lactate fluxes remained steady over time (Figure 17). The carbon flux was 
compared to Murine hybridoma cell line. Murine hybridoma cell had a glucose uptake of 380 
nmol/hr/106 cells and a lactate release of 630 nmol/hr/106 cells indicating a carbon flux of 83% 
into lactate production [87]. 
 
Figure 17: Measured glucose uptake (O) and lactate output (□) flux of NG108-15 cells 
Lactate excretion causes the cell to waste three carbons that can either be incorporated 
into macromolecular precursor biosynthesis or get utilized in ATP production [88]. The 
increased lactate excretion elevates carbon uptake and simultaneously increases the pentose 
phosphate pathway activity. The elevated carbon utilization and lactate production regardless 
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of the availability of oxygen suggests the presence of aerobic glycolysis. This phenomenon was 
found by Otto Warburg and termed as ‘the Warburg effect’. The effect was mostly found in 
cancer cells with lower mitochondrial respiration rates. This elevated glycolysis helps the cell to 
maintain higher proliferation rates or in differentiation mode enables the cell to produce 
neuronal process faster compared to primary neurons. Moreover, a sufficient amount of energy 
for maintaining cellular functions is produced by glycolysis in cancer cells. 
5.1.2. ATP and ADP concentrations 
Cellular ATP levels act as an indicator of cellular health and any disruption in cellular 
pathways may lead to impaired cellular bioenergetics. The assay kits measure the total cellular 
ATP and ADP levels including free and Mg-bound ATP/ADP. The intracellular ATP and ADP levels 
in NG108-15 cell were found to be 0.22 + 0.03 mM and 0.11 + 0.02 mM respectively. The ATP 
and ADP levels were stable over time (Figure 18) matching the literature reported values [89].  
 
Figure 18: Measured intracellular ATP (O) and (□) ADP levels in NG108-15 cells 
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A literature search on intracellular ATP levels in different cell lines has shown that they 
possess lower levels (Table 6). Furthermore, most cell lines depend on aerobic glycolysis, an 
inefficient pathway for ATP production. The alterations in cellular bioenergetic pathways 
produce different metabolites supporting rapid cell growth and proliferation [88]. Normal cells 
utilize the nutrients efficiently and cell lines have no selective pressure to optimize their 
metabolism for ATP production. Glycolysis is an inefficient mode of ATP generation compared 
to mitochondrial pathway. The intracellular ATP/ADP ratio is also maintained at steady state 
and determines which pathway the cell adapts for ATP production. A lower ATP/ADP ratio has 
been shown to favor glycolysis and a higher ratio would favor mitochondrial ATP production 
[88]. A slight change in cellular ATP/ADP or ADP/AMP ratio may impair cellular homeostasis and 
trigger apoptosis [90]. 
Table 6: Literature reported cellular ATP levels in different cell lines 
Cell type Origin ATP  
(nmol/106 cells) 
ADP  
(nmol/106 cells) 
ATP/ADP 
ratio 
Reference 
HeLa Cervical cancer cells (glycolysis dominated) 5.2 1.64 3.2 [91] 
BSC-40 Kidney epithelial cell line (oxidative phosphorylation 
dominated) 
9.47 1.08 8.8 [91] 
SH-SYSY Human dopaminergic neuroblastoma cell line 1.33 0.24 5.5 [92] 
NG108-15 Hybrid neuroblastoma and glioma cell 8 - 10 - - [89,93] 
NG108-15 Hybrid neuroblastoma and glioma cell 10 + 0.83 5.13 + 0.44 1.9 Measured 
values 
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5.2. Deconvolution of Electrophysiological Recordings 
5.2.1. Thermodynamic dependent Hodgkin-Huxley Model 
To deconvolute the electrophysiological recordings the neuronal model was constructed 
in a modular approach. The basic voltage gated ion channels were modeled by incorporating 
the thermodynamic dependences and simulated using previously published ion channel 
parameters [27]. The voltage clamp and the current clamp recordings were simulated for a 
NG108-15 cell. 
 
Figure 19: Voltage clamp simulation. (A) The voltage steps protocol used during a voltage clamp recording. (B) 
Simulated voltage clamp recording for NG108-15 cell 
During a voltage clamp recording, the voltage was held constant at different ‘steps’  
(Figure 19A) and the changes in the current were recorded (Figure 19B). The voltage 
dependence on the ionic current is demonstrated by plotting the current-voltage relationship 
(Figure 20). The properties of NG108-15 cells were demonstrated by varying the current during 
incremental impositions of voltage or the responses of voltage to current injections through a 
whole-cell patch. The IV-curve for NG108-15 defines the input resistance. 
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Figure 20: IV Curve for NG108-15 cell showing the changes in sodium (green), potassium (blue) and total current 
(red) at different voltages 
The current clamp recording was also simulated to generate an action potential using 
the same parameters by application of a stimulus current (Figure 21). 
 
Figure 21: Simulated current clamp recording showing an action potential 
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The activation and inactivation of gates determines the generation of action potentials. The 
probabilities during NG108-15 action potential are shown in the Figure 22. At rest, the 
activation variable for sodium (m) is small and inactivation variable (h) for sodium is large. The 
activation of potassium (n) and calcium (e) are also small. When a stimulus is applied, the 
membrane depolarizes causing an increase in m leading to the peak in action potential. The 
activation of potassium gate (n) also increases and h decreases. The activation of the calcium 
gate (e) also takes place during the action potential generation. The gates h and n slowly return 
to their initial state when compared to other gates where as other gates act rapidly (Figure 22). 
 
Figure 22: The activation and inactivation of voltage gated ion channel gates during an action potential 
5.2.2. Modeling ionic exchangers, pumps and leaks 
The ATP dependent potassium channel (KATP) has emerged as an important ion channel 
especially in neurodegenerative diseases and acute brain ischemia adapting to changes in 
metabolic activity. The probability of activation and inactivation depends on the intracellular 
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ATP levels directly coupling the metabolic activity and membrane electrical activity. The 
channel was modeled and simulated to visualize the changes in action potential peak shape due 
to changes in cellular ATP concentration (Figure 23). 
 
Figure 23: Effect of cellular ATP levels on action potential peak shape 
The resting membrane potential is mainly determined by the ionic pumps and leakages. 
The sodium and potassium ion leaks are counterbalanced by the Na/K-ATPase pump. The ATP 
dependent sodium potassium exchanger is a major pump responsible for maintaining sodium 
and potassium homeostasis. The current generated by moving three sodium ions out and two 
potassium ions against the concentration gradients has been added to the respective total 
specific ionic currents. At rest, the pump balances the sodium (Figure 24) and potassium (Figure 
25) fluxes of the ion channels and leaks. A stoichiometric balance of intracellular potassium and 
sodium ions was not achieved by Na/K-ATPase pump alone. Additional ionic pumps have been 
incorporated to maintain cellular ionic concentrations (Figure 26). 
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Figure 24: Restoration of intracellular sodium concentration by Na/K-ATPase pump. (A) Without Na/K-ATPase and 
(B) with Na/K-ATPase 
 
Figure 25: Restoration of intracellular potassium concentration by Na/K-ATPase pump. (A) Without Na/K-ATPase 
and (B) with Na/K-ATPase 
 
Figure 26: Rationale for implementation of other ionic pumps 
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Figure 27: Sodium-calcium exchanger currents mediated by changes in membrane potential 
 
Figure 28: Remodeled the IV curve for sodium calcium exchanger showing the exchanger activity for different 
calcium concentrations 
The sodium calcium exchanger (NCX) activity is dependent on the membrane potential 
and intracellular calcium concentration. NCX exchanges one calcium ion for three sodium ions 
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and has an electrogenic contribution to the membrane electrical properties. At rest, the 
exchanger activity is reversed transferring three sodium ions out and one calcium ion thereby 
generating a very small sodium and calcium current (Figure 27). The membrane depolarization 
reverses the pump activity again resulting in an outflow of calcium and influx of sodium [81]. A 
shift in curve representing the calcium influx and efflux is observed (Figure 27). The pump 
activity depends on the intracellular calcium concentration. Two intracellular calcium 
concentrations were used to model validate the exchanger activity (Figure 28). The slope of the 
curve varies with the increased calcium concentration leading to a faster extrusion of 
intracellular calcium ions. The activity from Courtemanche et al. [80] and Kager et al. [81] has 
been reproduced to validate NCX and adapted into the neuronal module. 
 The ATP dependent calcium pump (Ca-ATPase) transports intracellular calcium ions 
against the concentration gradient by consuming intracellular ATP. The pump activity increased 
with an accumulation of intracellular calcium (Figure 29). Kager at al. have assumed an 
unlimited availability of cellular ATP and modeled the pump [81]. Since ATP could be a limiting 
factor in the model, ATP dependence has been incorporated so that the pump could lower the 
extrusion of calcium ions upon lowering the intracellular ATP levels. The ATP dependence has 
been modeled to match the Ca-ATPase activity previously reported by Kager et al. (Figure 30). 
The activity of pump is made very sensitive to intracellular ATP levels so a slight decrease in ATP 
concentration would lower the pump activity and lead to an accumulation of intracellular 
calcium. 
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Figure 29: Calcium dependence on Ca-ATPase pump 
 
Figure 30: ATP dependence on Ca-ATPase pump 
Specific ionic leakages were implemented to represent all the other sodium, potassium 
and calcium ion channels [78]. The ions diffuse long the diffusion gradient and the ionic 
exchangers restore the altered intracellular levels. All the equations were implemented and the 
steady state was simulated using the experimental holding potential. The holding potential was 
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varying due to the experimental conditions. The resting membrane potential was calculated as 
shown in Figure 31A. The sodium, potassium and calcium ionic concentrations were at steady 
state when the model was simulated for 40 min (Figure 31). The parameter estimation for Imax 
of all the pumps and conductance for leakages was performed to simulate steady state. Model 
was compartmentalized by incorporating the ionic fluxes of subcellular space and bulk cytosol. 
The fluxes were simultaneously determined while generating the action potential. 
 
Figure 31: Calibration of the neuronal module to simulate steady state. (A) The resting membrane potential (red 
line) of the cell is determined based on holding potential (blue line). The changes in (B) sodium, (C) potassium and 
(calcium) concentrations are simulated 
 
 
A B 
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5.2.3. Extraction of electrophysiological parameters 
NG108-15 cells were observed to be fully differentiated on day-4 in serum-free 
differentiation medium and were patched to record their electrophysiological activity (Figure 
32). Voltage clamp and current clamp data were imported into Matlab and fitted using the 
custom graphical user interface. The curves were fitted after an initial 0.1ms delay to eliminate 
the effect of experimental artifacts. The voltage clamp recordings were fitted initially and an 
agreeable fit was obtained to the sodium, potassium and calcium ion channel data (Figure 32).  
 
Figure 32: Simulated (red) voltage clamp were fitted to an experimental (blue) recording 
Ion channel parameters were then automatically fitted using the fitting algorithm that 
converged in less than 4 minutes. Weighted least square error function was applied to quantify 
the difference between the simulated and the experimentally recorded data [27]. The 
implemented error function is: 
 Least square: ELsquare =∑(𝑆(𝑡𝑛) − 𝐸(𝑡𝑛)
𝑛
)2 
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Weighted least square: E𝑊Lsquare=ELsquare  if tn<30ms and EWLsquare=5 ×ELsquare  if tn≥30ms 
 
Figure 33: Simulated (red) action potentials were fitted to experimental (blue) action potential recording 
The action potentials (Figure 33) were evoked with a short 2 ms current injection in 
current clamp mode at holding potential. The following parameters were obtained from the 
patch-clamp recordings and used in the modeling: membrane resistance, resting membrane 
potential, membrane capacitance and injected current. The maximum conductance of the 
leakage current was calculated form the resting membrane potential in the model. The earlier 
averaged ion-channel parameters were used as initial values for AP fitting. Using the voltage 
dependent sodium, potassium and calcium ion channels, ATP-dependent potassium channel, 
ATP-dependent exchangers, sodium-calcium exchanger and specific leakages an excellent fit to 
the entire AP was obtained (Figure 33). The first action potential was fitted simultaneously with 
the voltage clamp recording and the extracted parameters were fed into the coupled neuronal-
metabolic model.  
The model showed a sharp rise in the subcellular ionic concentrations of sodium (Figure 
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34), potassium (Figure 35) and calcium (Figure 36) ions. However, the bulk cytosolic 
concentrations did not change significantly.  
 
Figure 34: Simulated changes in subcellular and bulk cytosolic sodium concentration during action potential 
 
Figure 35: Simulated changes in subcellular and bulk cytosolic potassium concentration during action potential 
These results were observed to be in agreement with the physiological observations. It is well 
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known that during action potential generation and propagation, the ionic concentrations close 
to the membrane change rapidly causing the membrane potential to alter. The bulk 
intracellular ionic concentrations do not change significantly. The ion channels on the plasma 
membrane only sense the ionic concentrations close to the membrane and act rapidly to 
restore the ionic balances. 
 
Figure 36: Simulated changes in subcellular and bulk cytosolic calcium concentration during action potential 
The sodium and calcium buffering takes place in the cell [70]. To keep the model simple, 
buffering systems have not been included. A sudden rise in ionic concentration leads to an 
increased activity of the exchangers and pumps to extrude and restore the intracellular ionic 
concentrations. The diffusion of ions takes place from the subcellular space to the bulk cytosol 
initially and when the pumps are reestablishing the sub-cellular concentrations, the bulk 
cytosolic concentrations also slowly reached the initial values.  
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5.2.4. Statistical analysis 
Ion channel parameters were extracted by fitting the voltage clamp recoding and the 
initial action potential of a total of forty nine data sets. Several fitting parameters were applied 
in fitting the action potentials. Each dataset produced a different set of parameters. Statistical 
analysis was performed to determine the variations in fitting parameters. A box plot has been 
created to visualize the skewness of parameters and to identify outliers. The box plot of 
voltage-gated sodium channel parameters is shown in Figure 37. 
 
Figure 37: Box plot for voltage gated sodium channel parameters 
The maximum conductance of sodium channel has a wide range and is much higher 
than the conductance of other ion channels. These conductances are unique for a particular cell 
to support its cellular functions. The variations in voltage thresholds and time constants for 
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channel activation and inactivation vary the ion channel conductance [94]. Moreover the 
location where the cells are patched can also cause variations. The activation and inactivation 
parameters are used to fit the exponential and sigmoidal functions of Hodgkin-Huxley model. 
No large change was found in these parameters while fitting it to the experimental data. The 
estimated half-activation potential was -43.41 + 6.47 mV and was agreement with that found in 
neuronal models. The experimentally determined half-activation potential from central neurons 
is -60 mV [95]. The variations could be due to the different resting membrane potentials of the 
cells (Figure 41C). 
 
Figure 38: Box plot for voltage gated potassium channel parameters 
The box plot of potassium channel parameters showed the variability in activation 
amplitude, half-activation potential and the maximum conductance (Figure 38). The half-
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activation potential of cortical pyramidal neurons was found to be -24.5mV and was close to 
the fitted result of -16.04 + 9.62 mV for NG 108-15 cells [96]. The activation time constant 
(Act_amp) has a higher standard deviation but the box plot shows that 25% of the values are in 
the 3rd quartile close to 22 ms. The maximum conductance (gmax) for voltage gated potassium 
channel is very low compared to the sodium channel.  
 
Figure 39: Box plot for voltage gated calcium channel parameters 
Similarly, the calcium parameters showed slight variations (Figure 39). The activation 
time constant and half-membrane potential had a few outliers. The fitted gmax of voltage gated 
calcium channel for NG108-15 cells is 6.77 + 3.69 mS and is in agreement with the earlier 
reported values [27]. Few recordings had a higher calcium conductance causing a ‘hump’ in 
action potential. The calcium entering the cell acts as serves as secondary messenger during AP. 
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A list of all the ion channel parameters with the standard deviations is given below in Table 7 
and 8. 
Table 7: Average electrophysiological parameters for NG108-15 cells obtained from fitting to voltage clamp and 
current clamp recordings. Data are mean + SD (n = 49) 
Ion channel Parameters Sodium Potassium Calcium Leak 
Conductance (g) 241.21 + 104.08 14.62 + 7.43 6.77 + 3.69 3.24 + 2.34 
Reversal potential (VRev) 67.85 -85.61 124.05 - 53 + 86 
Activation exp (m,n,e) 3 4 3 - 
Inactivation exp (h) 1 - - - 
Activation q (q) 14.92 + 8.97 1.61 + 0.42 1.71 + 1.67 - 
Half activation potential (V1/2) -43.41 + 6.47 -16.04 +  9.62 -25.41 + 14.44 - 
Act.assim (ξ) -0.43 + 0.08 -0.04 + 0.22 -0.17 + 0.05 - 
Act.Ampl (A) 0.83 + 0.77 35.39 + 30.38  32.19 + 18.29 - 
Inactivation q (q) -4.66 + 0.4 - - - 
Inact. Half-activation -73.9 + 7.07 - - - 
Inact. Assim 0.36 + 0.04 - - - 
Inact.Ampl 4.95 + 4.38 - - - 
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Table 8: Activities of exchangers and leaks 
 NaK-ATPase Ca-ATPase NCX K-ATP Na leak K leak Ca leak 
Imax 1520 + 351 1700 + 147 502 + 55 - - - - 
Conductance - - - 2.54 + 1.98 0.39 + 0.21 4.2 + 1.6 0.12 + 0.2 
 
The Imax’s for the exchangers also varied from cell to cell as the membrane potential, 
capacitance and fluxes varied (Table 8). The fitted Imax for Na/K-ATPase is close to that reported 
in the literature for neurons [78,79]. The Ca-ATPase was slightly higher than the Na/K-ATPase as 
NG108-15 cells have higher intracellular calcium levels similar to cancer cells. The cellular 
resting membrane potential was determined based on separation of potassium ions since the 
cellular membrane has higher permeability towards potassium. The potassium leak 
conductance is higher compared to the sodium and calcium leak conductances. 
 
Figure 40: Box plot for (A) leakage currents and (B) maximum conductance of ATP dependent potassium channel 
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The maximum conductance and reversal potential for general leak have also been analyzed 
(Figure 40A). The implementation of ion channels in the model lead to a decrease in leakage 
conductance. The maximum conductance of the ATP dependent potassium channel was 2.54 + 
1.98 (Table 8) and is higher than that of primary cortical neurons [77]. The sensitivity of KATP 
channel varies from cell to cell [97]. A decrease in cellular ATP level causes the KATP channel to 
activate and prevents the potassium ions to move across the membrane. The experimental 
membrane resistance is 0.64 + 0.30 GΩ and the membrane capacitance which is indicative of 
the cell size is 69.19 + 37.87 pF. The resting membrane potential (RMP) of the patched cells was 
-43.88 + 5.99 mV with 25% of the recordings in the third quartile showing a RMP of -47 mV 
(Figure 41C). The resting membrane potential of NG108-15 cell has been reported to range 
from -33.2 to -47 mV [98,99]. 
 
Figure 41: Box plot for experimentally obtained (A) membrane resistance, (B) membrane capacitance and (C) 
resting membrane potential 
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5.3. Steady state analysis 
Modeling cellular metabolic pathways integrates all the information into a functional 
networking model that simulates all the intracellular interactions. The aim is to construct and 
validate the model to predict cellular protein activities, fluxes, metabolite concentrations and 
action potentials at steady state. 
5.3.1. Forcing metabolic model to steady state 
The method for reconstructing large models is to obtain a validated model and 
recalibrate it to match the experimental data for the cell type of our interest. The cellular 
pathways possess a very complex feedback and feed-forward interactions that control the 
overall flux and must be maintained continuous check [100]. This means that the relative ratios 
of kinetic constants are important and any disruptions in the balance will render the model 
causing an accumulation of intracellular metabolites. In reality, cell controls the flux by 
adjusting protein concentrations. Metabolic genes are typically located in blocks within the 
genomes and are expressed together. In our model, we are essentially altering the Vmax of the 
reactions to mimic the changes in protein concentration within a cell as a means of controlling 
flux [58,72,101].  
The glycolytic model derived from red blood cell [72] was more favorable as it utilizes 
glucose as the primary source of carbon. This is important because glucose is the major source 
of carbon in brain and neuronal glycolysis is regulated by hexokinase [54]. In addition, the 
glycolytic model consists of the PPP that is active in brain [54]. Red blood cells lack 
mitochondria forcing them to completely rely on glycolysis for carbon and ATP [102]. Since the 
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glycolytic module from red blood cells has higher a glycolytic activity, we have lowered the Vmax 
of the glycolytic enzymes between 1-100% to match the experimentally measured data 
[58,101]. Similarly, the mitochondrial model obtained from cardiac cell provides 90% of the 
energy from mitochondrial oxidative phosphorylation and is highly active [103]. The TCA cycle 
activity was lowered by altering the enzyme concentrations. The total concentration of the TCA 
cycle metabolites was conserved [59] to match the experimental data.  
The ensemble metabolic model was calibrated by scaling a set of pathways 
simultaneously. At steady state, the rate of production and consumption of all metabolic 
concentrations is balanced and equals zero. A fitting algorithm was written to fit the model to 
experimental data in a modular approach. The fitting algorithm scaled the pathways by 
computing the range of possible fluxes for each pathway that enables a close-to-optimal fit with 
the experimental data. The fitting algorithm also iteratively performed the metabolic flux 
analysis while constraining the flux through each pathway. The metabolic model was 
constrained to match the glucose and lactate flux to 495 and 851 pM/hr/106 cells respectively. 
The total cellular ATP and ADP levels were constrained to 220 and 110 µM. The reassembled 
model attained steady state after running it for 120 min (Figure 42 and Figure 43).  
The initial concentrations of all species in the metabolic model were then changed to 
run the model in steady state from beginning. The overall adenosine pool was kept constant. 
The ATP/ADP and ATP/AMP ratios were 2.2 and 5 respectively. The Na/K-ATPase and Calcium-
ATPase activity were tied matched to the activities obtained from the neuronal module and 
later integrated in the coupled model. 
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Figure 42: Simulating glucose uptake and lactate release to steady state 
 
Figure 43: Simulated steady state of intracellular adenosine levels 
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The metabolic flux analysis of NG108-15 cells showed that 83.09 % of carbon ends up in 
lactate production, 14.76% enters the mitochondrial TCA cycle, 2.02% is used by pentose 
phosphate pathway (PPP) for PRPP synthesis and 0.13% is secreted out of cells as pyruvate 
(Figure 44). The activity of pentose phosphate pathway in cancer cells or cell lines has been 
shown to vary depending on the cellular activity that ranges from 0.1 % to 11% and considering 
that NG108-15 cells were in differentiation stage 2% seems to be reasonable. The transport of 
pyruvate into extracellular space is very less as most of it got converted into lactate or entered 
mitochondria. 
 
Figure 44: Fate of carbon in NG108-15 cell 
Analysis of the ATP production by NG108-15 cell showed that 81.3% of ATP is being 
produced by glycolysis and only 18.7% of ATP is being contributed by the mitochondria towards 
the total cellular ATP concentration (Figure 45). Due to the increased carbon flux through 
glycolysis, NG108-15 cells produced more ATP from glycolysis and less from mitochondria. The 
total concentrations of ATP and ADP represented in the figure include free and magnesium 
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(Mg)-bound ATP and ADP. The total magnesium concentration has been held constant in the 
model. 
 
Figure 45: ATP Production by different pathways in NG108-15 cell 
During steady state, the rate of ATP production is equivalent to ATP utilization. The 
analysis of ATP utilization revealed that 45% of total cellular ATP is used back in glycolysis to 
mediate the conversions by hexokinase and phosphofructokinase enzyme (Figure 46). Although 
the net production of ATP is more by glycolysis, 45% is a significant amount that is being used 
back. A higher utilization of ATP by glycolysis also enables the cells to consume more glucose 
which would be available for both glycolysis and pentose phosphate pathway. The ATP 
dependent sodium-potassium and the ATP-dependent calcium exchangers consumed 17 and 
11% of the total cellular ATP respectively. The PPP and AK consumed less than 2% of the total 
ATP levels. The general ATPases representing all the other ATP-dependent process consumed 
26% of the ATP (Figure 46). 
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Figure 46: ATP utilization by different cellular processess in NG108-15 cell 
NG108-15 cells lack glutamate [104] indicating the absence or a non-functional malate-
aspartate-shuttle. The other shuttle capable of transferring the high-energy electrons 
generated in the glycolytic pathway into mitochondria and simultaneously active in brain could 
be the Glyceraldehyde-3-phosphate shuttle (G3P shuttle) [102]. The G3P shuttle transfers four 
high-energy electrons from the cytosol to mitochondrial electron transport chain by the flavin 
nucleotides. The efficiency of G3P shuttle is lower compared to malate-aspartate shuttle (MAS). 
MAS transfers six high-energy electrons into mitochondria. The activity of NAD/NADH recycling 
was compared as it determines the activity of glycolysis and mitochondria. The glycolytic lactate 
dehydrogenase has recycled 93% of NAD/NADH and 7% was recycled by mitochondria (Figure 
47). The lower mitochondrial recycling of NAD/NADH demonstrates that not too many 
electrons are entering the mitochondria leading to a lower mitochondrial membrane potential 
generation. This lowered membrane potential reduced the drive for ATP synthase and resulted 
in lower mitochondrial ATP production. 
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Figure 47: Predicted NAD/NADH recycling between glycolytic lactate dehydrogenase (LDH) and glycerol-3-
phosphate (G3P) shuttle 
5.3.2. Simulating neuronal-metabolic model to steady state 
Cellular membrane properties are sensitive to changes in cellular metabolism especially 
in neurons. So, the calibrated metabolic model was coupled to neuronal module for building 
the neuronal-metabolic model. The coupled model was simulated to steady state and the 
activities of ATP-dependent pumps were matched. The extracted parameters (Table 7 and 
Table 8) including ion pumps and leaks parameters were exported into the neuronal-metabolic 
model for simulating steady state. The neuronal-metabolic model is simulated to continuously 
generate action potentials and predict the changes in the intracellular ionic concentrations. The 
model-generated action potentials were in good agreement with the experimentally obtained 
recordings (Figure 48A). The coupled model was simulated for 80 min and only the first 1000 
action potentials generated a time span of 12 min are shown here. 
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Figure 48: Simulated (red) and measured (blue) action potentials of NG108-15 cell 
The sub-cellular ionic concentrations of all ions change rapidly during AP generation and 
reaches back to a steady state. Moreover, the bulk cytosolic concentrations have increased 
slightly and reached steady state. Simulating multiple action potentials also caused the sub 
cellular sodium (Figure 49- blue), potassium (Figure 50- red) and calcium (Figure 51- pink) 
concentrations to spike along with the action potential. The exchangers sensed a rapid increase 
in subcellular ionic concentration and extruded increased concentrations from the cell to 
restore ionic balance. A certain amount of ions also diffused into the cell increasing intracellular 
concentrations. The altered concentrations sodium (Figure 49 – green), potassium (Figure 50 - 
green) and calcium (Figure 51- gold) were also determined. The change in bulk concentration is 
small and usually assumed to be negligible. The metabolic model senses changes in bulk 
cytosolic concentrations and alters the metabolic activity. The rate change of concentrations 
usually varies by the membrane electrical activities and cell types [105]. 
 111 
 
 
Figure 49: Predicted changes in subcellular and bulk cytosolic sodium concentrations during action potentials 
 
Figure 50: Predicted changes in subcellular and bulk cytosolic potassium concentrations during action potentials 
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Figure 51: Predicted changes in subcellular and bulk cytosolic calcium concentrations during action potentials 
The fluxes obtained from the neuronal-metabolic model was also extracted and 
compared to the experimentally determined values. An excellent fit was obtained to glucose 
and lactate flux (Figure 52). The intracellular ATP and ADP levels were also in agreement with 
the measured values (Figure 53).  
 
Figure 52: Compared glucose (blue) and lactate (red) flux obtained from neuronal-metabolic model (solid line) to 
experimental values (dotted line) 
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Figure 53: Compared ATP (blue) and ADP (red) flux obtained from neuronal-metabolic model (solid line) to 
experimental values (dotted line) 
The low levels of intracellular pyruvate levels were predicated by the model (Figure 54). The 
lower pyruvate levels enable cells to avoid cell death by inhibiting the HDAC1/HDAC3 [106]. The 
extracellular and mitochondrial levels of pyruvate levels are low compared to the cytosolic 
levels. However, most of the pyruvate ended up as lactate due to elevated glycolysis.  
 
Figure 54: Predicted extracellular (green), mitochondrial (red) and cytosolic (blue) pyruvate concentrations 
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Phosphoribosyl pyrophosphate (PRPP) in pentose phosphate pathway is a precursor for 
several biomolecules. The predicted PRPP levels are in close range to that found in B16 
melanoma cells [107]. PRPP transfers a high energy phosphate for the phosphorylation of 
purines bases and synthesis of purines, pyrimidines and pyridine nucleotides.  
A proton gradient is established across inner mitochondrial membrane as a result of 
transport of electrons by cytochrome complexes. The mitochondrial membrane potential of 
NG108-15 cells was found to be -122 mV (Figure 55) and was in range as with the other 
neuroblastoma cell lines [108]. This potential difference drives the ATP synthesis by F1F0ATPase 
pump. The redox mechanisms have a huge effect on the cellular metabolic activities. The 
metabolic activities, ATP levels and redox levels are tightly integrated into the model. The redox 
mechanism is sensitive to alterations in glycolytic enzyme activities. The intracellular metabolite 
concentrations are dependent on changes in protein activities. 
 
Figure 55: Predicted mitochondrial membrane potential of NG108-15 cell 
The metabolite concentrations and flux rates in the model were at steady state and the 
protein functions were dependent on the maximum activity of the enzymes. The activities of 
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these enzymes lie mostly at plateau. An increase or decrease in protein activity will determine 
the metabolite concentration and will also restore the model back to original steady state upon 
perturbations in metabolite levels. The stability of metabolic activity is not only due to the 
stoichiometry of metabolites but due to regulatory protein mechanisms. 
5.4. Perturbing glycolysis 
The first rate limiting step in glycolysis is the ATP dependent conversion of glucose to 
glucose-6-phosphate (G6P). The phosphorylation converts non-ionic form of glucose to anionic 
G6P. G6P act as the entry point for PPP and glycolysis. Several studies have shown that 
hexokinase plays a crucial role in initiating and maintain high glycolytic rates in rapidly 
proliferating cells [52]. To inhibit the glycolytic pathway, cells were treated with 2-Deoxy-
glucose (2DG). The molecular structure of 2DG is similar to glucose and the cell transports it 
through the glucose transporters. 2DG is an effective glycolytic inhibitor as it not only competes 
with cellular glucose for phosphorylation but also directly decreases cellular ATP levels by 
consuming ATP during the conversion to 2-deoxyglucose-6-phosphate (2DG6P). The metabolite 
2DG6P cannot be further metabolized down the glycolysis and get accumulated in the cell 
[105]. Moreover, neuronal cells lack glycogen stores and they depend on glycolysis as a source 
for carbon and energy production making glycolytic inhibition more pronounced. 
To determine and experimentally validate the metabolic perturbations induced by 
glycolysis, the NG108-15 were exposed to 2DG followed by determining the metabolic activity 
and electrophysiological changes. To mimic the experimental conditions, the hexokinase 
enzyme was inhibited in the neuronal-metabolic model using an event in Simbiology.  
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5.4.1. Analysis of carbon flux 
The scaling factor ‘b’ for inhibiting the hexokinase activity was estimated by predicting 
the IC50 values. The simulated lactate flux was initially fitted to experimentally measured values 
(Figure 56– red line) for determining the scaling factor (and IC50). The rapid decline of glucose 
flux during the first 20 min shows that NG108-15 cells are sensitive to 2DG treatment due to 
elevated glycolytic activity. A 60 min exposure to NG108-15 cells decreased the lactate flux by 
68%. The lactate flux has remained constant after 60 min and reached a plateau. The lactate 
flux obtained from the metabolic model gave a good fit to experimental measurements. The 
model predicted a decline in glucose flux upon inhibiting hexokinase activity (Figure 56 - blue 
line). A 60 min exposure of 2DG leads to a 61% decrease in glucose flux into the cell. The model 
predicts that a prolong exposure of 2DG has further lowered the glycolytic flux.  The glucose 
uptake rates were not determined as the assay kit was detecting both glucose and 2DG.  
 
Figure 56: Predicted glucose uptake and lactate flux of 2DG compared to experimental data 
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The metabolic flux analysis of carbon usage by NG108-15 cell upon exposure to 2DG is 
shown in Figure 57. The amount of carbon that ended up as lactate decreased from 83% to 
66%. The overall carbon flux into all the pathways decreased. But due to lowered carbon usage 
by glycolysis during 2DG treatment, the mitochondrial carbon usage has increased from 15% to 
33%. (Figure 44 and 57). 
 
Figure 57: Carbon flux analysis of NG108-15 cell exposed to 2DG 
The cellular pyruvate levels were also analyzed to examine the amount and rates of 
pyruvate flux into different pathways. Inhibition of glycolysis reduced the cytosolic pyruvate 
flux significantly and provoked a decrease in transport of pyruvate into mitochondria (Figure 
58). Moreover, an external supply of pyruvate could have significantly delayed the effect of 
glycolysis inhibition [105]. 
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Figure 58: Predicted pyruvate flux during simulating the effects of 2DG 
5.4.2. ATP production and utilization 
The exposure of 2DG decreased carbon flux into the cell resulting in a lowered cellular 
ATP levels. The model predicted intracellular ATP (Figure 59) and ADP levels (Figure 60) were in 
agreement with the experimentally measured ATP and ADP levels. Since the adenosine level in 
the model is conserved, a decrease in ATP and ADP levels caused the cellular AMP levels to rise 
(Figure 61). The conversion of ATP, ADP to AMP is mediated by the enzyme Adenylate kinase 
(AK). After 20 min, the cellular ADP level predicted by the model decreased faster compared to 
the experimental measurements. It may be due to the production of adenosine by cells or other 
mechanisms that are currently not accounted in the model. The overall trend of changes in the 
adenine nucleotide predicated by the model is in good agreement with the experimentally 
determined values. 
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Figure 59: Predicted (solid line) and experimentally (O-dotted line) measured ATP production exposed to 2DG 
 
Figure 60: Predicted (solid line) and experimentally (O-dotted line) measured ADP production exposed to 2DG 
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Figure 61: Predicted (solid line) AMP levels exposed to 2DG 
The ATP production by individual pathways exposed to 2DG were analyzed. The over all 
ATP production by both glycolysis and mitochondria has decreased. But the percent amount of 
ATP produced by glycolsyis has lowered from 81% to 60% (Figure 62). The mitochondrial ATP 
production has increased from 19% to 40%. The increase in mitochondrial activity is due to the 
inhibitoion of glycolysis which focred the cell to rely on mitochondrial ATP generation to meet 
its cellular requirments.  
The usage of ATP by difference cellular pathways was also evaluated simulaneously 
(Figure 63). The total ATP usage by cellular pathways went down. The ATP utilized in glycoslysis 
ishas reduced from 46% to 41%. The ATP consumption by general ATPases, NaK-ATPase, PPP 
and AK were 29%, 11%, 18% and 1% respectively. The lowered carbon influx into mitochondria 
has decreased the generation of protons necessary for maintaining the required mitochondrial 
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membrane potential for driving ATP synthase. The simulated mitochondrial membrane 
potential (ΔΨ) changed from -120mV to -107 mV (Figure 64). The decline in ΔΨ was not 
suffieicent enough inhibiting ATP generation infact a higher amount of mitochondrial ATP were 
synthesised and transported into cytosol by Adenine nucleotide transloactor (ANT). The ANT is 
responsible for exporting ATP from mitochondrial matrix and importing ADP from cytosol. 
 
Figure 62: Predicted ATP production by NG108-15 cell upon exposure to 2DG 
 
Figure 63: Predicted ATP utilization by NG108-15 cell upon exposure to 2DG 
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Figure 64: Predicted mitochondrial membrane potential of NG108-15 cell exposed to 2DG 
5.4.3. Predicting action potentials and ionic concentrations 
The neuronal-metabolic model predicted the changes in action potential peaks shapes 
as the cellular metabolism was being affected. The experimentally measured action potentials 
exposed to 2DG were compared to model generated action potentials and were in good 
agreement (Figure 65). The entire action potential time series was matched to experimental 
recordings to validate model predictions. The evaluation of time series data is crucial as most of 
the drugs reduced might cause similar effects in AP but the time scale of those effects would be 
significantly different. 
Inhibiting glycolysis caused a compelling change in intracellular ATP levels. Reduction of 
intracellular ATP levels lead to decreased ATP-dependent electrogenic pump activity and also 
activated ATP dependent potassium channel. The changes in membrane electrical activity cause 
changes in intracellular ionic concentrations. The intracellular accumulation of sodium (Figure 
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66) and calcium (Figure 68) followed by a decline in potassium (Figure 67) concentration was 
observed. 
 
Figure 65: Predicted (red) action potential time series compared to experimental (blue) recordings when treated 
with 2DG 
The sodium, potassium and calcium concentrations reached to 13.82, 132.8 and 0.085 
mM respectively after 17 min. It has been found that neurons are more sensitive and loose 
cellular homeostasis than glial cells upon exposure to metabolic perturbations [105]. The 
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simulation showed the calcium concentration has increased rapidly after 15 min (Figure 68) and 
is in agreement with the literature reported changes [105]. 
 
Figure 66: Predicted 2DG induced changes in subcellular and bulk cytosolic sodium concentrations 
 
Figure 67: Predicted 2DG induced changes in subcellular and bulk cytosolic potassium concentrations 
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Figure 68: Predicted 2DG induced changes in subcellular and bulk cytosolic calcium concentrations 
5.5. Perturbing mitochondrial electron transport chain 
The mitochondrial electron transport induced perturbations were studied by inhibiting 
oxidative phosphorylation reaction using cyanide. Cyanide is a potent reversible inhibitor of 
mitochondrial cytochrome oxidase and causes sudden death by acting on central nervous 
system. Cyanide predominately inhibits the consumption of oxygen required for ATP 
production. Although cyanide inhibition is reversible, a prolong exposure will lower cellular ATP 
levels inducing an irreversible damage to cell. The biochemical events during cyanide exposure 
have been studied on a wide variety of cells including neurons and NG108-15 cells [89]. To 
determine and experimentally validate the metabolic perturbations induced by electron 
transport chain, the NG108-15 were exposed to cyanide followed by determining the metabolic 
activity and electrophysiological changes.  
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To mimic the experimental conditions, the oxidative phosphorylation in the 
mitochondria was inhibited in neuronal-metabolic model by creating an event in Simbiology. 
Simultaneously, even the contribution of oxidative phosphorylation towards mitochondrial 
membrane potential was inhibited. 
5.5.1. Analysis of carbon flux 
The scaling factor ‘b’ for inhibiting oxidative phosphorylation was estimated by 
predicting the IC50 values. The IC50 values were obtained by fitting the simulated lactate flux to 
experimental data (Figure 69– red line). The model showed a decreased glucose flux into the 
cell upon inhibiting mitochondrial activity (Figure 69 - blue line). The lactate flux obtained from 
the metabolic model gave a satisfactory fit to experimental measurements. The experimental 
and simulated results showed an initial increase in lactate production by NG108-15 cell.  
 
Figure 69: Cyanide treated simulated glucose uptake and lactate flux compared to experimental data 
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The increase in lactate production was due to the inhibition of mitochondrial process 
forcing the cell to rely on glycolysis for ATP production. The mitochondrial pyruvate levels have 
increased during the first couple of minutes as the mitochondria were unable to metabolize 
pyruvate through TCA cycle (Figure 70 – red line). The mitochondrial pyruvate levels have 
increased to 203% whereas the cytosolic levels have lowered by 14% after a 5 min exposure to 
cyanide.  The prolonged exposure has caused the cytosolic pyruvate levels to lower as pyruvate 
was used during glycolysis to generate lactate and ATP (Figure 70 –blue line). The reduction in 
cytosolic levels of pyruvate caused the mitochondrial pyruvate to be transported back to into 
cytosol for ATP generation. The overall cytosolic pyruvate levels were reduced by 35% and the 
mitochondrial pyruvate levels were reduced by 24% after 80 min. 
 
Figure 70: Simulated pyruvate fluxes during cyanide treatment 
The metabolic flux analysis of carbon utilization showed that carbon utilization by 
glycolysis has increased from 83% to 88% upon exposure to cyanide (Figure 71). The 
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mitochondrial carbon utilization decreased from 15% to 10%. No significant change in PPP was 
observed as the glycolytic metabolites were deplting faster leaving no excess metabolities to 
enter PPP. The transport of pyruvate into the extracellular space was less than 1%. These 
results indicate a shift in metabolic activity from mitochondria to glycolysis occurs during 
hypoglycemia. 
 
Figure 71: Predicted carbon utilization by NG108-15 cells during cyanide treatment 
5.5.2. ATP production and utilization 
The contribution of ATP production by mitochondrial oxidative phosphorylation was 
determined by treating cells with cyanide, a respiratory chain inhibitor. Treatment with cyanide 
not only eliminates the utilization of pyruvate but also other endogenous fuels such as amino 
acids and fatty acids that may contribute high energy electrons for ATP synthesis [105]. The ATP 
production during cyanide treatment was measured and compared to simulated values. The 
model accurately predicted change in cellular ATP (Figure 72) and ADP (Figure 73) levels. These 
results were in accordance with the cyanide effects tested by Ray et al. [89].  Glycolysis alone 
could not maintain the cellular ATP level and the rate of decline in cellular ATP was slow 
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compared to 2DG treatment. The AMP levels slightly increased as the cellular ATP and ADP 
were converted by AK (Figure 74). A 60 minute exposure of cyanide lowered the cellular ATP 
levels to 148 + 29 µM. The ADP levels did not change significantly and remained at 109 + 15 µM 
indicating the conversion of cellular ATP to AMP. 
 
Figure 72: Predicted (solid line) and experimentally (O-dotted line) measured ATP production exposed to Cyanide 
 
Figure 73: Predicted (solid line) and experimentally (O-dotted line) measured ADP production exposed to Cyanide 
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Figure 74: Predicted AMP levels exposed to 2DG 
The ATP production by individual pathways exposued to cyanide was analyzed. The total 
production of ATP by both glycolysis and mitochondria has declined but the percent amount of 
ATP produced by glycolsyis has increased from 81% to 85% (Figure 75). The mitochondrial ATP 
production has decreased from 19% to 15%. Inhibition of mitochondria has focred the cell to 
rely on glycolysis for ATP generation. The ATP generated by glycolysis was sufficient enough for 
cellular functions. The ATP utilization by difference cellular pathways was determined (Figure 
76). The ATP utilization by glycoslysis has increased from 41% to 49%. The ATP consumption by 
general ATPases, NaK-ATPase, Ca-ATPase, PPP and AK was 25%, 15%, 10%, < 1% and < 1%. The 
activity of general ATPases decreased by 4%. The carbon influx into mitochondria has decreased 
and lower number of protons were generated by TCA cycle. 
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Figure 75: Predicted ATP production by NG108-15 cell upon exposure to Cyanide 
 
Figure 76: Predicted ATP utilization by NG108-15 cell upon exposure to Cyanide 
Since the activity of glycolytic enzymes has not decreased significaantly, the NAD/NADH 
recycling has elevated and electrons are probably being transported into the mitochondria by 
the G3P shuttle thereby enabling the maintainence of mitocondrial membrane potetnial. The 
simulated mitochondrial membrane potential (ΔΨ) changed from -121 mV to -100 mV within 2 
minutes due to usage of the existing electrons and slowly reached back to -110mV as the 
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electrons from glycolysis were transferred into mitochondria  (Figure 77). 
 
Figure 77: Predicted mitochondrial membrane potential of NG108-15 cell exposed to Cyanide 
5.5.3. Predicting action potentials and ionic concentrations 
The neuronal-metabolic model generated action potentials and predicted the changes in 
action potential peaks shapes as the cellular metabolism was inhibited. The action potential 
time series obtained from the model was plotted against the experimental recordings to 
validate the model. The measured action potentials matched the simulated action potentials 
(Figure 78). A visual analysis showed no change in the action potential peak shapes as the 
cellular ion channels and ATP dependent exchangers were functional. The required amount of 
ATP was being generated by glycolytic pathway. A detailed analysis of action potential time 
series has been performed in chapter 5.9. 
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Figure 78: Predicted (red) action potential time series compared to experimental (blue) recordings when treated 
with cyanide 
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Inhibiting mitochondrial membrane potential has slightly reduced cellular ATP levels. 
The electrogenic ATP-dependent exchangers activity were unaffected (Figure 76) and have 
been successful at restoring ionic concentrations (Figure 79, Figure 80 and Figure 81). The 
sodium, potassium and calcium concentrations reached to 10.78, 138.1 and 0.125 mM 
respectively after 17 min. The action potential peak shape has not significantly altered. The 
change in intracellular ionic concentrations less initially as the cellular ATP levels were not 
lowered. After 17 min of exposure to cyanide, the ATP levels slightly reduced and the 
intracellular ionic concentrations were altered. The changes in sodium, potassium and ATP 
concentrations lead to a rapid rise in intracellular calcium concentration. The changes in the 
subcellular space are swift and achieved equilibrium with the bulk cytosolic concentrations. The 
above results obtained from simulating neuronal-metabolic model and experiments suggests 
that NG108-15 cells are insensitive to cyanide. 
 
Figure 79: Predicted cyanide induced changes in subcellular and bulk cytosolic sodium concentrations 
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Figure 80: Predicted cyanide induced changes in subcellular and bulk cytosolic potassium concentrations 
 
Figure 81: Predicted cyanide induced changes in subcellular and bulk cytosolic calcium concentrations 
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5.6. Perturbing mitochondrial TCA cycle and electron transport chain 
Succinate dehydrogenase (SDH) was inhibited to investigate metabolic perturbations 
induced by mitochondrial TCA cycle and electron transport chain. SDH is the only enzyme that 
couples mitochondrial TCA cycle and electron transport chain. SDH is complex-II in the electron 
transport chain and does not pump protons directly across inner mitochondrial membrane. 
Complex-II transfers reducing equivalents through co-enzyme Q10 that gets re-oxidized by 
complex-III in inner mitochondrial membrane. Malonate is a competitive inhibitor of SDH and 
causes an accumulation of succinate in mitochondria. Malonate has been shown to induce in 
vivo and in vitro neuronal toxicity in a dose-dependent manner [109].  
To investigate the metabolic perturbations induced by malonate, NG108-15 cells were 
exposed to Malonate followed by determining the metabolic activity and electrophysiological 
changes. To simulate experimental conditions, SDH enzyme in TCA cycle was inhibited in the 
neuronal-metabolic model by creating an event in Simbiology. The inhibition factor was 
predicted by fitting the model to experimental lactate flux. The IC50 values obtained are used 
for simulating the neuronal-metabolic model. 
5.6.1. Analysis of carbon flux 
The carbon flux into the cell has increased upon treating cells with malonate. A 20 min 
exposure of malonate has increased the glucose flux into cell by 30% (Figure 82 – blue line). The 
increased glycolytic flux subsequently resulted in an elevated lactate flux. The lactate flux was 
increased by 22.5% (Figure 82 – red line). The model also predicted an overall increase in 
glucose and lactate flux which is in agreement with the experimentally determined values 
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(figure 82). The increased glucose and lactate flux were lowered by 10% and 6% respectively 
after 60 min exposure. The mitochondrial flux decreased and an increase in cellular glycolysis 
was observed indicating that the cell was probably running at its maximum glycolytic capacity. 
 
Figure 82: Simulated glucose uptake lactate release flux compared to experimental data by treating NG108-15 cells 
with malonate 
The pyruvate flux was analyzed to track the flow of carbon into different pathways over 
time (Figure 83). A 9x increase in mitochondrial pyruvate concentration was observed upon a 
30 min exposure to malonate. Similarly, the cytosolic pyruvate has also increased as the 
pyruvate was not metabolized in TCA cycle leading to a build-up in mitochondria and cytosolic 
compartments. The pyruvate levels were slowly reaching back to steady state adjusting to the 
perturbations caused by malonate. Due to increased requirement of pyruvate in glycolysis, a 
very small amount of carbon is exported out of the cell as pyruvate. Further analysis of the 
carbon flux into different pathways was performed. The glycolytic flux has increased by 2%. The 
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mitochondrial flux has decreased only by 2% since the pyruvate was getting accumulated in the 
mitochondrial compartment as shown in Figure 83. The carbon flux into PPP and extracellular 
pyruvate remained unaltered when compared with controls (Figure 44).  
 
Figure 83: Analysis of pyruvate concentrations in cytosol, mitochondria and extracellular compartments during 
malonate treatment 
 
Figure 84: Analysis of carbon fluxes for cells exposed to malonate 
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5.6.2. ATP production and utilization 
The changes in ATP and ADP levels were measured by exposing cells to malonate. The 
experimentally determined and simulated results of ATP (Figure 85) and ADP (Figure 86) 
measurements were in good agreement. The predicted AMP levels have also increased when 
treated with malonate (Figure 88). A 60 min exposure to malonate caused cellular ATP levels to 
decline by 22%. The reduction in ATP levels increased the ADP and AMP levels by 37% and 47% 
respectively. The adenine nucleotide levels were conserved in the model and their levels are 
governed by AK.  
 
Figure 85: Experimental and predicted changes in intracellular ATP concentration during malonate treatment 
The rate of decline in ATP production was slightly less compared to cells treated with 
cyanide. The protons generated from elevated glycolysis were transferred into the 
mitochondria by G3P shuttle. The transferred protons contribute towards the mitochondrial 
membrane potential. The mitochondrial membrane potential was reduced from -121 mV to -
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117 mV (Figure 87).  The mitochondrial membrane potential has been shown to be lowered by 
decrease in the cellular ATP production during malonate treatment in neurons. But due to the 
altered metabolic activity the mitochondrial membrane potential was not significantly altered. 
 
Figure 86: Experimental and predicted changes in intracellular ADP concentration during malonate treatment 
 
Figure 87: Mitochondrial membrane potential of NG108-15 cell during treatment with malonate 
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Figure 88: Predicted changes in intracellular AMP concentration during malonate treatment 
A complete analysis of cellular ATP production and utilization was performed to gain 
metabolic insights and identify protein activities. Since the mitochondrial membrane potential 
was not altered significantly, the mitochondrial ATP production declined by 2% and 
simultaneously the ATP production increased by 2%.   
 
Figure 89: Analysis of ATP production pathways during malonate treatment 
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The ATP utilization by glycolysis increased by 7% as glucose uptake was heighted. 
Despite a decrease in cellular ATP level, a sufficient amount of ATP was still being synthesised 
by the cell to carryout the necessary functions. The ATP utilization flux by Ca-ATPase, NaK-
ATPase, general ATPase, AK and PPP were 10%, 15%, 26%, <1% and <1%.  
 
Figure 90: ATP utilization by different pathways upon exposure to malonate 
5.6.3. Predicting action potentials and ionic concentrations 
The model generated action potentials (AP’s) were compared to experimentally 
determined action potentials. The simulated AP’s were in good agreement with the 
experimental recordings (Figure 91). The action potential peak height was maintained as the ion 
channels and exchangers were functional. The rate of decline in membrane resistance was 
estimated and included in the model during action potential simulation. The action potential 
parameters were not altered as malonate does not bind to ion channels and only the reversal 
potentials of all ions are allowed to change. 
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Figure 91: Simulated (red) and experimental (blue) malonate treated action potential time series  
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The neuronal and metabolic modules are driven by changes in the cellular ATP and ionic 
concentrations. The model predicted ATP concentrations were analyzed during malonate 
treatment. The intracellular sodium concentration increased by 1.7 mM (Figure 92) and 
potassium concentration decreased by 18.6 mM (Figure 93). The calcium concentrations did not 
change significantly (Figure 94). The subcellular calcium concentrations reached a maximum of 
8.48×10-4 mM. The maximum flux of ionic concentrations depends on the fitting parameters 
obtained during action potential deconvolution. The intracellular ionic concentrations were 
slowly altered and no rapid change was observed as cellular ATP levels were slowly lowered. A 
rapid significant decline might have caused intracellular ionic concentrations to rise quickly. 
 
Figure 92: Predicted changes in subcellular (red) and bulk (blue) cytosolic sodium concentrations in NG108-15 cells 
exposed malonate 
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Figure 93: Predicted changes in subcellular (red) and bulk (blue) cytosolic potassium concentrations in NG108-15 
cells exposed malonate 
 
Figure 94: Predicted changes in subcellular (red) and bulk (blue) cytosolic calcium concentrations in NG108-15 cells 
exposed malonate 
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5.7. Perturbing glycolysis and mitochondrial electron transport chain  
Most diseases such as cancer are being treated with some combination of surgery, 
radiation and/or multiple drug treatment. Drug treatment mainly involves using drugs that kill 
rapidly dividing cells. Cellular pathways in cancer cells are modified and certain pathways are 
over expressed. The rationale behind using such treatment is to use a combination of drugs that 
inhibit cellular pathways at multiple points. NG108-15 cells are insensitive to mitochondrial 
inhibitors, so a combinational treatment with a glycolytic inhibitor was tested to increase the 
sensitivity. Cells were treated with 2DG and cyanide simultaneously to induce metabolic 
perturbations in glycolysis and the mitochondrial pathways. The metabolic perturbations were 
validated by determining the metabolic and neuronal responses. 
5.7.1. Analysis of carbon flux 
The cellular glucose uptake and lactate production were measured by exposing the cells 
to 2DG and cyanide. These drugs significantly inhibited glycolysis and mitochondrial oxidative 
phosphorylation and lowered the carbon fluxes in the cell. A rapid decline in cellular glucose 
consumption and lactate production was observed within the first 20 min (Figure 95). The 
glucose and lactate fluxes were lowered by 66% and 72%, respectively, in 20 min. The decline 
was much faster than the standalone treatment of either drug. Prolonged exposure to 2DG and 
cyanide has further decreased the carbon fluxes and a complete inhibition of glucose flux was 
observed after 80 min. Inhibition glycolysis caused a decline in cytosolic pyruvate 
concentrations in 4 min (Figure 96). The pyruvate levels in the mitochondria have rapidly 
increased reaching a peak concentration of 0.02 mM. 
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Figure 95: Experimental lactate production compared to the model generated lactate and glucose flux during 
combinational treatment with 2DG and cyanide 
 
Figure 96: Predicted cytosolic, mitochondrial and extracellular concentrations of pyruvate in NG108-15 cell 
exposed to 2DG and Cyanide 
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The increased mitochondrial pyruvate levels were accumulated and transported back to 
the cytosol causing the cytosolic pyruvate concentrations to rise. Since carbon influx has been 
inhibited, the cellular metabolite levels got exhausted. This expedited depletion of the 
glycolytic metabolites forced the carbon flux towards lactate production. The cytosolic pyruvate 
decreased as it was converted to lactate and simultaneously the accumulated mitochondrial 
pyruvate was transported into the cytosol (Figure 96). 
 The flux balance analysis of carbon into different pathways was performed (Figure 97). 
The global fluxes have decreased and the ratio of carbon fluxes had also changed. The 
mitochondrial flux of carbon was lower than the lactate flux. The carbon in glycolysis and the 
mitochondria were 94% and 5% respectively. The PPP flux has also been lowered to 0.57%. The 
extracellular flux of carbon as pyruvate was less than 0.3%. The combinational treatment had a 
larger effect on glycolysis and significantly lowered its activity. Metabolic perturbations induced 
by inhibition of glycolysis and mitochondrial respiration had a huge effect on cellular functions. 
 
Figure 97: Flux balance analysis of carbon usage by different pathways during 2DG and cyanide treatment 
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5.7.2. ATP production and utilization 
The changes in ATP and ADP levels in cells exposed to a combinational treatment of 2DG 
and cyanide were assessed by experimental determination at different time intervals. The 
simulated ATP (Figure 98) and ADP (Figure 99) concentrations were compared to 
experimentally determined values. A 20 min exposure of 2DG and cyanide lowered the ATP 
levels to 32%. Prolonged exposure beyond 20 min caused cellular ATP levels to decrease further 
down to 18%. The ADP levels increased by 36% during the first 20 min and were decreased by 
18%, almost reaching the initial concentrations. The predicted AMP levels increased from 75 
µM to 345 µM (Figure 100). 
 
Figure 98: Measured and simulated ATP concentrations in NG108-15 cell exposed to a combinational treatment of 
2DG and Cyanide 
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Figure 99: Measured and simulated ADP concentrations in NG108-15 cell exposed to a combinational treatment of 
2DG and Cyanide 
 
Figure 100: Simulated AMP concentrations in NG108-15 cell exposed to a combinational treatment of 2DG and 
Cyanide 
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The mitochondrial membrane potential depolarized from -121 mV to -88 mV (Figure 
101). An initial small transient was observed lowering the potential to -113 mV due to the 
aberrant arrest of mitochondrial respiration by cyanide. As carbon flux was inhibited by 
metabolic inhibitors, the generation of protons required to maintain mitochondrial membrane 
potential had decreased. This decrease in mitochondrial membrane potential resulted in a 
decline in mitochondrial ATP generation mechanisms. 
 
Figure 101: Predicted changes in mitochondrial membrane potential of NG108-15 cell exposed to 2DG and cyanide 
The flux balance analysis was perfomed on the ATP production and utilization of 
different pathways during treatment with 2DG and cyanide. The analysis indicated an overall 
reduction in cellular ATP generation. After 80 min of combinational treatment, the glycolytic 
and mitochondrial ATP production were 93% and 7% respectively (Figure 102). The utilization of 
ATP by different pathways has shown that only 27% of ATP was used back again in cellular 
glycolysis pathway (Figure 103). The reduction in ATP levels have also decreased the conversion 
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of glucose by hexokinase. The NaK-ATPase and Ca-ATPase were utilized appromimately 14 and 
22% of cellular ATP, respectively, to restore cellular homeostasis. The general ATPases were 
utilizing around 36% of ATP. The ATP usage by PPP and AK was lowered and consumed less than 
1% of ATP. 
 
Figure 102: Analysis of ATP production by glycolysis and mitochondrial process during 2DG and Cyanide  
 
Figure 103: ATP utilization by different cellular process exposed to 2DG and cyanide 
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5.7.3. Predicting action potentials and ionic concentrations 
The model generated action potentials during metabolic perturbation induced by 2DG 
and cyanide were significantly altered. The simulated action potentials were compared to the 
experimental measurements (Figure 104) and an excellent fit was obtained between them. 
 
Figure 104: Predicted action potentials compared to experimental recordings exposed to 2DG and cyanide 
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The action potential peak height decreased and membrane potentials depolarized. The 
reversal potentials and cellular ATP concentrations were allowed to change during simulation. 
The changes in the subcellular and bulk ionic concentrations were predicted by the model. The 
calcium concentration initially increased linearly from 1.25e-4 mM to 2.64e-3 mM, but cellular 
ATP concentration did not significantly decrease (Figure 107). But after 8 minutes of exposure 
to 2DG and cyanide, a significant reduction in cellular ATP levels caused the calcium 
concentration to rise exponentially leading to a rapid influx of sodium and efflux of potassium 
ions. The bulk cytosolic sodium concentration increased from 10 mM to 20.4 mM (Figure 105). 
The potassium concentration decreased from 140 mM to 84 mM in 17 minutes (Figure 106). 
These results were in agreement with the ionic concentration changes found in C6 glioma cells 
treated with 2DG and cyanide [105]. 
 
Figure 105: Predicted changes in subcellular and bulk cytosolic sodium concentrations during combinational 
treatment with 2DG and cyanide  
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Figure 106: Predicted changes in subcellular and bulk cytosolic sodium concentrations during combinational 
treatment with 2DG and cyanide 
 
Figure 107: Predicted changes in subcellular and bulk cytosolic sodium concentrations during combinational 
treatment with 2DG and cyanide 
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5.8. Perturbing glycolysis, mitochondrial TCA cycle and electron transport chain 
Inhibiting the TCA cycle by malonate had no significant effect on cellular activities as the 
required ATP was being generated by glycolysis. The effects of inhibiting glycolysis with 2DG 
and the mitochondrial TCA cycle and electron transport chain with malonate were tested. 
Malonate inhibits complex-II (SDH enzyme) but does not completely seize the electron 
transport chain as the electrons from oxidation of NADH and FADH2 are directly transported 
into inner mitochondrial membrane. The metabolic perturbations that are due to inhibition of 
glycolysis and the TCA cycle were evaluated. 
To simulate the effect of combination treatment of drugs, both the events representing 
the effect of glycolysis and TCA cycle inhibition are turned on. The scaling factors for inhibiting 
the pathways were obtained from the earlier obtained fitting data for standalone drugs. 
5.8.1. Analysis of carbon flux 
The fate of carbon was analyzed to determine the effects of combinational treatment 
with 2DG and malonate. The model predicted glucose flux and lactate flux were compared to 
the experimental data (Figure 108). The glucose flux was not measured as 2DG and glucose 
have a similar molecular structure and the assay kit was unable to distinguish between them. 
The glucose uptake and lactate production were lowered to 55% and 51% respectively in 20 
min. The declines in carbon flux continued upon prolong exposure. The predicted glucose flux 
and lactate flux decreased to 10 and 18%, respectively, after 80 min.  
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Figure 108: Simulated glucose and lactate flux compared to experimental lactate flux of NG108-15 cell during 
combinational treatment with 2DG and malonate 
 The cytosolic and mitochondrial pyruvate concentrations decreased over time (Figure 
109). Unlike malonate treatment where accumulation of pyruvate was observed, the 
combinational treatment caused only a small increase in cytosolic and mitochondrial pyruvate 
levels. 2DG inhibited glucose flux which resulted in the transport of carbon to the mitochondria. 
The mitochondrial pyruvate slowly decreased as the cytosolic pyruvate was preferably being 
converted into lactate. The extracellular pyruvate flux initially remained unaltered but was 
completely inhibited after 80 min. 
 Carbon flux analysis has identified the percent of carbon being used by different 
pathways within the cell. Although the total carbon flux decreased, around 91% of carbon was 
routed through glycolysis and converted to lactate and only 8% of the carbon entered the 
mitochondria. The carbon flux towards the pentose phosphate pathway and extracellular 
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pyruvate were 0.01% and 0.7%. The decrease of carbon flux to PPP was significantly lowered as 
the reduction in glycolytic metabolites favored the carbon to route towards lactate generation 
by producing ATP for cellular functions. 
 
Figure 109: Predicted pyruvate flux during simulating the effects of combinational treatment of 2DG and malonate 
 
Figure 110: Carbon flux analysis of NG108-15 cell exposed to 2DG and malonate 
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5.8.2. ATP production and utilization 
The cellular ATP and ADP levels were measured by exposing the cells to 2DG and 
malonate simultaneously. The predicted ATP (Figure 111) and ADP (Figure 112) concentrations 
were in good agreement with the experimental data. A 40 min exposure to these drugs lowered 
the cellular ATP levels to 21%. The model predicted cellular ATP levels declined further after 
exposure to 2DG and malonate for 60 min. The experimental results have shown cellular ATP 
levels to remain at a plateau probably due to the production of ATP by other endogenous 
factors such as fatty acids. The decrease in cellular ATP levels caused the ADP levels to rise 
initially. The AMP levels (Figure 113) increased as the cellular ATP levels were decreasing. An 
uninterrupted exposure lowered the cellular ADP level, and subsequently increased the 
intracellular AMP level. 
 
Figure 111: Measured and simulated ATP concentrations in NG108-15 cell exposed to a combinational treatment 
of 2DG and malonate 
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Figure 112: Measured and simulated ADP concentrations in NG108-15 cell exposed to a combinational treatment 
of 2DG and malonate 
 
Figure 113: Simulated AMP concentrations in NG108-15 cell exposed to a combinational treatment of 2DG and 
malonate 
The mitochondrial membrane potential became more sensitive when treated with 2DG 
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and malonate. Treatment with malonate alone had reduced the mitochondrial membrane 
potential by -4 mV, but when the cells were treated with malonate in the presence of 2DG, the 
mitochondrial membrane potential depolarized to -32 mV (Figure 114). The reason behind this 
significant depletion of the mitochondrial membrane potential was due to lowered transport of 
high energy electrons generated during glycolytic inhibition. The G3P shuttle was unable to 
transfer the electrons as sufficient electron equivalents were not generated. On the other hand, 
malonate has lowered the TCA cycle activity, thereby obstructing the generation and transfer of 
electrons. Malonate has been shown to reduce cellular functions by depolarizing the 
mitochondrial membrane potential and increasing the oxidative stress in SH-SY5Y 
neuroblastoma cells [110]. 
 
Figure 114: Predicted mitochondrial membrane potential during treatment combinational treatment with 2DG and 
malonate 
ATP production and usage by different pathways in NG108-15 cell after 60 min exposure 
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to 2DG and malonate was analyzed. The ATP production from glycolysis and the mitochondria 
were 96% and 4% respectively (Figure 115). Although the total amount of ATP produced by the 
cell decreased to 21%, the glycolytic pathway was still active generating ATP. The low amount 
of ATP present in the cell was mainly used by hexokinase (HK), NaK-ATPase, Ca-ATPase and 
general ATPases (Figure 116). The activity of the HK enzyme increased due to lowered ATP and 
G6P levels. The lowered G6P levels triggered the influx of glucose and, more importantly, 2DG 
into the cell. 2DG was preferentially metabolized in the cell leading to an accumulation of 
2DG6P, a metabolitite that could not be metabolized futher down the glycolysis pathway. The 
next highest ATP consuming process was the NaK-ATPase and Ca-ATPase proteins. These 
proteins bind to free-cytosolic ATP and transfer ions across the memebrane to restore ionic 
balance. 
 
Figure 115: Analysis of ATP production by glycolysis and mitochondrial process during 2DG and malonate 
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Figure 116: ATP utilization by different cellular process exposed to 2DG and malonate 
5.8.3. Predicting action potentials and ionic concentrations 
The time dependent changes in action potential peak shapes were predicted by the 
neuronal-metabolic model. The action potentials generated by the model were plotted against 
the experimental recordings (Figure 117). An excellent fit was obtained between the simulated 
and experimental recordings. The fit to tail of an action potential was acceptable. A prolonged 
exposure to 2DG and malonate has caused the cellular action potentials to alter significantly.  
The intracellular ionic concentrations were predicted by the neuronal-metabolic model. 
The sodium, potassium and calcium ionic concentrations changed rapidly. The intracellular 
sodium reached a peak concentration of 21.1 mM in 18 min (Figure 118). The potassium 
concentration decreased to 90 mM in 18 min (Figure 119). The changes in ionic concentrations, 
and even cellular ATP levels, have caused a rapid exponential increase in calcium concentration 
after 15 min (Figure 120). The calcium concentration increased to 0.92 mM. 
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Figure 117: Predicted action potentials compared to experimental recordings exposed to 2DG and cyanide 
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Figure 118: Predicted changes in subcellular and bulk cytosolic sodium concentrations during combinational 
treatment with 2DG and malonate 
 
Figure 119: Predicted changes in subcellular and bulk cytosolic potassium concentrations during combinational 
treatment with 2DG and malonate 
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Figure 120: Predicted changes in subcellular and bulk cytosolic calcium concentrations during combinational 
treatment with 2DG and malonate 
5.9. Distinguishing the effects of metabolic inhibitors 
We hypothesized that the rate of change in action potentials would be characteristic to 
the pathway being inhibited and their deconvolution would enable the ability to back tract the 
effected pathways and allow continuous monitoring of the protein functions. Metabolic 
perturbations and changes in cellular proteins activities occur in the cellular network at 
different rates. The metabolic inhibitors tested act by lowering the cellular ATP levels, which 
cause impaired cellular homeostasis leading to alterations in the membrane electrical activity.  
Although the model was able to accurately predict the changes in action potential peaks 
shapes based on the pathways being inhibited, an analysis of the characteristic changes would 
enable us to gain a deeper insight. To characterize and differentiate the effects of the metabolic 
inhibitors, changes in cellular action potential time series and ATP levels were compared. 
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5.9.1. Analysis of action potentials 
  The time dependent changes in action potentials were determined by measuring the 
rate of change in the action potential peak amplitude, holding potential, area and half-width at 
the peak amplitude. The data were normalized to compare the effects of different inhibitors. 
5.9.1.1. Action potential peak height 
 The normalized rate of change in action potential peak amplitude for different drugs is 
shown in Figure 121. The peak height in control recordings remained stable and unaltered. The 
mitochondrial inhibitors had the least effect on cellular metabolic activity which was reflected 
in the AP peak height.  
 
Figure 121: Normalized action potential peak height of cells exposed to different metabolic inhibitors 
Cyanide and malonate lowered the action potential peak height by only 9% and 15% 
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respectively whereas 2DG lowered the peak height to 54%.  The rate of decline in 2DG treated 
and combinational treatment was similar for the first 5 min. Prolonged exposure to the drugs 
changed the peak height in a time-dependent manner. The combinational treatment of 2DG 
with cyanide and malonate reduced the peak height to 21% and 37%. The reduction in action 
potential is due to the reduction in cellular ATP levels. The reduced ATP levels failed to restore 
the ionic concentrations, which resulted in huge changes in the intracellular ionic 
concentrations. The intracellular accumulation of sodium concentrations reduced the drive for 
the sodium ions to enter into the cell, which caused a decrease in sodium current. 
5.9.1.2. Holding potential 
The membrane potential was altered by injecting the cell initially with a sufficent 
current to hyperpolarize the membrane to -70 mV. Although a stimulus pulse was given to 
generate action potential. The current required to hold the membrane potential was not 
altered during the course of the experiment. The holding potential reached the initial state in 
one second and assuming that cellular machinery was functional, the ionic balances would have 
also been restored. The holding potentials in the controls recordings did not change 
significantly (Figure 122). The holing potential of cyanide was slightly depolarized by 9% but the 
change was very small. The activity of cyanide had varied depending on the resting membrane 
potential of the cell. Cyanide exposed to the cells with a resting membrane potential less than -
38 mV caused the membrane potential to hyperpolarize and deplolarize in cells with resting 
membrane potentials between -38 mV and -50 mV [111]. This result was in agreement with the 
cyanide experiments perfomed on hippocampal pyrimidal neurons. 
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During the first five minutes of exposure to Malonate, a slight decline in ATP levels and 
changes in the intracellular ionic concentrations caused a decrease in the holding potential by 
13% (Figure 122). Similar to the effects on peak amplitude, the holding potetnial of the cells 
treated with 2DG alone and 2DG in combination with another drug had an immense effect. The 
holding potential of 2DG, 2DG with cyanide and 2DG with malonate was lowered by 38%, 65% 
and 88% (Figure 122). In accordance with the metabolic data, 2DG+cyanide treatement had an 
extensive effect on AP. 
 
Figure 122: Normalized initial holding potential of cells exposed to different metabolic inhibitors 
5.9.1.3. Area of an action potential 
The area under an action potential was also measured to characterize the drug effects 
(Figure 123). The area in the control, 2DG, cyanide, malonate, 2DG+cyanide and 2DG+malonate 
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had decreased to 96%, 51%, 90%, 82%, 25% and 34%. The treatment of the NG108-15 cell with 
2DG and cyanide had the highest decline in the area. The area for malonate recording had 
increased as the KATP channel was activated leading to a prolong depolarization of the action 
potential.   
 
Figure 123: Normalized area of an action potential of cells exposed to different metabolic inhibitors 
5.9.1.4. Half-width at peak amplitude 
The half width at peak amplitude (HWPA) varied in all conditions (Figure 124). The 
HWPA for 2DG treated cells decreased as the peak was shortened. After five minutes, the half 
width of the combinational treated 2DG and cyanide has increased due to elevated intracellular 
calcium concentration. The calcium flux is usually responsible for the hump generated in the 
action potential during depolarization. Combinational treatment with 2DG and malonate had 
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no initial effect but reduced the HWPA after 5 minutes. Cyanide and malonate had showed no 
significant effect on action potential peak height, holding potential and area of action potential. 
Instead the HWPA of cells treated with cyanide and malonate showed a 20% and 19% decline in 
amplitude. These results demonstrated that the changes in action potential are characteristic to 
the pathway being inhibited. 
 
Figure 124: Normalized action potential half-width at maximum peak height of cells exposed to different metabolic 
inhibitors 
5.9.2. Comparison of cellular ATP levels 
Intracellular ATP levels act as indicators of cellular health. Since neurons are sensitive to 
ATP levels, the effect of energy depletion on neuronal damage was studied [93]. Several cell 
viability assays have been developed based on the determination of the cellular ATP levels. The 
ATP levels in cells exposed to mitochondrial inhibitors, namely cyanide and malonate are 
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reduced to 81% and 85% respectively (Figure 125).  
 
Figure 125: Percent ATP levels after 20 min exposure to metabolic inhibitors 
Primary neuronal cells incubated with cyanide have been shown to lower the ATP level 
to 33% [89] and the clonal pheochromocytoma PC12 cell line has also been shown to be 
sensitive to cyanide [89]. Treatment of cells with 2DG had lowered cellular ATP levels to 45%. 
The combinational treatment had the highest effect on NG108-15 cellular ATP levels. After a 20 
min exposure ATP levels were reduced in 2DG with cyanide and 2DG with malonate treated 
cells to 32 and 38% respectively. These results clearly indicated that NG108-15 cells were more 
100 
45 
81 
85 
32 
38 
0
20
40
60
80
100
120
%
 A
TP
 
 173 
 
sensitive to 2DG. Ray et al. have demonstrated that pre-treatment of NG108-15 cells with CoCl2 
prevented the depletion of ATP during the combinational treatment with 2DG and cyanide [89]. 
5.10. Temporal proteomic analysis 
Proteomics deals with the identification of protein expression profiles and their 
interactions within the cell. Most proteins are not only expressed at various concentrations, 
their activities also differ in the cell. A certain subset of proteins synthesized in the cell might be 
inactive due to several rate limiting steps governing their activation. So, it is important to 
chronically monitor the activities of these proteins and their interactions in a large network. 
The overall goal of this dissertation is to be able to perform temporal proteomic analysis. 
5.10.1. Heat map of predicted protein activities 
The experimentally validated neuronal-metabolic model was able to predict the changes 
in neuronal action potentials and cellular metabolism. The predicted activity of all the proteins 
was analyzed to gain a deeper insight into the protein functions. The activities of the proteins 
involved in the core metabolic pathways were analyzed at different time points. Figure 126 
shows the changes in the proteins after a 10 minute exposure to metabolic perturbation. The 
first column indicates the activity of proteins in a steady state. The activity of these proteins has 
been normalized based on their activity. The activities of glycolytic proteins exposed to 2DG 
were reduced and the mitochondrial enzyme activities were slightly increased which was in 
accordance with the metabolic flux analysis of carbon (Figure 126).  
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Figure 126: Heat map of cellular proteins activities exposed to different metabolic inhibitors after 10 min 
The activity of glycerol-3 phosphate dehydrogenase (G3P shuttle) was also lowered as sufficient 
amount of electrons were not generated due to a decline in cellular glycolysis. The lowered 
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transport of electrons also resulted in decreased FADH2 oxidative phosphorylation. The activity 
of phosphoribosyl pyrophosphate synthase (PRPPs) also decreased along with a decreased flux 
into PPP. 
Cyanide inhibited the mitochondrial respiration and caused a drop in oxidative 
phosphotylation. The activity of F1F0 ATPase also deteriorated due to a lowered mitochondrial 
potential. The activity of the F1F0 ATPase protein was compared between the malonate and 
cyanide treatments. The inhibition of cellular respiration by cyanide increased the activity of 
the TCA cycle as sufficient amounts of ATP were not being produced the by mitochondria. 
Malonate had a mild effect on the TCA cycle and showed similar effects of cyanide induced 
perturbations. The effect of the combinational treatment on protein activies was also 
determined. The effect of 2DG and cyanide treatment had lowered protein activites in both the 
pathways. Whereas, the treatment with 2DG and malonate had slighly lowered the glycolytic 
activity compared to the 2DG and cyanide treatment. The activities of the metabolic proteins 
were also lowered during 2DG and cyanide treatment wheres 2DG and malonate treatment had 
a very low effect (Figure 126). 
A snapshot of the protein activities after 60 minutes exposure to specific drugs was 
analysed for changes in protein activites (Figure 127). Exposure to metabolic inhibitors varied 
protein activities. Prolonged exposure to 2DG lowered the activity of all glycolytic proteins and, 
specifically, reduced the actvity of phosphoglycerate  kinase (PGK). The primary function of PGK 
is to generate ATP by obtaining phosphate from 1,3 biphosphoglycerate.  
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Figure 127: Heat map of cellular proteins activities exposed to different metabolic inhibitors after 60 min 
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This is an important reaction where glycycolytic ATP is generated and inhibition could be a 
viable option for cancer treatment. The acitvity of PRPPs also decreased as most of the carbon 
ended up as lactate. Cyanide had lowered the activity of all  glycolytic poteins by   1̴0% and 
mitochondial TCA cycle proteins activities were lowered by   ̴40%. Malonate effected protein 
activities in both the glycolysis and mitochondrial pathways. The activity of G3P protein activity 
was significantly decreased during malonate treatment as the transport of electrons from 
glycolysis has decreased. The activities of all proteins decreased significantly after a 60 min 
combinational treatment of 2DG+ cyanide and 2DG+malonate. 
5.10.2. Time-dependent functional activities of proteins  
The activation and inactivation of proteins occurs in a time-dependent manner. Current 
proteomic tools lack the resolution to predict the changes in a large network simultaneously. 
The model’s ability to chronically monitor functional changes in cellular protein activities of the 
core metabolic pathways was demonstrated. Since the perturbations were induced using 
cellular bioenergetic inhibitors, the activities of the proteins with respect to changes in cellular 
ATP fluxes were investigated. The protein activities involved in carbon usage, ATP production 
and usage are shown below (Figure 128, 129 and 130). 
Temporal analysis of proteins involved in the cellular ATP consumption was determined 
(Figure 128). The activities of proteins that depend on cellular ATP levels are ATP dependent 
plasma membrane calcium transporter (Ca-ATPase), sodium-potassium ATPase (Na/K-ATPase), 
phosphoribosyl pyrophosphate synthase (PRPPS), general ATPase’s (ATPase), 
phosphofructokinase (PFK) and hexokinase (HK). The activities were normalized to the total ATP 
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consumption. These protein activities were in agreement with the results obtained from the 
metabolic flux analysis. Analysis of cellular proteins between treatments with 2DG, cyanide, 
malonate, 2DG+Cyanide and 2DG+malonate was performed. Similar to the metabolic flux 
analysis, the activities of the proteins decreased when the cells were exposed to 2DG alone or 
combinational treatment involving 2DG.  
 179 
 
 
Figure 128: Predicted activities of Calcium ATPase (Ca-ATPase), Sodium-potassium-ATPase (Na/K-ATPase), phosphoribosyl pyrophosphate synthase (PRPPS), 
general ATPases (ATPase), phosphofructokinase (PFK) and hexokinase (HK) during (A) control, (B) 2DG, (C) cyanide, (D) malonate,  (E) 2DG+cyanide and (F) 
2DG+malonate exposure. Their activities are normalized to total ATP usage by NG108-15
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The time dependent changes of the major proteins involved in determining carbon 
fluxes is shown in Figure 129. Although all the enzymes are important in maintaining a proper 
carbon flux throughout the cell, a few proteins were chosen to demonstrate the predictive 
capabilities of the model. The activities of glucose transporter, pyruvate dehydrogenase, 
monocarboxylate transporter and ribose-5 phosphate isomerase were analyzed. The glucose 
transporter senses the intracellular concentration of glucose in the cell and imports glucose. 
The monocarboxylate transporter (MCT) is responsible for transporting the intracellular lactate 
outside. These transporters are diffusion based and exchange metabolites by sensing the 
intracellular concentrations. The MCT’s have been shown to be highly active in cells with 
elevated glycolysis especially in astrocytes and cancer cells. Pyruvate dehydrogenase 
metabolizes the carbon entering the mitochondria so that it can be used in the TCA cycle. 
Several inhibitors have been designed to impede the activity of these enzymes in order to 
modulate and create a shift in cellular metabolism. 
The temporal analysis of proteins engaged in ATP production is shown in Figure 130. The 
major proteins involved in glycolytic ATP production are phosphoglycerate kinase (PGK) and 
pyruvate kinase (PK). These enzymes have lowered significantly upon exposure to 2DG (figure 
130 B). The PGK protein activity was completely inhibited after 60 min. The mitochondrial 
proteins were still actively generating ATP. The combinational exposure of 2DG with cyanide 
and malonate inhibited the protein activities completely. The protein activities were inhibited 
on a different time scale by a different metabolic inhibitor. For example, PGK activity was 
completely inhibited in 70 min when exposed to 2DG whereas the activity of the same enzyme 
decreased much faster when exposed to a combinational treatment with 2DG and cyanide. 
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Figure 129: Predicted activities of glucose transporter (GluT), pyruvate dehydrogenase (PDH), monocarboxylate transporter (MCT) and ribose-5-phosphate 
isomerase (Ri5PI) during (A) control, (B) 2DG, (C) cyanide, (D) malonate,  (E) 2DG+cyanide and (F) 2DG+malonate exposure.  The protein activities are 
normalized based on total carbon utilization in NG108-15 cell 
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Figure 130: Predicted activities of phosphoglycerate kinase (PGK), pyruvate kinase (PK), succinyl CoA synthase (SCaS) and F-type ATP synthase (F1F0ATPase) 
during (A) control, (B) 2DG, (C) cyanide, (D) malonate,  (E) 2DG+cyanide and (F) 2DG+malonate exposure. The protein activities are normalized based on the 
amount total amount of ATP generated by NG108-15 cell 
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CHAPTER-6: CONCLUSIONS AND FUTURE WORK 
6.1. Conclusions 
Proteomics is a dynamic and rapidly growing field where many advances have occurred 
during the past decade. Several high-throughput and high content screening technologies such 
as MS have been developed but none of them have the capability to perform non-invasive 
temporal analysis of cellular protein on a large-scale. The determination of protein activities 
over time would enable us to better understand disease progression and also analyze 
perturbations of pharmacologically active compounds. Pharmaceutical companies are in great 
need of tools capable of characterizing perturbations induced by active compounds in cellular 
networks. The work presented in this dissertation addresses this need with the development 
and experimental validation of a novel in silico model capable of predicting the changes in 
cellular protein activities and action potentials over time. 
To accurately predict protein activities, a validated in silico model is a prerequisite. 
Hence, the basal metabolism and cellular bioenergetics of NG108-15 cells were first 
experimentally determined to validate the metabolic model. The analysis of cellular carbon 
fluxes and ATP levels showed that metabolic pathways in a NG108-15 cell are reprogrammed. 
The reconstructed metabolic module included the core metabolic pathways, namely, glycolysis, 
pentose phosphate pathway, mitochondria and endoplasmic reticulum, which are essential to 
study energy metabolism. The model calibration was accomplished using a parameter 
estimation algorithm to simulate steady state by concurrently constraining the model to control 
experimental data. The metabolic model produced an excellent fit to experimental data and 
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predicted the activities of cellular proteins. A detailed analysis of cellular protein activities 
revealed that NG108-15 cells are utilizing the ‘Warburg effect’. 
A more realistic neuronal module was also constructed by incorporating additional ion 
channels and exchangers to predict the membrane electrical properties of NG108-15 cell. The 
electrophysiological readout from the NG108-15 cell was complex and deconvoluted by 
employing a custom algorithm to estimate ion channel parameters and exchanger activities. 
Deconvolution of the electrophysiological readout provided an excellent fit to voltage clamp 
and current clamp recordings. This estimation of ion channel parameters was important as 
these parameters determine ion fluxes. The developed neuronal module was coupled with a 
metabolic model to build a more comprehensive neuronal-metabolic model. The coupled 
neuronal-metabolic model accurately predicted cellular metabolic and neuronal protein 
activities along with the changes in intracellular ionic and metabolite concentrations. The 
model was capable of generating multiple action potentials over time. The neuronal module 
also included a subcellular compartment, a distinct feature that provides a more physiological 
representation of ionic fluxes during action potential generation in a neuron. 
The predictive capability of the neuronal-metabolic activity was confirmed by performing 
a series of known perturbations by inhibiting cellular proteins and simulating model behavior. 
The model predictions were supported with experimental measurements. The proteins 
involved in major energy producing pathways were perturbed. Initially, in silico perturbations of 
glycolytic enzymes were analyzed. Glycolytic perturbations identified a significant effect on 
cellular protein activities, leading to a decrease in carbon flux, cellular ATP levels and action 
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potentials. The experimental determination of metabolic and neuronal activity to glycolysis 
perturbations were in very good agreement with the model predictions. The glycolytic 
inhibition lowered the activities of several proteins which lead to time-dependent changes in 
neuronal AP.  
The inhibition of mitochondrial protein activities was also evaluated by exposing cells to 
cyanide and malonate. These mitochondrial inhibitors induced changes in metabolic and 
electrophysiological activity and were measured experimentally and simulated using the 
neuronal-metabolic model. The changes in neuronal APs predicted by the model were in good 
agreement with the experimental recordings. In addition, the carbon and adenosine fluxes 
were also in good agreement. The model predicted that the mitochondrial protein activity in 
the NG108-15 cells was lower compared to the activity of glycolytic proteins. This lower 
mitochondrial activity was reflected in metabolic and electrophysiological experiments where 
no significant changes were found upon cyanide and malonate exposure. A combinational 
perturbation in the neuronal-metabolic model showed that the sensitivity of the NG108-15 cells 
could be enhanced. An experimental determination of neuronal electrophysiological recordings 
and metabolic measurements showed that the model predictions were in good agreement.  
Analysis of AP time series data revealed that the shape of APs varies based on the 
pathway being inhibited. The characterization of these AP changes enabled the distinguishing of 
the pathways being affected. The developed model also allowed temporal analysis of cellular 
protein activities involved in core energy producing pathways. Thus, the developed model and 
validated results demonstrate the use of a system biology driven electrophysiological model as 
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an attractive platform for functional temporal proteomic analysis based on an 
electrophysiology readout. 
6.2. Future work 
Future work could focus on extending the current model by incorporating additional 
pathways representing all functional categories. The functional categories can be broadly 
divided into 6 categories, namely, 1) energy metabolism, 2) biosynthesis of aminoacids, 3) 
cellular processes, 4) fatty acid metabolism, 5) transcriptional regulation, 6) trasporters and 
binding proteins [26]. Currently, the energy metabolism has been incorporated and tied to 
neuronal actvitiy. A top-down model development approach has been followed that allows the 
flexibility of incorporating any new functional modules later on. 
The short-term future goals of the project could be to include cell-cycle to develop 
nuclear-signaling process, followed by a more precise implementation of calcium handling. At 
present the neuronal module is capable of predicting the ion concentration changes over time. 
In future work, the incorporation of secondary messenger systems and its activation based on 
altered ion concentrations would be useful to predict modifications in cellular activities. The 
model would have to be adapted and validated for NG108-15 cells followed by 
electrophysiological characterization, since time-scale of activities and corresponding AP peak 
shapes could be different. 
The long-term goal would be to include cellular process of functional categories listed 
above and experimentally validate them followed by building a database of their effects. This 
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would then enable analysis of APs after being treated with a compound to predict pathway 
perturbations. For understanding disease progression or identification of long-term effects of a 
drug, it is necessary to analyze APs on a longer time-scale. Long-term electrophysiological 
recordings obtained from MEAs would have to be deconvoluted using a custom algorithm. 
Although the resolutions of signals obtained from MEAs are not as high as compared to patch-
clamp electrophysiology, they could still be deconvoluted. In the event of complexity, other 
viable approaches can be adapted. Recent advances in electrophysiological recordings have 
enabled researchers to culture cells on carbon nanotubes [112] for achieving whole-cell 
recordings on a longer time scale. But these techniques need to be validated confirming that no 
other cellular mechanisms were triggered while using carbon nanotubes. 
Further, advancement in model development would allow cellular APs to be measured 
directly from a microfluidic system, followed by deconvolution of AP time-series to predict 
protein-protein interaction and changes in protein activities for performing high-throughput, 
non-invasive temporal proteomics. 
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APPENDIX A: METABOLIC MODEL DIFFERENTIAL EQUATIONS 
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Mitochondrial pyruvate d(Pyrm)
dt
=
1
mitochondrial
∗ (v35 −  v36) 
Mitochondrial NAD d(NADm)
dt
=
1
mitochondrial
∗ (−v36 –  v39 –  v40 –  v44 +  v49) 
Acetyl-CoA d(AcCoA)
dt
=
1
mitochondrial
∗ (v36 −  v37) 
Mitochondrial NADH d(NADHm)
dt
=
1
mitochondrial
∗ (v36 +  v39 +  v40 +  v44 –  v49) 
Oxaloacetate d(OAA)
dt
=
1
mitochondrial
∗ (−v37 +  v44) 
Citrate d(Cit)
dt
=
1
mitochondrial
∗ (v37 −  v38) 
Isocitrate d(IsoCit)
dt
=
1
mitochondrial
∗ (v38 −  v39) 
α-Ketoglutarate d(aKG)
dt
=
1
mitochondrial
∗ (v39 −  v40) 
Mitochondrial ADP d(ADPm)
dt
=
1
mitochondrial
∗ (−v41 +  v47 −  v48) 
Mitochondrial calcium d(Cam)
dt
=
1
mitochondrial
∗ (v45 −  v46) 
Succinyl CoA d(SucCoA)
dt
=
1
mitochondrial
∗ (v40 −  v41) 
Mitochondrial phosphate d(Pim)
dt
=
1
mitochondrial
∗ (−v41 −  v48 +  v57) 
Succinate d(Suc)
dt
=
1
mitochondrial
∗ (v41 −  v42) 
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Mitochondrial ATP d(ATPm)
dt
=
1
mitochondrial
∗ (v41 −  v47 +  v48) 
Fumarate d(Fum)
dt
=
1
mitochondrial
∗ (v42 −  v43) 
Malate d(Mal)
dt
=
1
mitochondrial
∗ (v43 −  v44) 
Mitochondrial membrane potential d(dPsi)
dt
=
1
mitochondrial
∗ (−2 ∗ v50 −  v51 −  v52 −  v53 +  v54 +  v55 −  v56) 
Mitochondrial FAD d(FAD)
dt
=
1
mitochondrial
∗ (−v42 −  v64 +  v65) 
Mitochondrial FADH2 d(FADH2)
dt
=
1
mitochondrial
∗ (v42 +  v64 −  v65) 
Endoplasmic reticulum calcium d(Caer)
dt
=
1
er
∗ (−v59 +  v60 −  v61) 
Cytosolic Glucose d(Glc)
dt
=
1
cellular
∗ (v1 −  v2) 
Magnesium bound ATP d(MgATP)
dt
=
1
cellular
∗ (−v2 −  v4 +  v8 +  v13 −  v16 −  v17 −  v26 −  v31 −  v67 −  v68) 
Glucose-6-phosphate d(G6P)
dt
=
1
cellular
∗ (v2 −  v3 −  v18) 
Magnesium bound ADP d(MgADP)
dt
=
1
cellular
∗ (v2 +  v4 −  v8 −  v13 +  v16 +  v17 −  v32 +  v67 +  v68) 
2,3-bisphosphoglycerate d(BPG23)
dt
=
1
cellular
∗ (v9 −  v10 +  v34) 
Magnesium d(Mg)
dt
=
1
cellular
∗ (v31 +  v32 +  v33 +  v34) 
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Magnesium bound 2,3-
bisphosphoglycerate 
d(MgBPG23)
dt
=
1
cellular
∗ (−v34) 
Fructose 6-phosphate d(F6P)
dt
=
1
cellular
∗ (v3 −  v4 +  v25 +  v27) 
AMP d(AMP)
dt
=
1
cellular
∗ (−v17 +  v33) 
ATP d(ATP)
dt
=
1
cellular
∗ (v31 +  v47) 
Fructose 1,6-biphosphate d(F16BP)
dt
=
1
cellular
∗ (v4 −  v5) 
Magnesium bound AMP d(MgAMP)
dt
=
1
cellular
∗ (v26 −  v33) 
Glyceraldehyde-3-phosphate d(GAP)
dt
=
1
cellular
∗ (v5 +  v6 −  v7 +  v24 −  v25 +  v27) 
Dihydroxyacetone phosphate d(DHAP)
dt
=
1
cellular
∗ (v5 −  v6) 
Cytosolic phosphate d(Pi)
dt
=
1
cellular
∗ (−v7 +  v10 +  v16 +  v29 −  v57 +  v67 +  v68) 
Cytosolic NAD d(NAD)
dt
=
1
cellular
∗ (−v7 +  v14 +  v64) 
1,3-bisphosphoglycerate d(BPG13)
dt
=
1
cellular
∗ (v7 −  v8 −  v9) 
Cytosolic NADH d(NADH)
dt
=
1
cellular
∗ (v7 −  v14 −  v64) 
3-Phosphoglycerate d(PG3)
dt
=
1
cellular
∗ (v8 +  v10 −  v11) 
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2-Phosphoglycerate d(PG2)
dt
=
1
cellular
∗ (v11 −  v12) 
Phosphoenolpyruvate d(PEP)
dt
=
1
cellular
∗ (v12 −  v13) 
Cytosolic pyruvate d(Pyr)
dt
=
1
cellular
∗ (v13 −  v14 −  v15 +  v30 −  v35) 
Cytosolic lactate d(Lac)
dt
=
1
cellular
∗ (v14 +  v15 +  v28) 
Cytosolic NADPH d(NADPH)
dt
=
1
cellular
∗ (−v15 +  v18 +  v19 −  v20) 
Cytosolic NADP d(NADP)
dt
=
1
cellular
∗ (v15 −  v18 −  v19 +  v20) 
ADP d(ADP)
dt
=
1
cellular
∗ (v17 +  v32 −  v47) 
6-phosphoglucono-δ-lactone d(PGL)
dt
=
1
cellular
∗ (v18 −  v19) 
Ribuloase-5-phosphate d(Ru5P)
dt
=
1
cellular
∗ (v19 −  v22 −  v23) 
Glutathione disulphide d(GSSG)
dt
=
1
cellular
∗ (−v20 +  v21) 
Glutathione d(GSH)
dt
=
1
cellular
∗ ( 2 ∗ v20 − −2 ∗ v21) 
Xyulose-5-phosphate d(X5P)
dt
=
1
cellular
∗ (v22 −  v24 −  v27) 
Ribose-5-phosphate d(Ri5P)
dt
=
1
cellular
∗ (v23 −  v24 −  v26) 
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Sedoheptulose 7-phosphate d(S7P)
dt
=
1
cellular
∗ (v24 −  v25) 
Erythrose 4-phosphate d(E4P)
dt
=
1
cellular
∗ (v25 −  v27) 
Phosphoribosyl pyrophosphate d(PRPP)
dt
=
1
cellular
∗ (v26 −  v66) 
Cytosolic calcium d(Ca)
dt
=
1
cellular
∗ (−v45 +  v46 +  v59 −  v60 +  v61) 
Phosphatidylinositol 4,5-bisphosphate D(PIP2)
dt
=
1
cellular
∗ (−v58) 
Inositol triphosphate d(IP3)
dt
=
1
cellular
∗ (v58 −  v62) 
Diacyl-glycerol d(DAG)
dt
=
1
cellular
∗ (v58 −  v63) 
Extracellular glucose d(Glce)
dt
=
1
extracellular
∗ (−v1) 
Extracellular lactate d(Lace)
dt
=
1
extracellular
∗ (−v28) 
Extracellular phosphate d(Pie)/dt =  1/extracellular ∗ (−v29) 
Extracellular pyruvate d(Pyre)
dt
=
1
extracellular
∗ (−v30) 
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APPENDIX B: METABOLIC MODEL FLUXES 
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Glucose transporter 
v1 =
Vmaxgt
KmGlcoutgt
∗
Glce −
Glc
Keqgt
1 +
Glce
KmGlcoutgt
+
Glc
KmGlcingt
+
Glce ∗ Glc
KmGlcoutgt ∗ KmGlcingt
 
Hexokinase 
v2 =
Glc
Glc + KmGlchk
∗ (
Vmax1hk
KmMgATPhk
) ∗
MgATP +
Vmax2hk
Vmax1hk
MgATP
Mg
KmMgATPMghk
 –  G6P ∗
MgADP
Keqhk
(
(1 +
MgATP
KmMgATPhk
)(1 +
Mg
KmMgATPMghk
) +
Mg
KmMghk
+
(1.55 +
G6P
KmG6Phk
) (1 +
Mg
KmMghk
) +
BPG23 + MgBPG23
KmBPG23hk
+Mg
BPG23 + MgBPG23
KmMghk ∗ KmMgBPG23hk
)
 
Glucosephosphate isomerase 
v3 =  Vmaxgpi ∗
G6P −
F6P
Keqgpi
G6P + KmG6Pgpi ∗ (1 +
F6P
KmF6Pgpi
)
 
Phosphofructokinase 
v4 = Vmaxpfk  ∗
F6P ∗ MgATP − F16BP ∗
MgADP
Keqpfk
(
 
 
 
 
(F6P + KmF6Ppfk) ∗ (MgATP + KmMgATPpfk) ∗
(
 
 
1+ Lopfk ∗
(
 
 
(1 +
ATP
KmATPpfk
) ∗
1 +
Mg
KmMgpfk
(1 +
AMP +MgAMP
KmAMPpfk
) ∗ (1 +
F6P
KmF6Ppfk
)
)
 
 
4
)
 
 
)
 
 
 
 
 
Aldolase 
v5 =
Vmaxald
KmF16BPald
∗
F16BP − GAP ∗
DHAP
Keqald
1 +
F16BP
KmF16BPald
+
GAP
KiGAPald
+ DHAP ∗
GAP + KmGAPald
KmDHAPald ∗ KiGAPald
+ F16BP ∗
GAP
KmF16BPald ∗ KiiGAPald
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Triosephosphate isomerase 
v6 =  Vmaxtpi ∗
DHAP −
GAP
Keqtpi
DHAP + KmDHAPtpi ∗ (1 +
GAP
KmGAPtpi
)
 
Glyceraldehyde phosphate 
dehydrogenase 
v7 =  
Vmaxgapdh
KmNADgapdh ∗ KmGAPgapdh ∗ KmPigapdh
∗
NAD ∗ GAP ∗ Pi − BPG13 ∗
NADH
Keqgapdh
(1 +
NAD
KmNADgapdh
) ∗ (1 +
GAP
KmGAPgapdh
) ∗ (1 +
Pi
KmPigapdh
) + (1 +
NADH
KmNADHgapdh
) ∗ (1 +
BPG13
KmBPG13gapdh
) − 1
 
Phosphoglycerate kinase 
v8 =
Vmaxpgk
KmMgADPpgk ∗ KmBPG13pgk
∗
MgADP ∗ BPG13 −MgATP ∗
PG3
Keqpgk
(1 +
MgADP
KmMgADPpgk
) ∗ (1 +
BPG13
KmBPG13pgk
) + (1 +
MgATP
KmMgATPpgk
) ∗ (1 +
PG3
KmPG3pgk
) − 1
 
Bisphosphoglycerate mutase 
v9 =  Kdbpgm ∗
BPG13 −
BPG23 + MgBPG23
Keqbpgm
1 +
BPG23 +MgBPG23
KmBPG23bpgm
 
Bisphosphoglycerate 
phosphatase 
v10 =  Vmaxbpgp ∗
BPG23+ MgBPG23−
PG3
Keqbpgp
BPG23 +MgBPG23+ KmBPG23bpgp
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Phosphoglycerate mutase 
v11 =  Vmaxpgm ∗
PG3 −
PG2
Keqpgm
PG3 + KmPG3pgm ∗ (1 +
PG2
KmPG2pgm
)
 
Enolase 
v12 =  Vmaxeno ∗
PG2 −
PEP
Keqeno
PG2 + KmPG2eno ∗ (1 +
PEP
KmPEPeno
)
 
Pyruvate kinase 
v13 =  Vmaxpk ∗
PEP ∗ MgADP − Pyr ∗
MgATP
Keqpk
(PEP+ KmPEPpk) ∗ (MgADP+ KmMgADPpk) ∗
(
 1 + Lopk ∗
(1 +
ATP + MgATP
KmATPpk
)
4
((1 +
PEP
KmPEPpk
)
4
) ∗ ((1 +
F16BP
KmF16BPpk
)
4
)
)
 
 
Lactate dehydrogenase (NADH) 
v14 =  Vmaxldh ∗ (Pyr ∗ NADH− Lac ∗
NAD
[Lactate dehydrogenase (NADH)]
. Keqldh) 
Lactate dehydrogenase 
(NADPH) 
v15 =  kldh ∗ (Pyr ∗ NADPH − Lac ∗
NADP
[Lactate dehydrogenase (NADPH)]
. Keqldh) 
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ATPase 
v16 =  kATPase ∗ MgATP 
Adenylate kinase 
v17 = =
Vmaxak
KmATPak ∗ KmAMPak
∗ (MgATP ∗ AMP −MgADP ∗
ADP
Keqak
)
(1 +
MgATP
KmATPak
) ∗ (1 +
AMP
KmAMPak
) +
MgADP+ ADP
KmADPak
+MgADP ∗ (
ADP
(KmADPak)2
)
 
Glucose phosphate 
dehydrogenase 
v18 =
Vmaxgpdh
KmG6Pgpdh ∗ KmNADPgpdh
∗
G6P ∗ NADP − PGL ∗
NADPH
Keqgpdh
1 + NADP ∗
1 +
G6P
KmG6Pgpdh
KmNADPgpdh
+
ATP+MgATP
KmATPgpdh
+
NADPH
KmNADPHgpdh
+
BPG23+ MgBPG23
KmBPG23gpdh
 
Phosphogluconate 
dehydrogenase 
v19 =
Vmaxpgldh
KmPGL1pgldh ∗ KmNADPpgldh
∗
PGL ∗ NADP − Ru5P ∗
NADPH
Keqpgldh
(
 
 
(1 +
NADP
KmNADPpgldh
) ∗ (1 +
PGL
KmPGL1pgldh
+
BPG23 + MgBPG23
KmBPG23pgldh
) +
ATP +MgATP
KmATPpgldh
+
NADPH ∗
1 +
PGL
KmPGL2pgldh
KmNADPHpgldh )
 
 
 
Glutathione reductase 
v20 =  Vmaxgr ∗
GSSG ∗
NADPH
KmGSSGgr ∗ KmNADPHgr
−
(GSH)2
(KmGSHgr)
2 ∗
NADP
KmNADPgr ∗ Keqgr
1 + NADPH ∗
1 +
GSSG
KmGSSGgr
KmNADPHgr
+
NADP
KmNADPgr
∗ (1 + GSH ∗
1 +
GSH
KmGSHgr
KmGSHgr
)
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Glutathione oxidation 
v21 =  Kgo ∗ GSH 
Phosphoribulose epimerase 
v22 =  Vmaxpre ∗
Ru5P −
X5P
Keqpre
Ru5P + KmRu5Ppre ∗ (1 +
X5P
KmX5Ppre
)
 
Ribose phosphate isomerase 
v23 =  Vmaxrpi ∗
Ru5P−
Ri5P
Keqrpi
Ru5P+ KmRu5Prpi ∗ (1 +
Ri5P
KmRi5Prpi
)
 
Tranketolase (Ri5P) 
v24 =  
[Tranketolase (Ri5P)]. Vmaxtk ∗ ∗  Ri5P ∗ X5P −
GAP ∗ S7P
[Tranketolase (Ri5P)]. 𝐾𝑒𝑞𝑡𝑘
(
 
 
(
 
([Tranketolase (Ri5P)]. K1tk + Ri5P) ∗ X5P +
([Tranketolase (Ri5P)]. K2tk + [Tranketolase (Ri5P)]. K6tk ∗ S7P) ∗ Ri5P +
([Tranketolase (Ri5P)]. K3tk + [Tranketolase (Ri5P)]. K5tk ∗ S7P) ∗ GAP+
[Tranketolase (Ri5P)]. K4tk ∗ S7P +@[Tranketolase (Ri5P)]. K7tk ∗ X5P ∗ GAP)
 
)
 
 
 
Transaldolase 
v25 =  Vmaxta ∗
S7P ∗ GAP − E4P ∗
F6P
Keqta
(K1ta + GAP) ∗ S7P + (K2ta + K6ta ∗ F6P) ∗ GAP+ (K3ta + K5ta ∗ F6P) ∗ E4P + K4ta ∗ F6P +
K7ta ∗ S7P ∗ E4P
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Phosphoribosylpyrophosphate 
synthetase 
v26 =  Vmaxprpps ∗
Ri5P ∗ MgATP − PRPP ∗
MgAMP
Keqprpps
(KmATPprpps +MgATP) ∗ (KmRi5Pprpps + Ri5P)
 
Transketolase (E4P) 
v27 =
(
[Transketolase (E4P)]Vmaxtk  ∗  E4P ∗ X5P −
GAP ∗
F6P
[Transketolase (E4P)]Keqtk
)
(
 
 
([Transketolase (E4P)]K1tk + E4P) ∗ X5P +
([Transketolase (E4P)]K2tk + [Transketolase (E4P)]K6tk ∗ F6P) ∗ E4P +
([Transketolase (E4P)]K3tk + [Transketolase (E4P)]K5tk ∗ F6P) ∗ GAP +
[Transketolase (E4P)]K4tk ∗ F6P +
[Transketolase (E4P)]K7tk ∗ X5P ∗ GAP )
 
 
 
Monocarboxylate transporter, 
Lactate transport 
v28 =  Vmaxlt ∗ (Lace −
Lac
Keqlt
) 
Phosphate transporter on 
plasma membrane 
v29 =  [Phosphate transport (Plasma membrane)]. Vmaxpt ∗ (Pie −
Pi
[Phosphate transport (Plasma membrane)]
. Keqpt) 
Pyruvate transporter on 
plasma membrane 
v30 = [Pyruvate transport (Plasma membrane)]. Vmaxpt ∗ (Pyre − (
Pyr
[Pyruvate transport (Plasma membrane)]
. Keqpt)) 
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MgATP dissociation 
v31 =  EqMgATP ∗ (MgATP −Mg ∗
ATP
KdMgATP
) 
MgADP dissociation 
v32 =  EqMgADP ∗ (MgADP −Mg ∗
ADP
KdMgADP
) 
MgAMP dissociation 
v33 =  EqMgAMP ∗ (MgAMP −Mg ∗ AMP/KdMgAMP)) 
MgBPG23 dissociation 
v34 =  EqMgBPG23 ∗ (MgBPG23 − Mg ∗ BPG23/KdMgBPG23)) 
Pyruvate transport 
(Mitochondrial membrane) 
v35 =  [Pyruvate transport (Mitochondrial membrane)]. Vmaxpt ∗ (Pyr −
Pyrm
[Pyruvate transport (Mitochondrial membrane)]
. Keqpt) 
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Pyruvate dehydrogenase 
v36 =  kpdh ∗ (Pyrm−
AcCoA
KpdhEQ
) ∗ CoA ∗ NADm 
Citrate synthase 
v37 =  
Kcatcs ∗ Etcs
1 +
KmAcCoAcs
AcCoA +
KmOAAcs
OAA + KmAcCoAcs ∗
KmOAAcs
AcCoA ∗ OAA
 
Aconitase 
v38 =  Kfaco ∗ (Cit −
IsoCit
Keqaco
) 
Isocitrate dehydrogenase 
v39 =
Kcatidh Etidh
(
 
 
 
 
 1+ (
Hm
kH1idh
) + (
kH2idh
Hm ) +
(
KmIsoCitidh
IsoCit )
nidh
(1 +
ADPm
KaADPidh
) ∗ (1 +
Cam
KaCaidh
)
+
KmNADidh
NADm ∗ (1 +
NADHm
KiNADHidh
) +
(
KmIsoCitidh
IsoCit )
nidh
∗
KmNADidh
NADm ∗
1 +
NADHm
KiNADHidh
(1 +
ADPm
KaADPidh
) ∗ (1 +
Cam
KaCaidh
)
)
 
 
 
 
 
 
α-Ketoglutarate 
dehydrogenase v40 =
KcatakgdhEtakgdh
1 +
KmaKGakgdh
aKG
(1 +
Mgm
KaMgakgdh
) ∗ (1 +
Cam
KaCaakgdh
)
+
(
KmNADakgdh
NADm )
nakgdh
(1 +
Mgm
KaMgakgdh
) ∗ (1 +
Cam
KaCaakgdh
)
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Succinyl CoA lyase 
v41 =  Kfscl ∗ (SucCoA ∗ ADPm− Suc ∗ ATPm ∗
CoA
Keqscl
) 
Succinate dehydrogenase 
v42 =  
Kcatsdh ∗ Etsdh
1 +
KmSucsdh
Suc ∗ (1 +
OAA
KiOAAsdh
) ∗ (1 +
Fum
KiFumsdh
)
 
Fumarate hydratase 
v43 =  Kffh ∗ (Fum−
Mal
Keqfh
) 
Malate dehydrogenase 
v44 =  Kcatmdh Etmdh  (
1
1 +
Hm
kH1mdh
+
Hm2
kH1mdh ∗ kH2mdh
+ koffset)
∗
1
(1 +
kH3mdh
Hm + kH3mdh ∗
kH4mdh
Hm )
2
1 +
KmMalmdh
Mal ∗ (1 +
OAA
KiOAAmdh
) +
KmNADmdh
NADm +
KmMalmdh
Mal ∗ (1 +
OAA
KiOAAmdh
) ∗ (
KmNADmdh
NADm )
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Calcium uniporter 
v45 =
Vmaxuni ∗ (
Ca
Ktrans) ∗ (1 +
Ca
Ktrans)
3
(1 +
Ca
Ktrans)
4
+ (
L
(1 +
Ca
Kact)
nauni) ∗
2F(dPsi − dPsio)
R ∗ T ∗ (1 − exp (−2F
dPsi − dPsio
R ∗ T ))
 
Sodium-Calcium exchanger 
v46 =
(Vmaxex ∗ exp (bF
dPsi − dPsio
R ∗ T ) ∗ (
Cam
Ca ))
 (1 +
KNa
Na )
nex
∗ (1 +
KCa
Cam)
 
 
Adenine nucleotide 
translocator 
v47 =  Vmaxant ∗
1 − 0.018 ∗ ATP ∗
ADPm
0.0225 ∗ ADP ∗ ATPm ∗ exp (−F ∗
dPsi
R ∗ T)
(1 + 0.05 ∗
ATP
0.45 ∗ ADP ∗ exp (−h ∗ F ∗
dPsi
R ∗ T)) ∗ (1 + 0.36 ∗
ADPm
0.05 ∗ ATPm)
 
F1F0 ATPase 
v48 =  −rhoF1 ∗
(
 
 
(100 ∗ pa + pc1 ∗ exp (3F ∗
dPsiB
R ∗ T)) ∗ KF1 ∗
Cm− ADPm
ADPm ∗ Pim−
(pa − pc2 ∗ KF1 ∗
Cm− ADPm
ADPm ∗ Pim) ∗ exp(3F ∗
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
 
 
(
 
 
(1 + p1 ∗ KF1 ∗
Cm− ADPm
ADPm ∗ Pim) ∗ exp (3F ∗
dPsiB
R ∗ T) +
(p2 + p3 ∗ KF1 ∗
Cm− ADPm
ADPm ∗ Pim) ∗ exp(3F ∗
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
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Oxidative phosphorylation 
v49 =  0.5 ∗ rhoNADH ∗
(
 
 
 
 (ra + rc1 ∗ exp (6F
dPsiB
R ∗ T)) ∗ KNADH ∗ sqrt (
NADHm
NADm ) − ra ∗ exp(g ∗ 6F
R ∗ T ∗
dpH
F + dPsi
R ∗ T )+
rc2 ∗ KNADH ∗ sqrt (
NADHm
NADm ) ∗ exp(g ∗ 6F
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
 
 
 
 
(
 
 
 
(1 + r1 ∗ KNADH ∗ sqrt (
NADHm
NADm )) ∗ exp (6F
dPsiB
R ∗ T) +
(r2 + r3 ∗ KNADH ∗ sqrt (
NADHm
NADm )) ∗ exp(g ∗ 6F
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
 
 
 
 
dPsi (Calcium uniporter) 
v50 =
Vmaxuni
Cmito
∗
(
Ca
Ktrans) ∗ (1 +
Ca
Ktrans)
3
(1 +
Ca
Ktrans)
4
+(
L
(1 +
Ca
Kact)
nauni) ∗
2F(dPsi − dPsio)
R ∗ T ∗ (1 − exp (−2F
dPsi − dPsio
R ∗ T ))
 
dPsi (Sodium-Calcium 
exchanger) 
v51 =  
Vmaxex
Cmito
(exp (bF
dPsi − dPsio
R ∗ T ) ∗ (
Cam
Ca ))
 (1 +
KNa
Na )
nex
∗ (1 +
KCa
Cam)
 
dPsi (Adenine nucleotide 
translocator) 
v52 =
Vmaxant
Cmito
∗
1 − 0.018 ∗ ATP ∗
ADPm
0.0225 ∗ ADP ∗ ATPm ∗ exp (−F ∗
dPsi
R ∗ T)
(1 + 0.05 ∗
ATP
0.45 ∗ ADP ∗ exp(−h ∗ F ∗
dPsi
R ∗ T)) ∗ (1 + 0.36 ∗
ADPm
0.05 ∗ ATPm)
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dPsi (F1F0 ATPase) 
v53 =  − (
3 ∗ rhoF1
Cmito
) ∗
100 ∗ pa ∗ (1 + KF1
Cm− ADPm
ADPm ∗ Pim) −
(pa + pb) ∗ exp(3F
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
(
 
 
 
(1 + p1 ∗ (KF1
Cm− ADPm
ADPm ∗ Pim)) ∗ exp (3F
dPsiB
R ∗ T ) +
(p2 + p3 (KF1
Cm− ADPm
ADPm ∗ Pim)) ∗ exp(3F
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
 
 
 
 
dPsi (Oxidative 
phosphorylation NADH) 
v54 =  
6 ∗ rhoNADH
Cmito
∗
ra ∗ KNADH ∗ sqrt (
NADHm
NADm )−
(ra + rb) ∗ exp(g ∗ 6 ∗ F ∗
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
(
 
 
 
(1 + r1 ∗ KNADH ∗ sqrt (
NADHm
NADm )) ∗ exp (6 ∗ F ∗
dPsiB
R ∗ T) +
(r2 + r3 ∗ KNADH ∗ sqrt (
NADHm
NADm )) ∗ exp(g ∗ 6 ∗ F ∗
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
 
 
 
 
dPsi (Oxidative 
phosphorylation FADH2) 
v55 =  
4 ∗ rhoFADH2
Cmito
∗
ra ∗ KFADH2 ∗ sqrt (
FADH2
FAD ) −
(ra + rb) ∗ exp(g ∗ 4F
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
(
 
 
 
(1 + r1 ∗ KFADH2 ∗ sqrt (
FADH2
FAD )) ∗ exp (4F
dPsiB
R ∗ T) +
(r2 + r3 ∗ KFADH2 ∗ sqrt (
FADH2
FAD )) ∗ exp(g ∗ 4F
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
 
 
 
 
dPsi (Leak) 
v56 =  gh ∗
R ∗ T ∗
dpH
F + dPsi
Cmito
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Phosphate transport 
(Mitochondrial membrane) 
v57 =  [Phosphate transport (Mitochondrial membrane)]. Vmaxpt ∗ (Pi −
Pim
[Phosphate transport (Mitochondrial membrane)]
. Keqpt) 
Phospholipase C 
v58 =  (PLC ∗ (Vmaxplc ∗
PIP2
KmPIP2plc + PIP2
)) 
ER calcium leak 
v59 =  (kLeak ∗ (Caer − Ca)) ∗ er 
ER calcium pump 
v60 =  (kPump ∗ Ca) ∗ cellular 
ER calcium channel 
v61 =  (Lchannel + Pchannel ∗ (IP3
3) ∗
Ca3
(IP3 + KmIP3channel)3 ∗ (Ca + KmCachannel)3
) ∗ (Caer − Ca) 
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IP3 consumption 
v62 =  kIP3 ∗ IP3 
DAG consumption 
v63 =  kDAG ∗ DAG 
G3P shuttle 
v64 =  VmaxG3P ∗ FAD ∗ NADH 
Oxidative phosphorylation 
FADH2 
v65 =  0.5 ∗ rhoFADH2 ∗
(
 
 
 
 (ra + rc1 ∗ exp (4F
dPsiB
R ∗ T)) ∗ KFADH2 ∗ sqrt (
FADH2
FAD ) − ra ∗ exp(g4F
R ∗ T ∗
dpH
F + dPsi
R ∗ T ) +
rc2 ∗ KFADH2 ∗ sqrt (
FADH2
FAD ) ∗ exp(g ∗ 4 ∗ F ∗
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
 
 
 
 
(
 
 
 
(1 + r1 ∗ KFADH2 ∗ sqrt (
FADH2
FAD )) ∗ exp (4F
dPsiB
R ∗ T ) +
(r2 + r3 ∗ KFADH2 ∗ sqrt (
FADH2
FAD )) ∗ exp(g ∗ 4F
R ∗ T ∗
dpH
F + dPsi
R ∗ T )
)
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Sink for protein synthesis 
v66 =  Vmaxproteinsyn ∗ PRPP 
Na/K-ATPase 
v67 =  
(
 
 1
((1 +
KmK
Ke )
2
) ∗ ((1 +
KmNa
Na )
3
) ∗ ((1 +
KATP
MgATP))
)
 
 
 
Ca-ATPase 
v68 =
1
(1 + (
𝐾𝑚𝐶𝑎
Ca )) ∗ (1 + (
KATP
MgATP))
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APPENDIX C: METABOLIC MODEL PARAMETERS 
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Description Symbol Value Units Ref 
Faraday constant F 96480 C mol-1 [59] 
Activation constant Kact 0.00038 mM [59] 
Kd for translocated Ca
+2 Ktrans 0.019 mM [59] 
Keq for conformational transitions in uniporter L 110 - [59] 
Gas constant R 8.3145 V C mol-1 0K-1 [59] 
Temperature T 302.15 0K [59] 
Vmax uniport Ca+2 transport Vmax_uni 0.625 uM s-1 [59] 
Offset membrane potential dPsio 0.091 Volts [59] 
Uniporter activation cooperativity na_uni 2.8 - [59] 
Antiporter Ca+ constant KCa 0.000375 mM [59] 
Antiporter Na+ constant KNa 9.4 mM [59] 
Vmax of Na
+/Ca+2 antiporter Vmax_ex 9 ∗ 10−7 mM s-1 Fitted 
dPsi dependence on Na+/Ca+2 antiporter b 0.5 - [59] 
Na+/Ca+2 antiporter cooperativity n_ex 3 - [59] 
Maximal rate of ANT Vmax_ant 0.005 mM [59] 
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Description Symbol Value Units Ref 
Fraction of ΔdPsi  h 0.5 - [59] 
Total sum of mitochondrial adenine nucleotides Cm 2.5 mM Fitted 
Equilibrium constant of ATP hydrolysis KF1  1.71e+06 - [59] 
Phase boundary potential dPsiB  0.05 V [59] 
pH gradient across the inner membrane dpH -0.6 pH units [59] 
Sum of products of rate constants p1 1.346e-08 - [59] 
Sum of products of rate constants p2 7.739e-07 - [59] 
Sum of products of rate constants p3 6.65e-15 - [59] 
Sum of products of rate constants pa 1.656e-05 s-1 [59] 
Sum of products of rate constants pc1 9.651e-14 s-1 [59] 
Sum of products of rate constants pc2 4.585e-14 s-1 [59] 
Concentration of electron carriers (respiratory 
complexes II-III-IV) 
rhoF1 0.003 mM Fitted 
Equilibrium constant of respiration KNADH 1.35e+18 - [59] 
Correction factor for voltage g 0.85 - [59] 
Sum of products of rate constants r1 2.077e-18 - [59] 
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Description Symbol Value Units Ref 
Sum of products of rate constants r2 1.728e-09 - [59] 
Sum of products of rate constants r3 1.059e-26 - [59] 
Sum of products of rate constants ra 6.394e-10 s-1 [59] 
Sum of products of rate constants rc1 2.656e-19 s-1 [59] 
Sum of products of rate constants rc2 8.632e-27 s-1 [59] 
Concentration of electron carriers (respiratory 
complexes I-III-IV) 
rhoNADH 0.005 mM [59] 
Inner membrane capacitance Cmito 1.812 mM V-1 [59] 
Sum of products of rate constants pb 2.023e-05 s-1 [59] 
Sum of products of rate constants rb 1.762e-13 s-1 [59] 
Equilibrium constant of FADH2 oxidation KFADH2 5.497e+13 - [59] 
Concentration of electron carriers (respiratory 
complexes II-III-IV) 
rhoFADH2 0.06 mM Fitted 
Ionic conductance of the inner membrane gh 0.01 mM s-1 V-1 [59] 
Equilibrium constant for PDH K_pdh_EQ 8.0 - [75] 
Rate constant G3P shuttle Vmax_G3P 0.031 s-1 Fitted 
Rate constant for protein synthesis/degradation  Vmax_proteinsyn 3.084 s-1 Fitted 
 214 
 
Description Symbol Value Units Ref 
Michaelis constant for ATP in NaK-ATPase KATP 5 mM Fitted 
Michaelis constant for K+ in NaK-ATPase KmK 3.5 mM [78] 
Michaelis constant for Na in NaK-ATPase KmNa 10 mM [78] 
Equilibrium constant of glucose transporter Keq_gt 0.25 - [58] 
Michaelis constant for forward glucose transporter KmGlcin_gt 6.9 mM [58] 
Michaelis constant for reverse glucose transporter KmGlcout_gt 1.7 mM [58] 
Maximal rate of glucose transporter Vmax_gt 0.0953 mM s-1 Fitted 
Equilibrium constant of HK Keq_hk 3900 mM [58] 
Michaelis constant for HK KmBPG23_hk 2.7 mM [58] 
Michaelis constant for HK KmG6P_hk 0.0045 mM [58] 
Michaelis constant for HK KmGlc_hk 0.1 mM [58] 
Michaelis constant for HK KmMgATPMg_hk 1.14 mM [58] 
Michaelis constant for HK KmMgATP_hk 1.44 mM [58] 
Michaelis constant for HK KmMgBPG23_hk 3.44 mM [58] 
Michaelis constant for HK KmMg_hk 1.02 mM [58] 
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Description Symbol Value Units Ref 
Maximal rate of HK Vmax1_hk 0.045 mM s-1 Fitted 
Maximal rate of HK Vmax2_hk 1.1067 mM s-1 [58] 
Equilibrium constant of GPI Keq_gpi 0.3925 - [58] 
Michaelis constant for GPI KmF6P_gpi 0.071 mM [58] 
Michaelis constant for GPI KmG6P_gpi 0.182 mM [58] 
Maximal rate for GPI Vmax_gpi 2.652 mM s-1 Fitted 
Equilibrium constant of PFK Keq_pfk 1e+05 mM [58] 
Michaelis constant for PFK KmAMP_pfk  0.033 mM [58] 
Michaelis constant for PFK KmATP_pfk  0.01 mM [58] 
Michaelis constant for PFK KmF6P_pfk  0.1 mM [58] 
Michaelis constant for PFK KmMgATP_pfk  0.068 mM [58] 
Michaelis constant for PFK KmMg_pfk  0.44 mM [58] 
Lo for PFK Lo_pfk  0.001072 - [58] 
Maximal rate of PFK Vmax_pfk  0.6779 mM s-1 Fitted 
Equilibrium constant of ALD Keq_ald  0.114 mM [58] 
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Description Symbol Value Units Ref 
Inhibition constant for ALD KiGAP_ald  0.0572 mM [58] 
Inhibition constant for ALD KiiGAP_ald 0.176 mM [58] 
Michaelis constant for ALD KmDHAP_ald 0.0364 mM [58] 
Michaelis constant for ALD KmF16BP_ald 0.0071 mM [58] 
Michaelis constant for ALD KmGAP_ald 0.1906 mM [58] 
Maximal rate of ALD Vmax_ald 0.2857 mM Fitted 
Equilibrium constant of TPI Keq_tpi 0.0407 mM [58] 
Michaelis constant for TPI KmDHAP_tpi 0.838 mM [58] 
Michaelis constant for TPI KmGAP_tpi 0.428 mM [58] 
Maximal rate of TPI Vmax_tpi 15.4784 mM s-1 [58] 
Equilibrium constant of GADPH Keq_gapdh 0.000192 mM [58] 
Michaelis constant for GADPH KmBPG13_gapdh 0.0035 mM [58] 
Michaelis constant for GADPH KmGAP_gapdh 0.005 mM [58] 
Michaelis constant for GADPH KmNADH_gapdh 0.0083 mM [58] 
Michaelis constant for GADPH KmNAD_gapdh 0.05 mM [58] 
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Description Symbol Value Units Ref 
Michaelis constant for GADPH KmPi_gapdh 3.9 mM [58] 
Maximal rate of GADPH Vmax_gapdh 12.197 mM s-1 Fitted 
Equilibrium constant of PGK Keq_pgk 1455 mM [58] 
Michaelis constant for PGK KmBPG13_pgk 0.002 mM [58] 
Michaelis constant for PGK KmMgADP_pgk 0.35 mM [58] 
Michaelis constant for PGK KmMgATP_pgk 0.48 mM [58] 
Michaelis constant for PGK KmPG3_pgk 1.2 mM [58] 
Maximal rate of PGK Vmax_pgk 14.184 mM s-1 Fitted 
Dissociation constant of bPGM Kd_bpgm 215.5866 Fitted [58] 
Equilibrium constant of bPGM Keq_bpgm  1e+05 mM [58] 
Michaelis constant for bPGM KmBPG23_bpgm 0.04 mM [58] 
Equilibrium constant of bPGM Keq_bpgp 1e+05 mM [58] 
Michaelis constant for bPGM KmBPG23_bpgp 0.2 mM [58] 
Maximal rate of bPGM Vmax_bpgp 0.0015 mM s-1 Fitted 
Equilibrium constant of PGM Keq_pgm 0.145 mM [58] 
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Description Symbol Value Units Ref 
Michaelis constant for PGM KmPG2_pgm 1 mM [58] 
Michaelis constant for PGM KmPG3_pgm 5 mM [58] 
Maximal rate of PGM Vmax_pgm 5.673 mM s-1 Fitted 
Equilibrium constant of ENO Keq_eno 1.7 mM [58] 
Michaelis constant for ENO KmPEP_eno 1 mM [58] 
Michaelis constant for ENO KmPG2_eno 1 mM [58] 
Maximal rate of ENO Vmax_eno 4.255 mM s-1 Fitted 
Equilibrium constant of PK Keq_pk 13790 mM [58] 
Michaelis constant for PK KmATP_pk 3.39 mM [58] 
Michaelis constant for PK KmF16BP_pk 0.005 mM [58] 
Michaelis constant for PK KmMgADP_pk 0.474 mM [58] 
Michaelis constant for PK KmPEP_pk 0.225 mM [58] 
Lo for PK Lo_pk 19 - [58] 
Maximal rate of PK Vmax_pk 1.617 mMs-1 Fitted 
Equilibrium constant of LDH (Lactate 
dehydrogenase-NADH) 
Keq_ldh 9090 mM [58] 
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Description Symbol Value Units Ref 
Maximal rate of LDH (NADH) Vmax_ldh 104.99 mM s-1 [58] 
Equilibrium constant of LDH (Lactate 
dehydrogenase-NADPH) 
Keq_ldh 32 mM [58] 
Maximal rate of LDH (NADPH) k_ldh 2 mM s-1 [58] 
Maximal rate of ATPase k_ATPase 0.015 mM s-1 Fitted 
Equilibrium constant of AK Keq_ak 0.25 mM [58] 
Michaelis constant for AK KmADP_ak 0.11 mM [58] 
Michaelis constant for AK KmAMP_ak 0.08 mM [58] 
Michaelis constant for AK KmATP_ak 0.09 mM [58] 
Maximal rate of AK Vmax_ak 46 mM s-1 Fitted 
Equilibrium constant of GPDH Keq_gpdh 2000 mM [58] 
Michaelis constant for GPDH KmATP_gpdh 0.749 mM [58] 
Michaelis constant for GPDH KmBPG23_gpdh 2.289 mM [58] 
Michaelis constant for GPDH KmG6P_gpdh 0.0667 mM [58] 
Michaelis constant for GPDH KmNADPH_gpdh 0.00312 mM [58] 
Michaelis constant for GPDH KmNADP_gpdh 0.00367 mM [58] 
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Description Symbol Value Units Ref 
Maximal rate of GPDH Vmax_gpdh 0.108 mM s-1 Fitted 
Equilibrium constant of PGLDH Keq_pgldh 141.7 mM [58] 
Michaelis constant for PGLDH KmATP_pgldh 0.154 mM [58] 
Michaelis constant for PGLDH KmBPG23_pgldh 0.12 mM [58] 
Michaelis constant for PGLDH KmNADPH_pgldh 0.0045 mM [58] 
Michaelis constant for PGLDH KmNADP_pgldh 0.018 mM [58] 
Maximal rate of PGLDH Vmax_pgldh 1.05 mM s-1 Fitted 
Michaelis constant for PGLDH KmPGL1_pgldh 0.01 mM [58] 
Michaelis constant for PGLDH KmPGL2_pgldh 0.058 mM [58] 
Equilibrium constant of Glutathione reduction Keq_gr  1.04 mM [58] 
Michaelis constant for Glutathione reduction (GR) KmGSH_gr  20 mM [58] 
Michaelis constant for GR KmGSSG_gr  0.0652 mM [58] 
Michaelis constant for GR KmNADPH_gr  0.00852 mM [58] 
Michaelis constant for GR KmNADP_gr  0.07 mM [58] 
Maximal rate of GR Vmax_gr  3 mM s-1 [58] 
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Description Symbol Value Units Ref 
Rate constant for Glutathione oxidation (GO) K_go 0.01 mM [58] 
Equilibrium constant of GO Keq_pre 2.7 mM [58] 
Michaelis constant for PRE KmRu5P_pre 0.19 mM [58] 
Michaelis constant for PRE KmX5P_pre 0.5 mM [58] 
Maximal rate of PRE Vmax_pre 3.0894 mM s-1 Fitted 
Equilibrium constant of RPI Keq_rpi 3 mM [58] 
Michaelis constant for RPI KmRi5P_rpi 2.2 mM [58] 
Michaelis constant for RPI KmRu5P_rpi 0.78 mM [58] 
Maximal rate of RPI Vmax_rpi 0.4866 mM Fitted 
Constant for Tranketolase (Ri5P) K1_tk  0.4177 mM [58] 
Constant for Tranketolase (Ri5P) K2_tk 0.3055 mM [58] 
Constant for Tranketolase (Ri5P) K3_tk 12.432 mM [58] 
Constant for Tranketolase (Ri5P) K4_tk 0.00496 mM [58] 
Constant for Tranketolase (Ri5P) K5_tk 0.41139 mM [58] 
Constant for Tranketolase (Ri5P) K6_tk 0.00774 mM [58] 
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Description Symbol Value Units Ref 
Constant for Tranketolase (Ri5P) K7_tk 48.8 mM [58] 
Equilibrium constant of Tranketolase (Ri5P) Keq_tk 1.05 mM [58] 
Maximal rate of Tranketolase (Ri5P) Vmax_tk 0.0157 mM Fitted 
Constant for Transaldolase (TA) (Ri5P) K1_ta 0.00823 mM [58] 
Constant for TA (Ri5P) K2_ta 0.04765 mM [58] 
Constant for TA (Ri5P) K3_ta 0.1733 mM [58] 
Constant for TA (Ri5P) K4_ta 0.006095 mM [58] 
Constant for TA (Ri5P) K5_ta 0.8683 mM [58] 
Constant for TA (Ri5P) K6_ta 0.4653 mM [58] 
Constant for TA (Ri5P) K7_ta 2.524 mM [58] 
Equilibrium constant of TA (Ri5P) Keq_ta 1.05 mM [58] 
Maximal rate of Transaldolase (Ri5P) Vmax_ta 0.01813 mM s-1 Fitted 
Equilibrium constant of PRPPS Keq_prpps 1e+05 mM [58] 
Michaelis constant for PRPPS KmATP_prpps 0.03 mM [58] 
Michaelis constant for PRPPS KmRi5P_prpps 0.57 mM [58] 
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Description Symbol Value Units Ref 
Maximal rate of PRPPS Vmax_prpps 0.001 mM s-1 Fitted 
Constant for Transketolase (E4P) K1_tk 0.00184 mM [58] 
Constant for Transketolase (E4P) K2_tk 0.3055 mM [58] 
Constant for Transketolase (E4P) K3_tk 0.0548 mM [58] 
Constant for Transketolase (E4P) K4_tk 0.0003 mM [58] 
Constant for Transketolase (E4P) K5_tk 0.0287 mM [58] 
Constant for Transketolase (E4P) K6_tk 0.122 mM [58] 
Constant for Transketolase (E4P) K7_tk 0.215 mM [58] 
Equilibrium constant of Transketolase (E4P) Keq_tk 1.2 mM [58] 
Maximal rate of Transketolase (E4P) Vmax_tk 0.0157 mM s-1 Fitted 
Equilibrium constant of LT Keq_lt  0.5 mM [58] 
Maximal rate for LT Vmax_lt 0.0015 mM s-1 Fitted 
Equilibrium constant of phosphate transport 
(Plasma membrane) 
Keq_pt 1 mM [58] 
Maximal rate of phosphate transport (Plasma 
membrane) 
Vmax_pt 3.3333 mMs-1 Fitted 
Equilibrium constant of pyruvate transport (Plasma 
membrane) 
Keq_pt 1 mM Fitted 
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Description Symbol Value Units Ref 
Maximal rate of pyruvate transport (Plasma 
membrane) 
Vmax_pt 0.0003 mM Fitted 
Equilibrium constant of MgATP EqMgATP 3.3333 ∗ 105 s-1 [58] 
Dissociation constant for MgATP KdMgATP 0.072 mM [58] 
Equilibrium constant of MgADP EqMgADP 3.3333 ∗ 105 s-1 [58] 
Dissociation constant for MgADP KdMgADP 0.76 mM [58] 
Equilibrium constant of MgAMP EqMgAMP 3.3333 ∗ 105 s-1 [58] 
Dissociation constant for MgAMP KdMgAMP 16.64 mM [58] 
Equilibrium constant of MgBPG23 EqMgBPG23 3.3333 ∗ 105 s-1 [58] 
Dissociation constant for MgBPG23 KdMgBPG23 1.667 mM [58] 
Equilibrium constant of pyruvate transport (Mito 
membrane) 
Keq_pt 2 - Fitted 
Maximal rate of pyruvate transport (Mito 
membrane)]. 
Vmax_pt 0.04 s-1 Fitted 
Rate constant of PDH k_pdh 1.2 - [75] 
Concentration of CS Et_cs 0.0258 mM Fitted 
Catalytic constant of CS Kcat_cs 3.2 s-1 [59] 
Michaelis constant for AcCoA KmAcCoA_cs 0.0126 mM [59] 
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Michaelis constant for OAA KmOAA_cs 0.00063 mM [59] 
Equilibrium constant of ACO Keq_aco 2.22 - [59] 
Forward rate constant of ACO Kf_aco 12.5 s-1 [59] 
Concentration of IDH Et_idh 0.007 mM Fitted 
Activation constant by ADP KaADP_idh 0.062 mM [59] 
Activation constant for Ca+2 KaCa_idh 0.00141 mM [59] 
Rate constant of IDH Kcat_idh 16.3 s-1 [59] 
Inhibition constant by NADH KiNADH_idh 0.19 mM [59] 
Michaelis constant for isocitrate KmIsoCit_idh 1.52 mM [59] 
Michaelis constant for NAD  KmNAD_idh 0.923 mM [59] 
Ionization constant of IDH kH1_idh 8.1e-05 mM [59] 
Ionization constant of IDH kH2_idh 5.98e-05 mM [59] 
Hill coefficient of IDH n_idh 2 - [59] 
Concentration of α-KGDH Et_akgdh 0.0323 mM Fitted 
Activation constant for Ca+2 KaCa_akgdh 0.00127 mM [59] 
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Activation constant for Mg+2 KaMg_akgdh 0.0308 mM [59] 
Rate constant of KGDH Kcat_akgdh 5 s-1 [59] 
Michaelis constant for NAD KmNAD_akgdh 38.7 mM [59] 
Michaelis constant for αKG KmaKG_akgdh 1.94 mM [59] 
Hill coefficient of KGDH for αKG n_akgdh 1.2 - [59] 
Equilibrium constant of SL Keq_scl 3.115 - [59] 
Forward rate constant of SL Kf_scl 0.127 mM-1 s-1 [59] 
Concentration of SDH Et_sdh 0.0323 mM Fitted 
Rate constant of SDH Kcat_sdh 1 s-1 [59] 
Inhibition constant by fumarate KiFum_sdh 1.3 mM [59] 
Inhibition constant by oxalacetate KiOAA_sdh 0.15 mM [59] 
Michaelis constant for succinate KmSuc_sdh 0.03 mM [59] 
Equilibrium constant of FH Keq_fh 1 - [59] 
Forward rate constant for FH Kf_fh 1.83 s-1 [59] 
Total MDH enzyme concentration Et_mdh 0.001 mM Fitted 
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Description Symbol Value Units Ref 
Rate constant of MDH Kcat_mdh 27.75 s-1 [59] 
Inhibition constant by oxalacetate KiOAA_mdh 0.0015 mM [59] 
Michaelis constant for malate KmMal_mdh 1.493 mM [59] 
Michaelis constant for NAD+ KmNAD_mdh 0.2244 mM [59] 
Ionization constant of MDH kH1_mdh 1.131e-05 mM [59] 
Ionization constant of MDH kH2_mdh 26.7 mM [59] 
Ionization constant of MDH kH3_mdh 6.68e-09 mM [59] 
Ionization constant of MDH kH4_mdh 5.62e-06 mM [59] 
pH-independent term in the pH activation factor of 
MDH 
koffset 0.0399 - [59] 
Equilibrium constant of phosphate transport (Mito 
membrane) 
Keq_pt 20 - Fitted 
Maximal rate of phosphate transport (Mito 
membrane) 
Vmax_pt 5.002 s-1 Fitted 
Michaelis constant for PLC  KmPIP2_plc 0.00045 mM [74] 
Maximum flux across PMCA Vmax_plc 0.001 mM s-1 [74] 
Maximal rate of IP3 production kPump 20 s-1 [74] 
Dissociation constant of IP3 sites on IP3R KmIP3_channel 0.001 mM [74] 
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Description Symbol Value Units Ref 
Ca2+ leak from ER to cytoplasm L_channel 0.00093 s-1 [74] 
Maximal total permeability of IP3 channels P_channel 66.6 s-1 [74] 
Dissociation constant of Ca2+-activation sites on 
IP3R 
KmCa_channel 0.0004 mM [74] 
Half maximal inhibitory concentration for 2DG 2DG IC50  23.34 mM Fitted 
Half maximal inhibitory concentration for cyanide CYN IC50 0.005 mM Fitted 
Half maximal inhibitory concentration for malonate MAL IC50 24.17 mM Fitted 
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APPENDIX D: METABOLIC MODEL INITIAL VALUES 
  
 230 
 
Description Symbol Value (mM) 
Mitochondrial pyruvate  Pyrm 0.0032449 
Mitochondrial NAD  NADm  10 
Acetyl-CoA  AcCoA  0.00013565 
Mitochondrial NADH  NADHm  5.4748e-07 
Oxaloacetate  OAA 0.0046568 
Citrate  Cit 0.025474 
Isocitrate  IsoCit 0.054419 
α-Ketoglutarate  aKG 0.00060511 
Mitochondrial ADP  ADPm 0.27199 
Mitochondrial calcium  Cam 0.00013734 
Succinyl CoA  SucCoA  0.3477 
Mitochondrial phosphate  Pim 19.99 
Succinate  Suc 0.00078309 
Mitochondrial ATP  ATPm 2.228 
Fumarate  Fum 0.037381 
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Description Symbol Value (mM) 
Malate  Mal 0.030819 
Mitochondrial FAD  FAD 5.25 
Mitochondrial FADH2  FADH2 3.2402e-05 
Endoplasmic reticulum calcium  Caer 0.044987 
Mitochondrial membrane potential  dPsi  0.12203 
Cytosolic Glucose  Glc  5.8843 
Magnesium bound ATP  MgATP  0.20011 
Glucose-6-phosphate  G6P 0.0014076 
Magnesium bound ADP  MgADP  0.070602 
2,3-bisphosphoglycerate  BPG23  0.31498 
Magnesium  Mg  1.0641 
Magnesium bound 2,3-bisphosphoglycerate  MgBPG23  0.20106 
Fructose 6-phosphate  F6P  0.00050133 
AMP  AMP  0.071164 
ATP  ATP  0.013541 
 232 
 
Description Symbol Value (mM) 
Fructose 1,6-biphosphate  F16BP  0.06041 
Magnesium bound AMP  MgAMP  0.0045507 
Glyceraldehyde-3-phosphate  GAP  0.016302 
Dihydroxyacetone phosphate  DHAP  0.40075 
Cytosolic phosphate  Pi  0.9999 
Cytosolic NAD  NAD  0.062889 
1,3-bisphosphoglycerate  BPG13  7.4997e-05 
Cytosolic NADH  NADH  0.0026113 
3-Phosphoglycerate  PG3  0.036012 
2-Phosphoglycerate  PG2  0.0045566 
Phosphoenolpyruvate  PEP  0.0056698 
Cytosolic pyruvate  Pyr  0.02099 
Cytosolic lactate  Lac  1.4259 
Cytosolic NADPH  NADPH  3.0797e-07 
Cytosolic NADP  NADP 0.004 
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Description Symbol Value (mM) 
ADP  ADP  0.050427 
6-phosphoglucono-δ-lactone  PGL  0.00032077 
Ribuloase-5-phosphate  Ru5P  0.02701 
Glutathione disulphide  GSSG  1.4447 
Glutathione  GSH  0.225 
Xyulose-5-phosphate  X5P  0.072808 
Ribose-5-phosphate  Ri5P  0.079043 
Sedoheptulose 7-phosphate  S7P  0.00085122 
Erythrose 4-phosphate  E4P  0.00045071 
Phosphoribosyl pyrophosphate  PRPP  3.4337e-05 
Cytosolic calcium  Ca  0.00012546 
Phosphatidylinositol 4,5-bisphosphate  PIP2  2000 
Inositol triphosphate  IP3  3.7369e-12 
Diacyl-glycerol  DAG  3.7369e-12 
Extracellular glucose  Glce  25 
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Description Symbol Value (mM) 
Extracellular lactate  Lace  3.3388e-05 
Extracellular phosphate  Pie  1 
Extracellular pyruvate  Pyre  1.1601e-07 
Extracellular potassium  Ke  5.4 
Extracellular calcium  Cae  1.8 
Extracellular magnesium  Mge  0.8 
Extracellular sodium  Nae  130.2 
CoA  CoA  0.02 
Mitochondrial proton  Hm 2.5e-05 
Mitochondrial magnesium   Mgm 0.4 
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